Scientific Opinion on the safety of caffeine
Open accessAbstract
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies was asked to deliver a scientific opinion on the safety of caffeine, providing advice on caffeine intakes, from all dietary sources that do not give rise to concerns about adverse health effects for the general healthy population and subgroups thereof. Possible interactions between caffeine and other constituents of so-called “energy drinks”, alcohol, p-synephrine and physical exercise should also be addressed. Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) do not give rise to safety concerns. The same amount does not give rise to safety concerns when consumed < 2 hours prior to intense physical exercise under normal environmental conditions. Other constituents of “energy drinks” at typical concentrations in such beverages (about 300–320, 4 000 and 2 400 mg/L of caffeine, taurine and d-glucurono-γ-lactone, respectively), as well as alcohol at doses up to about 0.65 g/kg bw, would not affect the safety of single doses of caffeine up to 200 mg. Habitual caffeine consumption up to 400 mg per day does not give rise to safety concerns for non-pregnant adults. Habitual caffeine consumption up to 200 mg per day by pregnant women does not give rise to safety concerns for the fetus. Single doses of caffeine and habitual caffeine intakes up to 200 mg consumed by lactating women do not give rise to safety concerns for breastfed infants. For children and adolescents, the information available is insufficient to derive a safe caffeine intake. The Panel considers that caffeine intakes of no concern derived for acute caffeine consumption by adults (3 mg/kg bw per day) may serve as a basis to derive single doses of caffeine and daily caffeine intakes of no concern for these population subgroups.
Verified 2026-10-10 · 1 reference not checked yet
AI snapshot
Written from a shortened version of the paper’s full text (it is longer than we read).
TL;DR
The EFSA NDA Panel concluded that single caffeine doses up to 200 mg (about 3 mg/kg bw for a 70-kg adult) and habitual intake up to 400 mg/day do not raise safety concerns for healthy non-pregnant adults, with lower levels for pregnant and lactating women. For children and adolescents, data were insufficient to derive a safe intake, but the Panel proposed 3 mg/kg bw/day for single and habitual consumption.
Key findings
- For healthy adults, single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) from all sources do not give rise to safety concerns, including when consumed less than two hours before intense physical exercise under normal environmental conditions; 100 mg may increase sleep latency and reduce sleep duration in some adults, especially close to bedtime. Habitual caffeine intake up to 400 mg/day (about 5.7 mg/kg bw/day for a 70-kg adult) does not give rise to safety concerns for healthy adults, except pregnant women.
- For pregnant women, habitual caffeine intake up to 200 mg/day does not give rise to safety concerns for the fetus; for lactating women, single doses up to 200 mg and habitual intake of 200 mg/day do not give rise to safety concerns for the breastfed infant, with infant intakes estimated not to exceed 0.3 mg/kg bw/day, 10-fold below the lowest tested dose of 3 mg/kg bw.
- For children and adolescents, available information was insufficient to derive a safe caffeine intake; the Panel considered that the adult single-dose level of 3 mg/kg bw/day may also apply to children, and proposed 3 mg/kg bw/day for habitual consumption. The 95th percentile of single-day caffeine intake exceeded 3 mg/kg bw in 6/16 countries for adolescents, 9/16 for children, and 3/10 for toddlers, with proportions of survey days ranging from about 7–12%, 6–15%, and 7–37%, respectively.
- Other common “energy drink” constituents at typical concentrations (about 300–320, 4,000, and 2,400 mg/L of caffeine, taurine, and D-glucurono-γ-lactone, respectively) and alcohol up to about 0.65 g/kg bw (blood alcohol concentration about 0.08%) would not affect the safety of single caffeine doses up to 200 mg; whether p-synephrine modifies acute cardiovascular effects of caffeine was not adequately investigated, so no conclusions could be drawn.
Methods
- The EFSA NDA Panel conducted a scientific opinion based on previous risk assessments and human intervention and observational studies, preferring human intervention and prospective cohort studies over case-control and cross-sectional studies; case reports of adverse events were not used to derive levels of no concern.
- Dietary caffeine intake was estimated using the EFSA Comprehensive European Food Consumption Database, containing 39 surveys in 22 European countries for 66,531 participants, plus the EFSA report on “energy drinks” involving more than 52,000 participants from 16 Member States for single-session intakes.
- The assessment covered cardiovascular outcomes, hydration and body temperature, central nervous system outcomes (sleep, anxiety, perceived exertion, subjective alcohol intoxication), and pregnancy outcomes, using systematic reviews and meta-analyses where available.
Limitations
- The paper states that data are particularly scarce for pregnant and lactating women, absent for caffeine-containing supplements, and that surveys differ in methodology so direct country-to-country comparisons should be cautious; no studies were available in pregnant women or middle-aged/elderly subjects undertaking intense physical exercise.
- The paper states that p-synephrine interactions with caffeine have not been adequately investigated, that information for children and adolescents is insufficient to derive a safe intake, and that prospective cohort studies cannot prove causality for pregnancy outcomes, although the Panel assumed causality for the safety assessment.
- Evident from the text: the “single session” time frame in the energy drink report is imprecise, energy drink consumers may not represent the general population, food-frequency questionnaires may overestimate consumption of specific foods, and observational studies are subject to confounding, reverse causality, and recall bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 175 cited sources checked · 0 supported · 0 flagged
- Findingnone given
There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.
“There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.”
- Also stated in: § 5.2. Pregnant women 5.2.1. Single doses of caffeine · plain
“There are no studies on the health effects of single doses of caffeine consumed by pregnant women prior to intense physical exercise.”
Quote in the paperNot a substantial claim - Also stated in: § 5.2. Pregnant women 5.2.1. Single doses of caffeine · plain
- Findingnone given
Data to characterise the risk of habitual caffeine consumption in pregnant women are scarce.
“Data to characterise the risk of habitual caffeine consumption in this population subgroup are scarce.”
Quote in the paperNot a substantial claim - Findingreasoning
At doses of up to 200 mg consumed by lactating women, daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study and at which no adverse effects were observed in the majority of infants.
“At these doses of caffeine, daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study and at which no adverse effects were observed in the majority of infants.”
Quote in the paperSubstantial claim - Findingnone given
In 7 out of 13 countries, the 95th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.
“In 7 out of 13 countries, the 95 th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.”
Quote in the paperNot a substantial claim - Findingnone given
Single doses of 100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.
“Single doses of 100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.”
Quote in the paperSubstantial claim
- Findingreasoning
Like for adults, caffeine doses of about 1.4 mg/kg bw may increase sleep latency and reduce sleep duration in some children and adolescents, particularly when consumed close to bedtime.
“Like for adults, caffeine doses of about 1.4 mg/kg bw may increase sleep latency and reduce sleep duration in some children and adolescents, particularly when consumed close to bedtime.”
- Also stated in: § 5.4.1. Single doses of caffeine · hedged
“The Panel notes that, like for adults, caffeine doses of about 1.4 mg/kg bw may increase sleep latency and reduce sleep duration in some children and adolescents, particularly when consumed close to bedtime.”
Quote in the paperSubstantial claim - Also stated in: § 5.4.1. Single doses of caffeine · hedged
- Findingnone given
There are no data available to characterise the risk of single doses of caffeine from all sources consumed by children and adolescents.
“There are no data available to characterise the risk of single doses of caffeine from all sources consumed by children and adolescents.”
Quote in the paperSubstantial claim - Findingreasoning
No new data have become available on these or other clinical outcomes which could justify modifying the conclusions on habitual caffeine consumption up to 400 mg per day.
“and no new data have become available on these or other clinical outcomes which could justify modifying these conclusions.”
Quote in the paperSubstantial claim - Findingnone given
In these studies, the contribution of energy drinks to total caffeine intake was low (about 2%).
“In these studies, the contribution of”
Quote in the paperNot a substantial claim - Findingown data
In Ireland and the UK, tea was the main source of caffeine, contributing 59% and 57%, respectively, to total caffeine consumption.
“In Ireland and the UK, tea was the main source of caffeine, which contributed 59 and 57 %, respectively, to total caffeine consumption (Appendix E).”
Quote in the paperNot a substantial claim - Findingnone given
Data on pregnant women are available for Latvia only (n = 1002).
“Data on pregnant women are available for Latvia only (n = 1 002).”
Quote in the paperNot a substantial claim - Findingown data
For toddlers, 95th percentile caffeine intake ranged from 0.1 to 3.5 mg/kg bw per day.
“The 95 th percentile ranged from 0.1 to 3.5 mg/kg bw per day.”
Quote in the paperNot a substantial claim - Findingown data
Daily caffeine intake from all sources could be estimated for adults from 16 Member States.
“Daily caffeine intake from all sources could be estimated for adults from 16 Member States.”
Quote in the paperSubstantial claim - Findingown data
Mean daily caffeine intake for toddlers in Belgium was 1.1 mg/kg bw per day.
“Mean daily caffeine intake was 1.1 mg/kg bw per day in this country (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
For children aged 3 to <10 years, mean daily caffeine intake from all sources ranged from 0.2 to 2.0 mg/kg bw per day.
“Mean daily intake of caffeine from all sources ranged from 0.2 to 2.0 mg/kg bw per day.”
Quote in the paperNot a substantial claim - Findingnone given
The main sources of caffeine in the diet include coffee, tea, caffeinated soft drinks (including 'energy drinks') and chocolate.
“The main sources of caffeine in the diet include coffee, tea, caffeinated soft drinks (including “energy drinks”) and chocolate.”
Quote in the paperNot a substantial claim - Findingown data
For children aged 3 to <10 years, 17 surveys were available.
“For children aged 3 to < 10 years, 17 surveys were available.”
Quote in the paperNot a substantial claim - Findingnone given
Data on lactating women are available from only a small survey in Greece (n = 65).
“Data on lactating women are available from only a small survey in Greece (n = 65).”
Quote in the paperNot a substantial claim - Findingown data
For toddlers, the highest 95th percentile of caffeine intake per kg bw on a single day when considering all days recorded was 7.1 mg/kg bw.
“For toddlers, the highest 95 th percentile of caffeine intake per kg bw on a single day when considering all days recorded was 7.1 mg/kg bw (Appendices C and D).”
Quote in the paperNot a substantial claim - Findingown data
When considering only coffee consumption days, the highest 95th percentile of caffeine intake from coffee on a single day for adolescents was 445 mg.
“When considering only coffee consumption days, the highest 95 th percentile of caffeine intake from coffee on a single day was 445 mg (Appendix C).”
Quote in the paperNot a substantial claim - Findingown data
For children aged 3 to <10 years, 95th percentile caffeine intake ranged from 1.2 to 4.6 mg/kg bw per day.
“The 95 th percentile ranged from 1.2 to 4.6 m/kg bw per day.”
Quote in the paperNot a substantial claim - Findingown data
For adults, the highest 95th percentile of caffeine intake on a single day was 809 mg (10.8 mg/kg bw).
“For adults, the highest 95 th percentile of caffeine intake on a single day was 809 mg (10.8 mg/kg bw) (Appendices C and D).”
Quote in the paperNot a substantial claim - Findingnone given
Cola beverages and energy drinks were negligible as sources of caffeine in the elderly and very elderly in all surveys.
“Cola beverages and energy drinks were negligible as sources of caffeine in these population groups in all surveys.”
Quote in the paperNot a substantial claim - Findingown data
For toddlers, mean daily caffeine intake ranged from 0 to 2.1 mg/kg bw per day.
“Mean daily intakes of caffeine ranged from 0 to 2.1 mg/kg bw per day (Table 2, Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
Daily caffeine intakes from all sources could be estimated for adolescents from 13 Member States.
“Daily caffeine intakes from all sources could be estimated for adolescents from 13 Member States.”
Quote in the paperSubstantial claim - Findingcitation
Variability in caffeine levels for different foods and beverages, in particular for coffee drinks, espresso coffee and tea, has been noticed within the same product and for the same country.
“Variability in caffeine levels for different foods and beverages, in particular for coffee drinks, espresso coffee and tea, have been noticed within the same product and for the same country.”
Quote in the paperSubstantial claim - Findingown data
There were large differences among countries regarding the contribution of different food sources to total caffeine intake in adolescents.
“There were large differences among countries regarding the contribution of different food sources to total caffeine intake (Appendix E).”
Quote in the paperNot a substantial claim - Findingown data
For children aged 3 to 10 years, the highest 95th percentile of caffeine intake from all sources on a single day was estimated to be 5.7 mg/kg bw.
“For children aged 3 to 10 years, the highest 95 th percentile of caffeine intake from all sources on a single day was estimated to be 5.7 mg/kg bw (Appendices C and E).”
Quote in the paperNot a substantial claim - Findingcitation
Data on caffeine intakes from energy drinks in a single session were available from 16 Member States.
“Data were available from 16 Member States (Zucconi et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
- Findingown data
Even using a conservative approach, the contribution of 'energy drinks' to total caffeine intakes was very low in all surveys published before 2000.
“Even using this conservative approach, the contribution of “energy drinks” to total caffeine intakes was very low in all surveys published before 2000.”
Quote in the paperNot a substantial claim - Findingreasoning
On a per kg bw basis, these intakes for adolescent energy drink consumers were estimated to be 2.9 and 7.2 mg.
“On a per kg bw basis, these intakes were estimated to be 2.9 and 7.2 mg, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
- Findingown data
On a per kg bw per day basis, mean caffeine intakes for adolescents ranged from 0.4 to 1.4 mg/kg bw per day.
“On a per kg bw per day basis, the mean intakes ranged from 0.4 to 1.4 mg/kg bw per day.”
Quote in the paperNot a substantial claim - Findingown data
In most surveys, coffee was the predominant source of caffeine for the adult population, contributing between 40 and 94% to total caffeine intake.
“In most surveys, coffee was the predominant source of caffeine for the adult population and contributed between 40 and 94 % to total caffeine intake.”
Quote in the paperNot a substantial claim - Findingnone given
The scientific publications identified almost exclusively reported no relationship or an inverse relationship between habitual caffeine intake and other adverse health effects.
“The scientific publications identified almost exclusively reported no relationship or an inverse relationship between habitual caffeine intake and other adverse health effects.”
Quote in the paperSubstantial claim - Findingown data
When considering only coffee consumption days, the highest 95th percentile of caffeine intake from coffee on a single day for adults was 890 mg.
“When considering only coffee consumption days, the highest 95 th percentile of caffeine intake from coffee on a single day was 890 mg.”
Quote in the paperNot a substantial claim - Findingown data
There were no major differences among surveys and publications from different countries regarding average caffeine levels in foods and beverages.
“The Panel notes that there were no major differences among surveys and publications from different countries regarding average caffeine levels in foods and beverages (Table 1).”
Quote in the paperSubstantial claim - Findingown data
The 95th percentile of caffeine intake for adolescents varied between 1.5 and 4.1 mg/kg bw per day.
“The 95 th percentile varied between 1.5 and 4.1 mg/kg bw per day (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
About 41% of adolescent energy drink consumers (about 28% of all respondents) declared that they usually consume energy drinks in relation to sport activities.
“About 41 % of adolescent”
Quote in the paperNot a substantial claim - Findingown data
About 52% of adult energy drink consumers (15% of all respondents) declared that they usually consume energy drinks before/in association with/after sports activities.
“About 52 % of adult”
Quote in the paperNot a substantial claim - Findingown data
No single prospective cohort study reported an increased risk of heart failure associated with habitual coffee consumption.
“The Panel also notes that no single prospective cohort study reported an increased risk of heart failure associated with habitual coffee consumption.”
Quote in the paperSubstantial claim - Findingnone given
No single prospective cohort study reported an increased risk of stroke associated with habitual coffee or tea consumption in the general adult population.
“The Panel also notes that no single prospective cohort study reported an increased risk of stroke associated with habitual coffee or tea consumption in the general adult population.”
Quote in the paperSubstantial claim - Findingown data
The estimated proportion of children with intakes exceeding 3 mg/kg bw per day of caffeine from foods and beverages in the countries where the 95th percentile exceeded 3 mg/kg bw ranged from 6% to about 13%.
“The estimated proportion of children with intakes exceeding 3 mg/kg bw per day of caffeine from foods and beverages in these countries ranged from 6 % to about 13 % (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
In the countries where the 95th percentile of caffeine intake exceeded 3 mg/kg bw per day for adolescents, the estimated proportion of the adolescent population exceeding caffeine intakes of 3 mg/kg bw per day from food and beverages ranged from 5 to 10%.
“In these countries, the estimated proportion of the adolescent population exceeding caffeine intakes of 3 mg/kg bw per day from food and beverages ranged from 5 to 10 % (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
For only one out of nine Member States did the 95th percentile of caffeine intake from all sources exceed 3 mg/kg bw per day for toddlers.
“For only one out of nine Member States did the 95 th percentile of caffeine intake from all sources exceed 3 mg/kg bw per day.”
Quote in the paperNot a substantial claim - Findingown data
The proportion of days in which daily intakes of caffeine from all sources exceed 3 mg/kg bw ranges from 7% to 37% for toddlers.
“The proportion of days in which daily intakes of caffeine from all sources exceeds 3 mg/kg bw ranges from 7 % to 37 % (Appendix D).”
Quote in the paperNot a substantial claim - Findingown data
Coffee was the main source of dietary caffeine in the seven countries for which the 95th percentile of daily caffeine intake exceeded 400 mg.
“The Panel notes that coffee was the main source of dietary caffeine in the seven countries for which the 95 th percentile of daily caffeine intake exceeded 400 mg, and that the use of a mean value for the caffeine content in coffee on a volume basis may not accurately reflect caffeine intakes in all countries.”
Quote in the paperNot a substantial claim - Findingown data
The proportion of days on which daily intakes of caffeine from food and beverages exceed 3 mg/kg bw in the countries where the 95th percentile exceeded 3 mg/kg bw ranges from about 7% to about 12% for adolescents.
“The proportion of days on which daily intakes of caffeine from food and beverages exceeds 3 mg/kg bw in these countries ranges from about 7% to about 12 % (Appendix D).”
Quote in the paperNot a substantial claim - Findingown data
About 6% of the toddlers had a daily consumption greater than 3 mg/kg bw in the country where the 95th percentile of caffeine intake from all sources exceeded 3 mg/kg bw per day.
“About 6 % of the toddlers had a daily consumption > 3 mg/kg bw in that country (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
In the countries where the 95th percentile of daily caffeine intake exceeded 400 mg, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6% to almost one-third (32.9%).
“In these countries, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6 % to almost one-third (32.9 %) (Appendix B).”
Quote in the paperNot a substantial claim - Findingown data
For 3 out of 10 Member States, the estimated 95th percentile of caffeine intake from all sources on a single day exceeded 3 mg/kg bw for toddlers.
“For 3 out of 10 Member States, the estimated 95 th percentile of caffeine intake from all sources on a single day exceeded 3 mg/kg bw.”
Quote in the paperNot a substantial claim - Findingown data
For 6 out of 16 Member States, the estimated 95th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw for adolescents.
“For 6 out of 16 Member States, the estimated 95 th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw.”
Quote in the paperSubstantial claim - Findingown data
For 7 out of 13 Member States, estimates of the 95th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.
“For 7 out of 13 Member States, estimates of the 95 th percentile of daily caffeine intake from foods and beverages exceeded 400 mg.”
Quote in the paperNot a substantial claim - Findingown data
For 9 out of 16 Member States, the estimated 95th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw for children.
“For 9 out of 16 Member States, the estimated 95 th percentile of caffeine intake from food and beverages on a single day exceeded 3 mg/kg bw.”
Quote in the paperNot a substantial claim - Findingnone given
There are no data available to characterise the risk of single doses of caffeine consumed by adults in relation to physical exercise.
“There are no data available to characterise the risk of single doses of caffeine consumed by adults in relation to physical exercise.”
Quote in the paperNot a substantial claim - Findingown data
For 5 out of 13 Member States, the 95th percentile of caffeine intake from food and beverages exceeded 3 mg/kg bw per day for adolescents.
“For 5 out of 13 Member States, the 95 th percentile of caffeine intake from food and beverages exceeded 3 mg/kg bw per day.”
Quote in the paperNot a substantial claim - Findingreasoning
As only single doses of caffeine of 200 mg have been tested in relation to MBF, a dose-response relationship cannot be derived on the basis of the data available.
“As only single doses of caffeine of 200 mg have been tested in relation to this outcome, a dose-response relationship cannot be derived on the basis of the data available.”
Quote in the paperSubstantial claim - Findingown data
The proportion of days on which daily intakes of caffeine from food and beverages exceed 3 mg/kg bw in the countries where the 95th percentile exceeded 3 mg/kg bw ranges from about 6% to about 15% for children.
“The proportion of days on which daily intakes of caffeine from food and beverages exceeds 3 mg/kg bw in these countries ranges from about 6 % to about 15 % (Appendix D).”
Quote in the paperSubstantial claim - Findingown data
No women in the small survey of lactating women (n = 65) consumed more than 400 mg of caffeine per day.
“No women in that small survey (n = 65) consumed more than 400 mg of caffeine per day.”
Quote in the paperNot a substantial claim - Findingown data
About 6.5% of the women in the only survey available for pregnant women (n = 1002) had daily caffeine intakes greater than 200 mg per day.
“About 6.5 % of the women in that survey (n = 1 002) had daily caffeine intakes > 200 mg per day.”
Quote in the paperNot a substantial claim - Findingnone given
No studies are available in pregnant women or middle-aged/elderly subjects undertaking intense physical exercise.
“The Panel also notes that no studies are available in pregnant women or middle-aged/elderly subjects undertaking intense physical exercise.”
Quote in the paperNot a substantial claim - Findingown data
Chocolate beverages were important contributors to total caffeine intakes in children and toddlers in most countries.
“The Panel notes that chocolate beverages were important contributors to total caffeine intakes in this age group in most countries, and that the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in children.”
Quote in the paperNot a substantial claim - Findingnone given
The information available for children and adolescents on the relationship between caffeine intakes and health outcomes is insufficient to derive a safe level of caffeine intake.
“The Panel notes that the information available for this population subgroup on the relationship between caffeine intakes and health outcomes is insufficient to derive a safe level of caffeine intake.”
Quote in the paperSubstantial claim - Findingnone given
There is an absence of data for repeated caffeine doses in relation to the majority of health outcomes discussed for single doses of caffeine.
“The Panel notes the absence of data for repeated caffeine doses in relation to the majority of health outcomes discussed for single doses of caffeine.”
Quote in the paperSubstantial claim - Premisenone given
No health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for habitual caffeine consumption up to 400 mg per day.
“No health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for this level of habitual caffeine consumption”
Quote in the paperSubstantial claim - Interpretationnone given
The same amount of caffeine (up to 200 mg) does not give rise to safety concerns when consumed less than two hours prior to intense physical exercise under normal environmental conditions.
“The same amount does not give rise to safety concerns when consumed < 2 hours prior to intense physical exercise under normal environmental conditions.”
- Also stated in: § Single doses of caffeine · plain
“The same amount of caffeine does not give rise to safety concerns when consumed less than two hours prior to intense physical exercise under normal environmental conditions.”
Quote in the paperSubstantial claim - Also stated in: § Single doses of caffeine · plain
- Interpretationreasoning
A level of no safety concern of 3 mg/kg bw per day (i.e. the level of no concern derived for single doses of caffeine for adults) is proposed for habitual caffeine consumption by children and adolescents.
“A level of no safety concern of 3 mg/kg bw per day (i.e. the level of no concern derived for single doses of caffeine for adults) is proposed for habitual caffeine consumption by children and adolescents.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
- Interpretationnone given
Other common constituents of energy drinks at typical concentrations (about 300-320, 4 000 and 2 400 mg/L of caffeine, taurine and D-glucurono-γ-lactone, respectively) would not affect the safety of single doses of caffeine up to 200 mg.
“Other common constituents of”
Quote in the paperSubstantial claim - Interpretationnone given
Alcohol consumption at doses up to about 0.65 g/kg bw, leading to a blood alcohol concentration of about 0.08%, would not affect the safety of single doses of caffeine up to 200 mg from any dietary source, including energy drinks.
“Alcohol consumption at doses up to about 0.65 g/kg bw, leading to a blood alcohol concentration of about 0.08 %, would not affect the safety of single doses of caffeine up to 200 mg from any dietary source, including”
Quote in the paperSubstantial claim - Interpretationnone given
For children and adolescents, the information available is insufficient to derive a safe caffeine intake.
“For children and adolescents, the information available is insufficient to derive a safe caffeine intake.”
- Also stated in: § Children and adolescents · plain
“The information available for this population subgroup on the relationship between caffeine intakes and health outcomes is insufficient to derive a safe level of caffeine intake.”
Quote in the paperSubstantial claim - Also stated in: § Children and adolescents · plain
- Study design and conductnone given
The human intervention studies on which the conclusions on single doses are based were primarily conducted with caffeine supplements for most of the outcomes assessed (changes in myocardial blood flow, hydration status, body temperature, perceived exertion/effort during exercise, sleep).
“The human intervention studies on which these conclusions are based were primarily conducted with caffeine supplements for most of the outcomes assessed (i.e.changes in myocardial blood flow, hydration status, body temperature, perceived exertion/effort during exercise, sleep).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Up to alcohol doses of about 0.65 g/kg bw, caffeine is unlikely to mask the subjective perception of alcohol intoxication.
“Up to these levels of intake, caffeine is unlikely to mask the subjective perception of alcohol intoxication.”
- Also stated in: § 5.1.2. Single doses of caffeine in combination with other common constituents of "energy drinks", alcohol and p-synephrine · hedged
“Up to these levels of intake, caffeine is unlikely to mask the subjective perception of alcohol intoxication.”
Quote in the paperSubstantial claim - Also stated in: § 5.1.2. Single doses of caffeine in combination with other common constituents of "energy drinks", alcohol and p-synephrine · hedged
- Interpretationreasoning
Habitual caffeine consumption up to 400 mg per day does not give rise to safety concerns for non-pregnant adults.
“Habitual caffeine consumption up to 400 mg per day does not give rise to safety concerns for non-pregnant adults.”
- Also stated in: § Habitual caffeine consumption · plain
“Caffeine intakes from all sources up to 400 mg per day (about 5.7 mg/kg bw per day for a 70-kg adult) consumed throughout the day do not give rise to safety concerns for healthy adults in the general population, except pregnant women (see below).”
Quote in the paperSubstantial claim - Also stated in: § Habitual caffeine consumption · plain
- Interpretationnone given
Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) from all sources do not give rise to safety concerns for the general healthy adult population.
“Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) do not give rise to safety concerns.”
- Also stated in: § Single doses of caffeine · plain
“Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) from all sources do not give rise to safety concerns for the general healthy adult population.”
Quote in the paperSubstantial claim - Also stated in: § Single doses of caffeine · plain
- Interpretationreasoning
Up to the levels of typical energy drink constituents, other common constituents are not expected to adversely interact with caffeine on its effects on the cardiovascular system, the central nervous system or hydration status.
“Up to these levels of intake, other common constituents of”
Quote in the paperSubstantial claim - Interpretationreasoning
Caffeine intakes of no concern derived for acute caffeine consumption by adults (3 mg/kg bw per day) may serve as a basis to derive single doses of caffeine and daily caffeine intakes of no concern for children and adolescents.
“The Panel considers that caffeine intakes of no concern derived for acute caffeine consumption by adults (3 mg/kg bw per day) may serve as a basis to derive single doses of caffeine and daily caffeine intakes of no concern for these population subgroups.”
- Also stated in: § Single doses of caffeine · hedged
“Single doses of caffeine of no concern derived for adults (3 mg/kg bw per day) may also apply to children, considering that caffeine clearance in children and adolescents is at least that of adults, and that the limited studies available on the acute effects of caffeine on anxiety and behaviour in children and adolescents support this level of no concern.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
- Also stated in: § Single doses of caffeine · hedged
- Interpretationcitation
Habitual caffeine consumption up to 200 mg per day by pregnant women does not give rise to safety concerns for the fetus.
“Habitual caffeine consumption up to 200 mg per day by pregnant women does not give rise to safety concerns for the fetus.”
- Also stated in: § Habitual caffeine consumption · plain
“Caffeine intakes from all sources up to 200 mg per day consumed throughout the day by pregnant women in the general population do not give rise to safety concerns for the fetus.”
Quote in the paperSubstantial claim - Also stated in: § Habitual caffeine consumption · plain
- Interpretationreasoning
Single doses of caffeine and habitual caffeine intakes up to 200 mg consumed by lactating women do not give rise to safety concerns for breastfed infants.
“Single doses of caffeine and habitual caffeine intakes up to 200 mg consumed by lactating women do not give rise to safety concerns for breastfed infants.”
- Also stated in: § Single doses of caffeine and habitual caffeine consumption · plain
“Single doses of caffeine up to 200 mg and habitual caffeine consumption at doses of 200 mg per day consumed by lactating women in the general population do not give rise to safety concerns for the breastfed infant.”
Quote in the paperSubstantial claim - Also stated in: § Single doses of caffeine and habitual caffeine consumption · plain
- Interpretationreasoning
Single doses of caffeine which are of no safety concern for non-pregnant adults do not apply to pregnant women performing physical exercise.
“With regard to the different kinetics of caffeine in this population subgroup, single doses of caffeine which are of no safety concern for non-pregnant adults do not apply to pregnant women performing physical exercise.”
Quote in the paperSubstantial claim - Study design and conductown data
Only two studies (the Netherlands and Ireland) with a sufficient number (≥ 60) of subjects who had consumed 'energy drinks' were available to estimate statistically robust 95th percentiles.
“(e): Only two studies (the Netherlands and Ireland) with a sufficient number (≥ 60) of subjects who had consumed “energy drinks”, were available to estimate statistically robust 95 th percentiles.”
Quote in the paperSubstantial claim - Study design and conductown data
These surveys do not provide information about the consumption of caffeine-containing food supplements.
“These surveys do not provide information about the consumption of caffeine-containing food supplements.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Only one study (the Netherlands) with a sufficient number (≥ 60) of subjects who had consumed 'energy drinks' was available to estimate a statistically robust 95th percentile.
“(d): Only one study (the Netherlands) with a sufficient number (≥ 60) of subjects who had consumed “energy drinks”, was available to estimate a statistically robust 95 th percentile.”
Quote in the paperSubstantial claim - Premisecitation
The highly variable caffeine concentrations in coffee beverages depend on the manufacturing process, on the type of coffee beans used and on the type of preparation (e.g. drip coffee, espresso).
“The highly variable caffeine concentrations in coffee beverages depend on the manufacturing process, on the type of coffee beans used and on the type of preparation (e.g.drip coffee, espresso) (Waizenegger et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Waizenegger et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
Differences between surveys regarding contribution of different caffeine sources to total caffeine intakes in adolescents could be explained, at least in part, by different mean age of adolescents studied and by dietary habits.
“Differences between surveys regarding the contribution of different caffeine sources to total caffeine intakes could be explained, at least in part, by the different mean age of the adolescents studied in the different surveys and by dietary habits.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
'Energy drink consumers' may not be representative of the general population with respect to caffeine intake from all sources.
“(i) “energy drink consumers” may not be representative of the general population with respect to caffeine intake from all sources;”
Quote in the paperSubstantial claim - Premisecitation
The volume of distribution of caffeine is 0.671 L/kg bw.
“The volume of distribution is 0.671 L/kg bw (Abernethy and Todd, 1985).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abernethy and Todd, 1985
Not checked in the free run.
- Premisecitation
In normotensive subjects, a single caffeine dose of 200-250 mg increases systolic blood pressure by 3-14 mmHg and diastolic blood pressure by 4-13 mmHg.
“A single dose of caffeine (200-250 mg, equivalent to two to three cups of coffee) was found to increase systolic blood pressure (SBP) by 3-14 mmHg and diastolic blood pressure (DBP) by 4-13 mmHg in normotensive subjects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nurminen et al. (1999) source
Not checked in the free run.
- Premisecitation
Lower CYP1A2 activity was found in women taking oral contraceptives.
“A lower CYP1A2 activity was found in women taking oral contraceptives.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rasmussen et al., 2002 source
Not checked in the free run.
- Premisecitation
In subjects with hypertension, single caffeine doses of 200 to 300 mg induce a mean increase in systolic blood pressure of 8.1 mmHg and diastolic blood pressure of 5.7 mmHg, observed in the first 60 minutes after intake and persisting up to 180 minutes afterwards.
“single caffeine doses of 200 to 300 mg induced a mean increase in SBP and DBP of 8.1 mmHg (95 % confidence interval (CI) = 5.7-10.6 mmHg) and 5.7 mmHg (95 % CI = 4.1-7.4mmHg), respectively, which was observed in the first 60 minutes after intake and persisted up to 180 minutes afterwards.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mesas et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
The Panel considers that, from the information available, no conclusions can be drawn on whether or not the simultaneous consumption of p-synephrine modulates the pressor effects of caffeine, and if so to what extent or at what doses this occurs.
“The Panel considers that, from the information available, no conclusions can be drawn on whether or not the simultaneous consumption of p-synephrine modulates the pressor effects of caffeine, and if so to what extent or at what doses this occurs.”
Quote in the paperSubstantial claim - Premisecitation
No significant changes in blood pressure were found with p-synephrine (12-13 mg) and lower doses of caffeine (150-176 mg).
“Conversely, no significant changes in BP were found with p-synephrine (12-13 mg) and lower doses of caffeine (150-176 mg).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stohs et al., 2012 source
Not checked in the free run.
- Premisenone given
The main route of caffeine metabolism in humans (70-80%) is via N-3 demethylation to paraxanthine catalysed by CYP1A2 in the liver.
“The main route of metabolism in humans (70-80 %) is via N-3 demethylation to paraxanthine (also known as 1,7-dimethylxanthine or 17X) catalysed by cytochrome (CYP) 1A2 in the liver.”
Quote in the paperNot a substantial claim - Premisecitation
Significant increases in systolic and diastolic blood pressure were reported for p-synephrine from C. aurantium extracts when consumed at doses of 54 mg, but not at lower doses (13.5-50 mg).
“Significant increases in SBP and DBP were reported for p-synephrine from C. aurantium extracts when consumed at doses of 54 mg, but not at lower doses (13.5-50 mg).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stohs et al., 2012 source
Not checked in the free run.
- Premisecitation
Acute increases in systolic blood pressure, diastolic blood pressure or both, as well as in pulse pressure and mean arterial blood pressure, have been reported after single caffeine doses ranging from 80 to 250 mg in coffee abstainers, in habitual caffeine consumers after 12-48 hours' withdrawal, and after caffeine habituation (300-600 mg per day for six days).
“Acute increases in SBP, DBP or both, as well as in pulse pressure and mean arterial blood pressure (MABP), have been reported after single doses of caffeine ranging from 80 to 250 mg in coffee abstainers, in habitual caffeine consumers after 12-48 hours' withdrawal and after caffeine habituation (300-600 mg per day for six days)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Hodgson et al., 1999 source
Not checked in the free run.
- cites Lane et al., 2002
Not checked in the free run.
- cites Farag et al., 2005a
Not checked in the free run.
- Premisecitation
The clinical relevance of acute changes in endothelial function and arterial compliance following an intervention is unclear, particularly when simultaneous changes in blood pressure occur.
“The clinical relevance of acute changes in endothelial function and arterial compliance following an intervention is unclear, particularly when simultaneous changes in BP occur (Anderson, 2006;McCall et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The kinetics of caffeine have been reported to be linear in doses up to 10 mg/kg bw.
“The kinetics of caffeine have been reported to be linear in doses up to 10 mg/kg bw (Bonati et al., 1982), whereas a later study claimed non-linearity beginning at doses as high as 500 mg, corresponding to about 7.1 mg/kg bw (Kaplan et al., 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bonati et al., 1982 source
Not checked in the free run.
- Interpretationreasoning
Acute changes in endothelial function and arterial compliance following caffeine consumption are vascular phenomena concordant with the acute increase in blood pressure, which can be predicted from arterial physiology.
“The acute changes in endothelial function and arterial compliance following caffeine consumption are vascular phenomena concordant with the acute increase in BP, which can be predicted from arterial physiology.”
Quote in the paperSubstantial claim - Interpretationreasoning
Caffeine consumption acutely increases blood pressure in virtually all adult population subgroups tested, regardless of baseline blood pressure, regular caffeine consumption or time of caffeine withdrawal, age, sex or hormonal status.
“The Panel notes that caffeine consumption acutely increases BP in virtually all adult population subgroups tested, regardless of baseline BP, regular caffeine consumption/time of caffeine withdrawal, age, sex or hormonal status.”
Quote in the paperSubstantial claim - Premisecitation
CYP1A2 polymorphism has been reported to be a source of variability in caffeine metabolism between individuals measured by caffeine metabolites in urine.
“CYP1A2 polymorphism has been reported to be a source of variability in the metabolism of caffeine between individuals measured by caffeine metabolites in urine (Rasmussen et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rasmussen et al., 2002 source
Not checked in the free run.
- Premisecitation
The Panel notes that none of the available studies has investigated the effects on blood pressure of single doses of caffeine alone, of p-synephrine alone, or of their combination.
“The Panel notes that none of the available studies has investigated the effects on BP of single doses of caffeine alone, of p-synephrine alone or of their combination.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stohs et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
The Panel considers the effect of caffeine-induced changes in blood pressure and myocardial blood flow to be of low clinical relevance for healthy individuals in the general population under normal environmental conditions.
“the Panel considers the effect to be of low clinical relevance for healthy individuals in the general population under normal environmental conditions.”
Quote in the paperSubstantial claim - Interpretationcitation
Studies suggest an increased risk of acute cardiovascular events in the hour following consumption of caffeinated coffee, particularly in subjects with low habitual coffee intake.
“The Panel notes that these studies suggest an increased risk of acute cardiovascular events in the hour following consumption of caffeinated coffee, particularly in subjects with low habitual coffee intake.”
Quote in the paperSubstantial claim - Premisecitation
In habitual coffee consumers consuming three to six cups of coffee per day, 4 mg/kg body weight per day of caffeine from coffee consumed for three consecutive days did not lead to significant changes in hydration measures compared with placebo.
“and 4 mg/kg bw per day of caffeine from coffee were consumed for three consecutive days by habitual coffee consumers (three to six cups of coffee per day) (Killer et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Killer et al., 2014 source
Not checked in the free run.
- Interpretationreasoning
Studies in subjects with an established cardiovascular event do not provide information about the risk of acute cardiovascular events following caffeine consumption in the general population.
“and do not provide information about the risk of acute cardiovascular events following caffeine consumption in the general population”
Quote in the paperSubstantial claim - Premisecitation
Baylin et al. 2006 found that the relative risk of myocardial infarction in the hour after drinking coffee was 1.49 (95% CI 1.17-1.89).
“The relative risk (RR) of MI in the hour after drinking coffee was 1.49 (95 % CI = 1.17-1.89).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baylin et al., 2006 source
Not checked in the free run.
- Interpretationnone given
A single dose of 200 mg of caffeine decreases myocardial blood flow if consumed approximately one hour prior to endurance exercise, when the blood-pressure-raising effect of caffeine reaches its peak.
“A single dose of 200 mg of caffeine also decreases MBF if consumed approximately one hour prior to endurance exercise (i.e. when the BP-raising effect of caffeine reaches its peak).”
Quote in the paperSubstantial claim - Premisecitation
In a study of cyclists, no significant differences among trials were found regarding measures of hydration status, relative dehydration, fluid retention, urine output or sweat rate.
“No significant differences among trials were found regarding measures of hydration status, relative dehydration, fluid retention, urine output or sweat rate.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Millard-Stafford et al., 2007
Not checked in the free run.
- Interpretationreasoning
Changes in blood pressure and myocardial blood flow induced by caffeine could increase the risk of acute cardiovascular events in subjects with an increased risk of cardiovascular disease, such as those with underlying hypertension and/or advanced atherosclerosis.
“Although such changes could increase the risk of acute cardiovascular 18314732, 2015, 5, Downloaded from https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4102,Wiley Online Library on [26/08/2026].See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions)on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License”
Quote in the paperSubstantial claim - Premisecitation
In a study of nonhabitual caffeine consumers, tympanic body temperature increased significantly pre-exercise only following caffeine consumption.
“whereas tympanic body temperature increased significantly pre-exercise only (by 0.12 C).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kim et al., 2011 source
Not checked in the free run.
- Study design and conductown data
Studies conducted in subjects with an established fatal or non-fatal cardiovascular event included few cases, which may limit the value of sensitivity and subgroup analyses conducted to explore modifying factors.
“The Panel also notes that these studies conducted in subjects with an established (fatal or non-fatal) cardiovascular event included few cases, which may limit the value of the sensitivity and subgroup analyses conducted to explore modifying factors (e.g.influence of other risk factors of the event, such as disease conditions or physical activity prior to the event)”
Quote in the paperSubstantial claim - Interpretationnone given
A single dose of 200 mg of caffeine consumed one to two hours pre-exercise significantly increases blood pressure during resistance training in habitual coffee consumers after 24-48 hours of caffeine withdrawal.
“as well as in habitual coffee consumers after 24-48 hours of caffeine withdrawal.”
Quote in the paperSubstantial claim - Interpretationreasoning
Studies in subjects with an established cardiovascular event do not provide information on the dose of caffeine which could trigger such events.
“or on the dose of caffeine which could trigger such events.”
Quote in the paperSubstantial claim - Interpretationcitation
Any diuretic effects resulting from chronic caffeine consumption are unlikely to have adverse health consequences for healthy individuals in the general population.
“However, any diuretic effects resulting from chronic caffeine consumption are unlikely to have adverse health consequences for healthy individuals in the general population.”
Quote in the paperSubstantial claim - Premisereasoning
The acute effects of lower caffeine doses and/or caffeine taken at longer time intervals on blood pressure have not been tested in the studies available.
“The acute effects of lower caffeine doses and/or taken at longer time intervals on BP have not been tested in the studies available.”
Quote in the paperSubstantial claim - Interpretationnone given
A single dose of 200 mg of caffeine consumed one to two hours pre-exercise significantly increases blood pressure during resistance training in caffeine-naive subjects.
“A single dose of 200 mg of caffeine consumed one to two hours pre-exercise significantly increases BP during resistance training in caffeine-naive subjects”
Quote in the paperSubstantial claim - Premisecitation
Doses of caffeine up to 6 mg/kg body weight per day consumed for four days by habitual caffeine consumers, after a one-week run-in with doses of 3 mg/kg body weight per day, did not lead to significant changes in body mass, urine osmolality, urine specific gravity, urine colour, 24-hour urine volume, 24-hour sodium and potassium excretion, 24-hour creatinine, blood urea nitrogen, serum sodium and钾
“In addition, doses of caffeine up to 6 mg/kg bw per day consumed for four days by habitual caffeine consumers (one week run-in with doses of 3 mg/kg bw per day) did not lead to significant changes in body mass, urine osmolality, urine specific gravity, urine colour, 24-hour urine volume, 24-hour Na + and K + excretion, 24-hour creatinine, blood urea nitrogen, serum Na + and K + , serum osmolality,”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Armstrong et al., 2005 source
Not checked in the free run.
- Premisecitation
In the Stroke Onset Study, the relative risk of stroke in the hour after consuming coffee was 2.0 (95% CI 1.4-2.8; p < 0.001).
“The RR of stroke in the hour after consuming coffee was 2.0 (95 % CI = 1.4-2.8;p < 0.001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mostofsky et al., 2010a, b
Not checked in the free run.
- Premisecitation
In a study of nonhabitual caffeine consumers, mean body temperature was significantly higher before and after exercise following caffeine consumption than following water consumption.
“Mean body temperature (calculated from tympanic and skin temperatures) was significantly higher in pre-(by 0.08 C) and post exercise (by 0.14 C) following caffeine consumption than following water consumption”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kim et al., 2011 source
Not checked in the free run.
- Premisecitation
In a study of endurance-trained cyclists, no significant differences in fluid losses, serum osmolality or core temperature were observed between the water and carbohydrate-electrolyte groups with caffeine and without caffeine.
“No significant differences in fluid losses, serum osmolality or core temperature were observed between the WAT and CES groups with caffeine and without caffeine.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Del Coso et al., 2008 source
Not checked in the free run.
- Premisecitation
In Selb Semerl and Selb 2004, alcohol drinking did not appear to influence the risk in coffee drinkers.
“Alcohol drinking did not appear to influence the risk in coffee drinkers.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Selb Semerl and Selb, 2004
Not checked in the free run.
- Premisecitation
In a study of endurance-trained cyclists, rehydration with water or carbohydrate-electrolyte solution, with or without caffeine, prevented the significant losses of body fluid, the increase in serum osmolality and the significant rise in core temperature observed with no fluid replacement, with or without caffeine.
“Rehydration with WAT or CES, with or without caffeine, prevented the significant losses of body fluid, the increase in serum osmolality and the significant rise in core temperature observed with no fluid replacement, with or without caffeine.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Del Coso et al., 2008 source
Not checked in the free run.
- Interpretationcitation
The Panel notes that the Millard-Stafford et al. study does not show a clinically significant effect of caffeine on core rectal temperature or hydration status at doses of 5.3 mg/kg body weight consumed during physical exercise and hot and humid conditions.
“The Panel notes that this study does not show a clinically significant effect of caffeine on core (rectal) temperature or hydration status at doses of 5.3 mg/kg bw consumed during physical exercise and hot and humid conditions.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Millard-Stafford et al., 2007
Not checked in the free run.
- Premisecitation
Caffeine has a diuretic effect.
“It is well established that caffeine has a diuretic effect (SCF, 1983;EFSA, 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites SCF, 1983
Not checked in the free run.
- cites EFSA, 2009
Not checked in the free run.
- Premisecitation
Higher doses of caffeine (≥400-500 mg) consumed either on a single occasion or within short periods of time have been reported to increase anxiety upon oral consumption, mostly in patients with psychiatric anxiety disorders, but also in healthy adults, particularly if they are non-habitual caffeine consumers.
“Higher doses (≥ 400-500 mg) consumed either on a single occasion or within short periods of time have been reported to increase anxiety upon oral consumption, mostly in patients with psychiatric anxiety disorders, but also in healthy adults, particularly if they are non-habitual caffeine consumers (FSANZ, 2000;Nawrot et al., 2003;Childs and de Wit, 2006;NNT, 2008;SHC, 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
The Panel notes that caffeine at doses of 3 mg/kg body weight, equivalent to 210 mg for a 70-kg adult, ingested about one hour prior to endurance exercise appears to induce only a modest increase in body temperature compared with placebo.
“The Panel notes that caffeine at doses of 3 mg/kg bw (equivalent to 210 mg for a 70-kg adult) ingested about one hour prior to endurance exercise appear to induce only a modest increase in body temperature compared with placebo.”
Quote in the paperSubstantial claim - Interpretationcitation
The Panel notes that the studies do not show an effect of single doses of caffeine ranging from 2.5 to 10 mg/kg body weight on most self-reported measures of anxiety in children.
“The Panel notes that these studies (Elkins et al., 1981;Rapoport et al., 1981b;Bernstein et al., 1994) do not show an effect of single doses of caffeine ranging from 2.5 to 10 mg/kg bw on most selfreported measures of anxiety in children.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In adults, single doses of caffeine of about 100 mg, about 1.4 mg/kg body weight per day in a 70-kg adult, have been shown to increase sleep latency and reduce sleep duration when consumed close to bedtime.
“In adults, single doses of caffeine of about 100 mg (1.4 mg/kg bw per day in a 70-kg adult) have been shown to increase sleep latency and reduce sleep duration when consumed close to bedtime (Landolt et al., 1995)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Landolt et al., 1995 source
Not checked in the free run.
- Interpretationnone given
The Panel notes that the results from prospective cohort studies on the association between habitual caffeine consumption and long-term changes in blood pressure are mixed.
“The Panel notes that the results from prospective cohort studies on the association between habitual caffeine consumption and long-term changes in BP are mixed.”
Quote in the paperNot a substantial claim - Interpretationcitation
The Panel notes that 100 mg of caffeine, about 1.4 mg/kg body weight for a 70-kg adult, may increase sleep latency and reduce sleep duration in some individuals, particularly when consumed close to bedtime.
“The Panel notes that 100 mg of caffeine (about 1.4 mg/kg bw for a 70-kg adult) may increase sleep latency and reduce sleep duration in some individuals, particularly when consumed close to bedtime.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Landolt et al., 1995 source
Not checked in the free run.
- Interpretationnone given
The Panel notes that regular consumption of caffeine up to about 3 mg/kg body weight per day does not appear to induce behavioural changes in children and adolescents.
“The Panel notes that regular consumption of caffeine up to about 3 mg/kg bw per day does not appear to induce behavioural changes in children and adolescents”
Quote in the paperSubstantial claim - Premisecitation
Doses of caffeine less than 100 mg do not appear to have an effect on sleep.
“whereas doses < 100 mg do not appear to have such an effect on sleep (Dorfman and Jarvik, 1970).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dorfman and Jarvik, 1970 source
Not checked in the free run.
- Interpretationnone given
Single doses of caffeine up to about 200 mg do not alter the subjective perception of alcohol intoxication when alcohol is consumed at doses of about 0.65 g/kg body weight.
“or alter the subjective perception of alcohol intoxication when alcohol is consumed at doses of about 0.65 g/kg bw.”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to about 200 mg, 3 mg/kg body weight for a 70-kg adult, do not appear to induce anxiety in unselected adult subjects from the general population.
“Single doses of caffeine up to about 200 mg (3 mg/kg/bw for a 70-kg adult) do not appear to induce anxiety in unselected adult subjects from the general population”
Quote in the paperSubstantial claim - Interpretationcitation
The Panel notes that the Steffen et al. (2012) meta-analysis does not show a significant increase in fasting BP following consumption of caffeinated coffee for >7 days at doses of about three to six cups per day.
“The Panel notes that this meta-analysis does not show a significant increase in fasting BP following consumption of caffeinated coffee for > 7 days at doses of about three to six cups per day.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Steffen et al., 2012 source
Not checked in the free run.
- Interpretationcitation
The Panel also notes that higher doses of caffeine (5-6 mg/kg body weight) ingested one hour before and during prolonged endurance exercise in a hot environment do not affect body temperature or hydration status significantly beyond what could be expected from the testing conditions.
“The Panel also notes that higher doses of caffeine (5-6 mg/kg bw) ingested one hour before and during prolonged endurance exercise in a hot environment do not affect body temperature or hydration status significantly beyond what could be expected from the testing conditions.”
Quote in the paperSubstantial claim - Premisecitation
In adults, tolerance to the anxiogenic effect of caffeine develops with frequent consumption, even in genetically susceptible individuals.
“In adults, tolerance to the anxiogenic effect of caffeine develops with frequent consumption, even in genetically susceptible individuals (Rogers et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rogers et al., 2010 source
Not checked in the free run.
- Interpretationreasoning
The Panel considers that the results of these studies cannot be used on their own to derive single doses of caffeine of no concern for children or adolescents.
“The Panel considers that the results of these studies cannot be used on their own to derive single doses of caffeine of no concern for children or adolescents.”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to about 200 mg do not reduce the perceived exertion or effort during exercise when consumed one hour prior to exercise after 12-24 hours of caffeine withdrawal.
“reduce the perceived exertion/effort during exercise when consumed one hour prior to exercise after 12-24 hours of caffeine withdrawal”
Quote in the paperSubstantial claim - Interpretationnone given
The Panel notes that single doses of caffeine which have been observed to reduce the rated perceived exertion or effort during exercise (≥4 mg/kg body weight) are equivalent to 280 mg of caffeine for a 70-kg adult.
“The Panel notes that single doses of caffeine which have been observed to reduce the rated perceived exertion/effort during exercise (≥ 4 mg/kg bw) are equivalent to 280 mg of caffeine for a 70-kg adult.”
Quote in the paperNot a substantial claim - Premisecitation
In Steffen et al. (2012), coffee drinking was not significantly associated with an increased risk of hypertension at any category of coffee intake compared with the reference category.
“Coffee drinking was not significantly associated with an increased risk of hypertension at any category of coffee intake compared with the reference category.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Steffen et al., 2012 source
Not checked in the free run.
- Premisecitation
Palatini et al. (2009) reported an increased risk of developing sustained hypertension requiring pharmacological treatment with increasing caffeinated coffee consumption in carriers of the slow CC or CA allele (59%) of the CYP1A2 gene, but not in carriers of the fast AA allele.
“A subsequent study by the same authors (Palatini et al., 2009) reported an increased risk of developing sustained hypertension requiring pharmacological treatment with increasing caffeinated coffee consumption in carriers of the slow CC or CA allele (59 %) of the CYP1A2 gene, but not in carriers of the fast AA allele”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Palatini et al., 2009 source
Not checked in the free run.
- Premisecitation
Bertoia et al. (2013) found no association between total caffeine, caffeinated coffee, decaffeinated coffee or caffeinated tea and risk of sudden cardiac death.
“No association between total caffeine, caffeinated (regular) coffee, decaffeinated coffee or caffeinated tea and the risk of SCD was found.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bertoia et al., 2013 source
Not checked in the free run.
- Interpretationcitation
The Panel notes that caffeine intakes at doses of about 400 mg/day did not raise fasting BP significantly after caffeine habituation in human intervention studies.
“The Panel notes that caffeine intakes at doses of about 400 mg per day did not raise fasting BP significantly after caffeine habituation in human intervention studies.”
Quote in the paperSubstantial claim - Premisecitation
In NHS I and II, no linear association between caffeine consumption and risk of incident hypertension was observed after multivariate adjustment.
“In both cohorts, no linear association between caffeine consumption and the risk of incident hypertension was observed after multivariate adjustment.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
- Interpretationcitation
The Panel notes that three meta-analyses and the vast majority of the 56 prospective cohort studies reported no increased risk of CHD associated with habitual coffee consumption at any level of intake.
“The Panel notes that three meta-analyses and the vast majority of the 56 prospective cohort studies included in these review publications reported no increased risk of CHD associated with habitual coffee consumption at any level of intake.”
Quote in the paperSubstantial claim - Interpretationcitation
The Panel notes that the NHS study shows an inverse U-shaped relationship between total caffeine intake from dietary sources and incident hypertension.
“The Panel notes that this study shows an inverse U-shaped relationship between total caffeine intake from dietary sources and incident hypertension.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
- Study design and conductnone given
Two studies (Murray et al., 1981; Stensvold and Tverdal, 1995) were not adjusted for any confounding variable.
“Two studies (Murray et al., 1981;Stensvold and Tverdal, 1995) were not adjusted for any confounding variable.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Murray et al., 1981 source
Not checked in the free run.
- cites Stensvold and Tverdal, 1995
Not checked in the free run.
- Premiseown data
Among 56 prospective cohort studies, eight studies (seven published in or before 1995) reported a positive association between coffee consumption and risk of CHD, including fatal and non-fatal CAD, fatal ischaemic heart disease and fatal and non-fatal MI.
“Among the 56 prospective cohort studies included in the meta-analyses above, eight studies, seven of which were published in or before 1995, reported a positive association between coffee consumption and the risk of CHD, including fatal and non-fatal CAD, fatal ischaemic heart disease and fatal and non-fatal MI.”
Quote in the paperSubstantial claim - Premisecitation
Compared with the reference category, the pooled RR for hypertension was 1.09 (95% CI 1.01-1.18) for low coffee consumption (one to three cups/day).
“Compared with the reference category, the pooled RRs (95 % CI) for hypertension were 1.09 (1.01-1.18)for the low category (one to three cups per day)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al., 2011 source
Not checked in the free run.
- Premisecitation
In the AF meta-analyses, there was no significant association between caffeine exposure and AF risk in primary or subgroup analyses considering age, sex, race, study quality, caffeine from coffee versus all sources, caffeine dose or duration of follow-up.
“There was no significant association between caffeine exposure and AF risk in primary or subgroup analyses, considering age, sex, race, study quality, caffeine from coffee versus caffeine from all sources, caffeine dose or duration of follow-up.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In Wu et al. (2009), stratified analyses by sex, region, study quality, duration of follow-up and adjustment for confounding variables did not affect the results significantly.
“Stratified analyses by sex, region, study quality and duration of follow-up and adjustment for confounding variables did not affect the results significantly.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wu et al., 2009
Not checked in the free run.
- Premisecitation
An inverse relationship was found between habitual caffeine intake and risk of AF in a dose-response analysis (Cheng et al., 2014).
“An inverse relationship was found between habitual caffeine intake and the risk of AF in a dose-response analysis (Cheng et al., 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cheng et al., 2014 source
Not checked in the free run.
- Interpretationown data
The Panel notes that the risk of hypertension did not increase significantly at any dose of coffee consumption in the dose-response analysis.
“The Panel notes that the risk of hypertension did not increase significantly at any dose of coffee consumption in this dose-response analysis.”
Quote in the paperSubstantial claim - Premisecitation
In Lopez-Garcia et al. (2006), after adjustment for confounders, neither coffee nor total caffeine intake were significantly associated with risk of CHD in men or women.
“After adjustment for confounders, neither coffee nor total caffeine intake were significantly associated with the risk of CHD in either men or women.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lopez-Garcia et al., 2006
Not checked in the free run.
- Interpretationreasoning
The Panel notes that the available studies do not provide sufficient information to conclude on whether or not consumption of p-synephrine modifies the effects of daily caffeine consumption on fasting BP.
“The studies available do not provide sufficient information to conclude on whether or not consumption of p-synephrine modifies the effects of daily caffeine consumption on fasting BP.”
Quote in the paperSubstantial claim - Premisecitation
In NHS I and II, significant positive associations between intake of sugar-containing and sugar-free caffeinated cola drinks and incident hypertension were observed in both cohorts.
“A significant positive association between the intake of sugar-containing (p for trend = 0.03 and < 0.001 in NHS I and NHS II, respectively) and sugar-free (p for trend = 0.03 and < 0.001 in NHS I and NHS II, respectively) caffeinated cola drinks and incident hypertension was observed in both cohorts.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
- Premisecitation
In Klag et al. (2002), no association between caffeinated coffee consumption and risk of incident hypertension was observed after adjusting for confounding variables in normotensive young males.
“No association between caffeinated coffee consumption and the risk of incident hypertension was observed after adjusting for confounding variables in the study by Klag et al. (2002) in normotensive young males.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klag et al., 2002 source
Not checked in the free run.
- Premisecitation
One meta-analysis (Arab et al., 2009) of tea consumption and stroke risk found similar results.
“One meta-analysis (Arab et al., 2009) of prospective cohort studies which assessed the relationship between green and black tea consumption and the risk of stroke and included data from nine individual studies involving 4 378 strokes among 194 965 individuals in total found similar results.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Arab et al., 2009 source
Not checked in the free run.
- Premisecitation
In the dose-response meta-analysis by Ding et al. (2014), coffee consumption up to about four cups per day was inversely associated with the risk of stroke.
“Coffee consumption up to about four cups per day was inversely associated with the risk of stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al. (2014) source
Not checked in the free run.
- Premisecitation
Among the prospective cohort studies included in the meta-analyses, none reported a positive association between coffee consumption and the risk of stroke of any type.
“Among the prospective cohort studies included in the meta-analyses above, none reported a positive association (increased risk) between coffee consumption and the risk of stroke of any type.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Larsson and Orsini, 2011
Not checked in the free run.
- cites Kim et al., 2012 source
Not checked in the free run.
- Premisecitation
In the Sengpiel et al. (2013) study, total caffeine and coffee caffeine were significantly associated with increased gestational length.
“total caffeine and coffee caffeine were significantly associated with increased gestational length.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sengpiel et al., 2013 source
Not checked in the free run.
- Interpretationown data
Total caffeine intake was not associated with an increased CVD risk in any of the studies that investigated all sources of caffeine.
“However, total caffeine intake was not associated with an increased CVD risk in any of the studies that investigated all sources of caffeine.”
Quote in the paperSubstantial claim - Premisecitation
In the study by Larsson et al. (2008), consumption of caffeinated coffee, caffeinated tea or total caffeine was not associated with an increased risk of ischaemic or haemorrhagic stroke.
“Consumption of caffeinated coffee, caffeinated tea or total caffeine (from coffee and tea) was not associated with an increased risk of ischaemic or haemorrhagic stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Larsson et al. (2008) source
Not checked in the free run.
- Interpretationnone given
The Panel notes that the Bakker et al. (2010) study did not assess caffeine intake during pregnancy from all dietary sources.
“The Panel notes that this study did not assess caffeine intake during pregnancy from all dietary sources.”
Quote in the paperNot a substantial claim - Premisecitation
In the Bakker et al. (2010) study, no clear dose-response associations were found for caffeine intakes during pregnancy and fetal growth.
“No clear dose-response associations were found for caffeine intakes during pregnancy and fetal growth.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bakker et al., 2010 source
Not checked in the free run.
- Premisecitation
In the Bech et al. (2007) RCT, the adjusted difference in length of gestation between the decaffeinated and caffeinated coffee groups was -1.31 days (95% CI -2.87 to 0.25).
“The adjusted difference in length of gestation between the decaffeinated and caffeinated coffee groups was -1.31 days (-2.87 to 0.25).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bech et al., 2007 source
Not checked in the free run.
- Premisecitation
In the CARE Study Group, caffeine intake was associated with an increased risk of late miscarriage or stillbirth.
“Caffeine intake was also associated with an increased risk of late miscarriage or stillbirth (Greenwood et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Greenwood et al., 2010 source
Not checked in the free run.
- Premisecitation
In the dose-response meta-analysis by Ding et al. (2014), no association was observed between coffee consumption and CVD risk at higher intake.
“No association was observed between coffee consumption and CVD risk at higher intake.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al. (2014) source
Not checked in the free run.
- Premisecitation
In the dose-response meta-analysis by Ding et al. (2014), no association was observed between coffee consumption of higher intakes and the risk of stroke.
“No association was observed between coffee consumption of higher intakes and the risk of stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al. (2014) source
Not checked in the free run.
- Premisecitation
In the CARE Study Group, after adjustment for confounding variables, the relationship between total caffeine intake in pregnancy and FGR showed a significant trend with increasing caffeine intake (p for trend = 0.02).
“After adjustment for confounding variables, the relationship between total caffeine intake in pregnancy and FGR showed a significant trend with increasing caffeine intake (p for trend = 0.02).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites CARE Study Group, 2008 source
Not checked in the free run.
- Premisecitation
In the dose-response meta-analysis by Ding et al. (2014), coffee consumption was inversely associated with the risk of CVD up to six cups per day.
“In the dose-response analysis, coffee consumption was inversely associated with the risk of CVD up to six cups per day.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al. (2014) source
Not checked in the free run.
- Premisecitation
In Mostofsky et al. (2012), a non-linear association between coffee consumption and heart failure risk was found (p for non-linearity=0.02; p for overall significance=0.02).
“A non-linear association between coffee consumption and heart failure risk was found (p for non-linearity = 0.02; p for overall significance of curve = 0.02).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mostofsky et al., 2012
Not checked in the free run.
- Interpretationown data
In the meta-analysis, coffee intake up to 11 cups per day, corresponding to about 1100 mg of caffeine, was not significantly associated with an increased risk of heart failure.
“The Panel notes that coffee intake up to 11 cups per day, corresponding to about 1 100 mg of caffeine, were not significantly associated with an increased risk of heart failure in this meta-analysis.”
Quote in the paperSubstantial claim - Premisecitation
In the meta-analysis by Larsson and Orsini (2011), a non-linear inverse association between coffee consumption and stroke risk was observed (p for non-linearity = 0.005).
“A non-linear inverse association between coffee consumption and stroke risk was observed (p for non-linearity = 0.005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Larsson and Orsini (2011)
Not checked in the free run.
- Interpretationreasoning
Habitual caffeinated coffee consumption has not been associated with an increased risk of total CVD or CVD subtypes in the general adult population at any level of intake in any summary publication.
“Habitual caffeinated coffee consumption has not been associated with an increased risk of total CVD or CVD subtypes in the general adult population at any level of intake in any summary publication.”
Quote in the paperSubstantial claim - Interpretationcitation
The Panel notes that habitual caffeine consumption from all sources up to about 1,000 mg/day was not significantly associated with an increased risk of AF in the two meta-analyses.
“The Panel notes that habitual caffeine consumption from all sources up to about 1 000 mg per day was not significantly associated with an increased risk of AF in these two meta-analyses.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In the Sengpiel et al. (2013) study, an additional 100 mg total caffeine per day was associated with a 21- to 28-g birth weight decrease.
“An additional 100 mg total caffeine per day was associated with a 21-to 28-g birth weight decrease, depending on the growth curve.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sengpiel et al., 2013 source
Not checked in the free run.
- Premisecitation
In the Sengpiel et al. (2013) study, black tea caffeine was associated with increased risk of early spontaneous pre-term delivery (OR 1.61, 95% CI 1.10-2.35, p = 0.01).
“black tea caffeine was associated with increased risk of early spontaneous pre-term delivery (OR 1.61, 95 % CI = 1.10-2.35,p = 0.01).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sengpiel et al., 2013 source
Not checked in the free run.
- Interpretationnone given
The Panel notes that the relationship between caffeine intake and outcomes related to the length of gestation is inconsistent.
“The Panel also notes that the relationship between caffeine intake and outcomes related to the length of gestation is inconsistent.”
Quote in the paperNot a substantial claim - Premisecitation
Loomba et al. (2014) reported no association between coffee consumption and CVD mortality in multivariate analysis adjusted for confounding variables at any level of intake among 8 608 subjects > 45 years of age.
“An additional prospective cohort study published thereafter (Loomba et al., 2014) using data from the US National Health and Nutrition Examination Survey III (NHANES III) reported no association between coffee consumption and CVD mortality (including stroke, congestive heart failure and ischaemia-related mortality) in multivariate analysis adjusted for confounding variables at any level of intake”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Loomba et al., 2014
Not checked in the free run.
- Interpretationown data
The Panel notes that the Bech et al. (2007) study did not report an effect of decreasing caffeine consumption from about 300 mg per day to about 100 mg per day in the last four months of pregnancy on length of gestation or birth weight.
“The Panel notes that this study did not report an effect of decreasing caffeine consumption from about 300 mg per day to about 100 mg per day in the last four months of pregnancy on length of gestation or birth weight.”
Quote in the paperSubstantial claim - Interpretationcitation
The Panel notes that coffee intake up to 8-11 cups per day, corresponding to about 800-1100 mg of caffeine per day, was not significantly associated with an increased risk of stroke in the meta-analyses considered.
“The Panel notes that coffee intake up to 8-11 cups per day, corresponding to about 800-1 100 mg of caffeine per day, were not significantly associated with an increased risk of stroke in the meta-analyses considered.”
Quote in the paperSubstantial claim - Premisecitation
In the Bakker et al. (2010) study, caffeine intake was positively associated with the risks of delivering an SGA child.
“Caffeine intake was positively associated with the risks of delivering an SGA child.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bakker et al., 2010 source
Not checked in the free run.
- Interpretationreasoning
The Panel considers that habitual caffeine intake up to about 400 mg per day from all sources does not increase the risk of CVD in habitual alcohol drinkers from the general adult population.
“the Panel considers that habitual caffeine intake up to about 400 mg per day from all sources does not increase the risk of CVD in habitual alcohol drinkers from the general adult population.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The Panel also notes that no single prospective cohort study reported an increased risk of AF associated with habitual caffeine consumption.
“The Panel also notes that no single prospective cohort study reported an increased risk of AF associated with habitual caffeine consumption.”
Quote in the paperSubstantial claim - Interpretationreasoning
The Panel notes that genetic polymorphisms for genes involved in caffeine metabolism may explain only a small proportion of the inter-individual variability in caffeine intake.
“The Panel notes that genetic polymorphisms for genes involved in caffeine metabolism may explain only a small proportion of the inter-individual variability in caffeine intake.”
Quote in the paperNot a substantial claim - Premisecitation
In the Bech et al. (2007) RCT, after adjustment, the mean birth weight of babies born to women in the decaffeinated coffee group was 16 g (95% CI -40 to 73 g) higher than those born to women in the caffeinated group.
“After adjustment for length of gestation, parity, pre-pregnancy body mass index and smoking at baseline, the mean birth weight of babies born to women in the decaffeinated coffee group was 16 g (95 % CI = -40 to 73 g), which was higher than those born to women in the caffeinated group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bech et al., 2007 source
Not checked in the free run.
- Interpretationnone given
Data from RCTs suggest that caffeine intake (from coffee or supplements) at doses ≤ 400 mg per day does not raise fasting BP significantly after caffeine habituation takes place.
“Data from RCTs suggest that caffeine intake (from coffee or supplements) at doses ≤ 400 mg per day does not raise fasting BP significantly after caffeine habituation takes place.”
Quote in the paperSubstantial claim - Premisereasoning
No single prospective cohort study reported an increased risk of AF associated with habitual caffeine or coffee consumption.
“No single prospective cohort study reported an increased risk of AF associated with habitual caffeine or coffee consumption.”
Quote in the paperSubstantial claim - Premisecitation
Incidence of AF decreased by 6% (RR=0.94, 95% CI 0.90-0.99) for every 300 mg/day increment in habitual caffeine intake up to about 1,000 mg/day.
“Incidence of AF decreased by 6 % (RR = 0.94, 95 % CI = 0.90-0.99)for every 300 mg per day increment in habitual caffeine intake up to about 1 000 mg per day.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cheng et al., 2014 source
Not checked in the free run.
- Interpretationreasoning
Higher doses of caffeine could lead to prolonged physical exercise that might compromise the cardiovascular and/or musculoskeletal systems.
“Higher doses could lead to prolonged physical exercise that might compromise the cardiovascular and/or musculoskeletal systems.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A level of no safety concern for habitual caffeine consumption by children and adolescents of 3 mg/kg bw per day is appropriate.
“The Panel, therefore, considers a level of no safety concern for habitual caffeine consumption by children and adolescents of 3 mg/kg bw per day (i.e. the level of no safety concern derived for single doses of caffeine for adults) as appropriate.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
- Interpretationnone given
Moderate habitual alcohol consumption would not affect the safety of habitual caffeine consumption up to 400 mg per day.
“In addition, the Panel considers that moderate habitual alcohol consumption would not affect the safety of habitual caffeine consumption up to 400 mg per day.”
Quote in the paperNot a substantial claim - Interpretationcitation
Single doses of caffeine up to 200 mg consumed by lactating women in the general population do not give rise to safety concerns for the breastfed infant.
“Single doses of caffeine up to 200 mg consumed by lactating women in the general population do not give rise to safety concerns for the breastfed infant.”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) are unlikely to mask the subjective perception of alcohol intoxication when alcohol is consumed at doses up to about 0.65 g/kg bw.
“Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) are also unlikely to mask the subjective perception of alcohol intoxication when alcohol is consumed at doses up to about 0.65 g/kg bw.”
Quote in the paperSubstantial claim - Interpretationreasoning
The Panel notes that the relationship between caffeine intakes and adverse birth weight-related outcomes is observed at all levels of intake, with no threshold below which the relationship is not observed.
“The Panel also notes that the relationship between caffeine intakes and adverse birth weight-related outcomes is observed at all levels of intake, with no threshold below which the relationship is not observed.”
Quote in the paperSubstantial claim - Interpretationreasoning
The Panel considers that the risk becomes clinically relevant at daily doses of about 200 mg of caffeine from all sources.
“However, the Panel considers that the risk becomes clinically relevant at daily doses of about 200 mg of caffeine from all sources.”
Quote in the paperSubstantial claim - Interpretationreasoning
Taking into account the different kinetics of caffeine in pregnant women, single doses of caffeine which are of no safety concern for non-pregnant adults may not apply to pregnant women performing physical exercise.
“Taking into account the different kinetics of caffeine in this population subgroup, the Panel considers that single doses of caffeine which are of no safety concern for non-pregnant adults may not apply to pregnant women performing physical exercise.”
Quote in the paperSubstantial claim - Study design and conductnone given
The human intervention studies on which these conclusions are based were primarily conducted with caffeine supplements for most of the outcomes assessed, namely changes in MBF, hydration status, body temperature, perceived exertion/effort during exercise, and sleep.
“The human intervention studies on which these conclusions are based (Section 4.4) were primarily conducted with caffeine supplements for most of the outcomes assessed (i.e.changes in MBF, hydration status, body temperature, perceived exertion/effort during exercise, sleep).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Caffeine intakes from all sources up to 400 mg per day (corresponding to about 5.7 mg/kg bw for a 70-kg adult) consumed throughout the day do not give rise to safety concerns for healthy adults in the general population, except for pregnant women.
“Caffeine intakes from all sources up to 400 mg per day (corresponding to about 5.7 mg/kg bw for a 70-kg adult) consumed throughout the day do not give rise to safety concerns for healthy adults in the general population, except for pregnant women (see Section 5.2).”
Quote in the paperSubstantial claim - Interpretationreasoning
Because information on caffeine intake is not available for other sources of caffeine or for caffeine from all sources including food supplements, the percentage of adults exceeding 200 mg caffeine in a single sports session may be underestimated.
“On the one hand, the Panel notes that this information is not available for other sources of caffeine, or for caffeine from all sources, including food supplements, and thus the percentage of adults exceeding 200 mg caffeine in a single sports session may be underestimated.”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to 200 mg are unlikely to induce clinically relevant changes in blood pressure, hydration status or body temperature, both at rest and when consumed less than two hours prior to intense physical exercise under normal environmental conditions.
“Single doses of caffeine up to 200 mg are also unlikely to induce clinically relevant changes in blood pressure, hydration status or body temperature.This is the case both at rest or when consumed less than two hours prior to intense physical exercise under normal environmental conditions.”
Quote in the paperSubstantial claim - Interpretationnone given
100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.
“The Panel notes that 100 mg (about 1.4 mg/kg bw for a 70-kg adult) of caffeine may increase sleep latency and reduce sleep duration in some adult individuals, particularly when consumed close to bedtime.”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult), or the same amount consumed within a short period, are unlikely to induce clinically relevant changes in MBF in the general healthy adult population, either at rest or when consumed less than two hours prior to intense physical exercise under normal environmental conditions.
“Single doses of caffeine up to 200 mg, corresponding to about 3 mg/kg bw for a 70-kg adult, or the same amount consumed within a short period of time, are unlikely to induce clinically relevant changes in MBF in the general healthy adult population, either at rest or when consumed less than two hours prior to intense physical exercise, under normal environmental conditions.”
Quote in the paperSubstantial claim - Interpretationreasoning
The use of a mean value for the caffeine content in coffee on a volume basis may not accurately reflect caffeine intakes in all countries.
“The Panel notes that coffee was the main source of dietary caffeine in the seven countries for which the 95 th percentile of daily caffeine intake exceeded 400 mg, and that the use of a mean value for the caffeine content in coffee on a volume basis may not accurately reflect caffeine intakes in all countries.”
Quote in the paperNot a substantial claim - Premisecitation
Two prospective cohort studies (CARE Study Group, 2008; Sengpiel et al., 2013) show a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes, namely fetal growth restriction and small for gestational age.
“This conclusion is based on two prospective cohort studies (CARE Study Group, 2008;Sengpiel et al., 2013) showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (i.e.FGR, SGA).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
Caffeine intakes from all sources up to 200 mg per day consumed throughout the day by pregnant women in the general population do not give rise to safety concerns for the fetus.
“Caffeine intakes from all sources up to 200 mg per day consumed throughout the day by pregnant women in the general population do not give rise to safety concerns for the fetus.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The relationship between caffeine intake during pregnancy and adverse birth weight-related outcomes is causal in the context of this safety assessment.
- Interpretationcitation
Decreasing caffeine intake from about 300 mg per day to about 100 mg per day in the third trimester of pregnancy does not decrease the risk, as observed in one human intervention study (Bech et al., 2007).
“decreasing caffeine intake from about 300 mg per day to about 100 mg per day in the third trimester of pregnancy does not decrease the risk, as observed in one human intervention study (Bech et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bech et al., 2007 source
Not checked in the free run.
- Interpretationnone given
The conclusion that single doses of caffeine up to 200 mg are unlikely to induce clinically relevant changes in blood pressure, hydration status or body temperature applies to non-habitual caffeine consumers, caffeine-deprived subjects and habitual caffeine consumers.
“This applies to non-habitual caffeine consumers, to caffeine-deprived subjects and to habitual caffeine consumers.”
Quote in the paperSubstantial claim - Interpretationreasoning
Doses of 200 mg per day from all sources consumed throughout the day by lactating women do not give rise to safety concerns for the breastfed infant.
“In this context, the Panel considers that doses of 200 mg per day from all sources consumed throughout the day by lactating women do not give rise to safety concerns for the breastfed infant.”
Quote in the paperSubstantial claim- Rests on an assumption: The half-life of caffeine in women is mean four hours, range two to eight hours, and the half-life in infants is longer, namely 50-103 hours in neonates with no CYP1A2 activity and about 14 hours at three to four months of age.
- Premisenone given
The association between caffeine intakes and other adverse pregnancy-related outcomes is less consistent.
“The association between caffeine intakes and other adverse pregnancy-related outcomes is less consistent.”
Quote in the paperNot a substantial claim - Interpretationcitation
The Panel notes that two prospective cohort studies show a dose-dependent positive association between caffeine intake during pregnancy from all dietary sources and the risk of adverse birth weight-related outcomes (i.e. FGR, SGA).
“The Panel notes that two prospective cohort studies (CARE Study Group, 2008;Sengpiel et al., 2013) show a dose-dependent positive association between caffeine intake during pregnancy from all dietary sources and the risk of adverse birth weight-related outcomes (i.e.FGR, SGA).”
Quote in the paperSubstantial claim - Interpretationnone given
Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) are unlikely to reduce the perceived exertion/effort during exercise.
“Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) are unlikely to reduce the perceived exertion/effort during exercise.”
Quote in the paperNot a substantial claim - Premisenone given
Prospective cohort studies cannot provide evidence for a causal association between caffeine and adverse birth weight-related outcomes.
“The Panel notes that prospective cohort studies cannot provide evidence for a causal association between caffeine and adverse birth weight-related outcomes.”
Quote in the paperSubstantial claim
- May combine two claims. 162
- The quote only partly states this claim. 15
- Classified as probably not a substantial claim. 46
May combine two claims. The quote only partly states this claim.
Findingnone givenAbout 6% of the adult population may exceed 200 mg of caffeine in a single session of energy drink consumption, and about 4% do so in connection with physical exercise.
“About 6 % of the adult population may exceed 200 mg of caffeine in a single session of”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe proportion of survey days in which the level of 3 mg/kg bw was exceeded ranged from about 7 to 12% in adolescents, from 6 to 15% in children and from 7 to 37% in toddlers in the aforementioned countries.
“The proportion of survey days in which the level was exceeded ranged from about 7 to 12 % in adolescents, from 6 to 15 % in children and from 7 to 37 % in toddlers in the aforementioned countries.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone givenThere are no data to characterise the risk of single doses of caffeine consumed by lactating women, and data on habitual caffeine consumption in this population subgroup are scarce.
“There are no data to characterise the risk of single doses of caffeine consumed by lactating women, and data on habitual caffeine consumption in this population subgroup are scarce.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningAs only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.
“As only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longerterm effects of habitual caffeine consumption in this age group.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe proportion of subjects exceeding that level of intake in the above-mentioned countries was about 5 to 10% for adolescents, 6 to 13% for children and about 6% for toddlers.
“The proportion of subjects exceeding that level of intake in the above-mentioned countries was about 5 to 10 % for adolescents, 6 to 13 % for children and about 6 % for toddlers.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe question of whether p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.
“The question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.”
- Also stated in: § 5.1.2. Single doses of caffeine in combination with other common constituents of "energy drinks", alcohol and p-synephrine · plain
“The Panel also considers that the question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine has not been adequately investigated in humans, particularly if consumed shortly before intense physical exercise, and therefore no conclusions could be drawn.”
Quote in the paperSubstantial claim- Also stated in: § 5.1.2. Single doses of caffeine in combination with other common constituents of "energy drinks", alcohol and p-synephrine · plain
May combine two claims.
Findingnone givenChocolate beverages were important contributors to total caffeine intakes in children and toddlers in most countries, and the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in these age groups.
“Chocolate beverages were important contributors to total caffeine intakes in children and toddlers in most countries, and the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in these age groups.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe conclusion that caffeine intakes up to 200 mg per day by pregnant women do not give rise to safety concerns for the fetus is based on prospective cohort studies showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (fetal growth retardation, small for gestational age) in the offspring.
“This conclusion is based on prospective cohort studies showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (i.e.fetal growth retardation, small for gestational age) in the offspring.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe estimated 95th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw in 6 out of 16 countries for adolescents (10 to <18 years), in 9 out of 16 countries for children (3 to <10 years) and in 3 out of 10 countries for toddlers (12 to <36 months).
“The estimated 95 th percentile of caffeine intake from foods and beverages on a single day exceeded 3 mg/kg bw in 6 out of 16 countries for adolescents (10 to < 18 years), in 9 out of 16 countries for children (3 to < 10 years) and in 3 out of 10 countries for toddlers (12 to < 36 months).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThis information (proportion exceeding 200 mg in a single session) is not available for other sources of caffeine.
“This information is not available for other sources of caffeine.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningIn these countries, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6% to almost one-third (33%), and coffee was the main source of caffeine.
“In these countries, the estimated proportion of the adult population exceeding daily intakes of 400 mg ranged from about 6 % to almost one-third (33 %), and coffee was the main source of caffeine.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenThe question of whether p-synephrine modifies the acute cardiovascular effects of single doses of caffeine or the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans and therefore no conclusions could be drawn.
“The question of whether or not p-synephrine modifies the acute cardiovascular effects of single doses of caffeine or the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans and therefore no conclusions could be drawn.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSufficient days (n ≥ 60) to obtain statistically robust 95th percentiles for toddlers regarding caffeine intakes from different sources on consumption days were available only for chocolate and tea, for which the highest values across Member States were 5.3 and 9.6 mg/kg bw per day, respectively.
“Sufficient (n ≥ 60) days to obtain statistically robust 95 th percentiles for toddlers regarding caffeine intakes from different sources on consumption days were available only for chocolate and tea, for which the highest values across Member States were estimated to be 5.3 and 9.6 mg/kg bw per day of caffeine, respectively (Appendix C).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.
FindingcitationIn adolescent energy drink consumers, mean caffeine intake from energy drinks in a single session was 176 mg and 95th percentile was 450 mg.
“The mean and 95 th percentile of caffeine intakes in a”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
May combine two claims.
Findingown dataFor lactating women in Greece, mean daily caffeine intake from all sources was 31 mg and 95th percentile was 97 mg per day.
“The mean and the 95 th percentile of the daily caffeine intake from all sources were 31 mg and 97 mg per day, respectively (Appendix B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe highest contribution to total caffeine intakes from energy drinks for adolescents was in the UK (11%), followed by the Netherlands (8.1%) and Belgium (5.3%).
“The highest contribution to total caffeine intakes from”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor adolescents, the highest 95th percentiles of caffeine intake on a single day were 240 mg and 4.3 mg/kg bw.
“The highest 95 th percentiles of caffeine intake on a single day in absolute values and on a per kg bw basis were 240 mg and 4.3 mg/kg bw, respectively (Appendices C and D).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong countries, mean daily caffeine intake for adolescents ranged from 18 to 70 mg and 95th percentile from 61 to 212 mg.
“Means and 95 th percentiles ranged from 18 to 70 mg and from 61 to 212 mg, respectively, among countries (Table 2, Appendix B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOn a per kg bw basis, the highest 95th percentile of caffeine intake on a single day for adolescents was from coffee (7.1 mg), followed by chocolate (5.4 mg), energy drinks (5.2 mg), tea (5.0 mg) and cola beverages (2.4 mg).
“On a per kg bw basis, the highest 95 th percentile of caffeine intake was from coffee (7.1 mg), followed by chocolate (5.4 mg),”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn adolescent energy drink consumers, 51, 25, 11, 6 and 7% declared consuming one, two, three, four and five or more cans of energy drinks within a single session.
“In this survey, 51, 25, 11, 6 and 7 % of”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
May combine two claims.
Findingown dataIn most countries, chocolate (including cocoa drinks) was the predominant source of caffeine for children aged 3 to 10 years, followed by tea and cola drinks.
“In most countries,”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn adult energy drink consumers, mean caffeine intake from energy drinks in a single session was 155 mg and 95th percentile was 344 mg.
“The mean and 95 th percentile of caffeine intakes in a”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
May combine two claims.
Findingown dataThe highest 95th percentiles of caffeine intake on a single day for adults from energy drinks, tea and cola were 330, 308 and 216 mg, respectively.
“The highest 95 th percentiles of caffeine intake from”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong countries, mean daily caffeine intake from all sources for adults ranged from 37 to 319 mg and 95th percentile from 109 to 742 mg.
“Means and 95 th percentiles ranged from 37 to 319 mg and from 109 to 742 mg, respectively, among countries (Table 2, Appendix B).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn adult energy drink consumers, 52, 29, 11, 5 and 3% declared consuming one, two, three, four and five or more cans of energy drinks within a single session.
“In this survey, 52, 29, 11, 5 and 3 % of”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zucconi et al., 2013
Not checked in the free run.
May combine two claims.
Findingown dataTea or chocolate was the main caffeine source in all toddler surveys except Belgium, where cola drinks contributed the most (58%).
“Tea or chocolate was the main caffeine source in all surveys except for Belgium, where cola drinks contributed the most to total caffeine intake (58 %; Appendix E).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenFor toddlers, 10 surveys were available.
“For toddlers, 10 surveys were available.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.
Findingnone givenThe highest 95th percentiles of caffeine intake on a single day for adolescents from energy drinks, tea, chocolate and cola were 330, 308, 253 and 142 mg, respectively.
“The highest 95 th percentiles of caffeine intake from”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn adolescents, chocolate was the main contributor to caffeine intake in six surveys, coffee in four, cola beverages in three, and tea in two.
“Chocolate was the main contributor to caffeine intake in six surveys, coffee was the main contributor in four surveys, cola beverages were the main contributors in three surveys and tea was the main contributor in two surveys.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataAmong consumers of different caffeine-containing food groups, coffee consumers had the highest 95th percentile of caffeine consumption per day (up to 776 mg from coffee), followed by tea drinkers (up to 264 mg), energy drink consumers (up to 200 mg), and cola beverage consumers (up to 122 mg).
“Considering caffeine intake in consumers of the different caffeine-containing food groups, coffee consumers had the highest 95 th percentile of caffeine consumption per day (up to 776 mg of caffeine from coffee), followed by tea drinkers (up to 264 mg of caffeine from tea),”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWhen considering only days with consumption of different food categories, the 95th percentile of caffeine intake for children aged 3 to 10 years from coffee provided the highest estimate (15 mg/kg bw per day), followed by chocolate (7.7 mg/kg bw per day).
“When considering only days with consumption of the different food categories, the 95 th percentile of caffeine intake from coffee provided the highest estimate (15 mg/kg bw per day), followed by chocolate (7.7 mg/kg bw per day) (Appendix C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor pregnant women in Latvia, mean daily caffeine intake from all sources was 109 mg and 95th percentile was 206 mg per day.
“The mean and the 95 th percentile of the daily caffeine intake from all sources were 109 mg and 206 mg per day, respectively (Appendix B).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn only the UK and the Netherlands was a specific code for energy drinks available in the database.
“In only the first two was a specific code for”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingnone givenDaily intake estimates for the elderly and very elderly are of similar magnitude to adults, with a tendency for lower 95th percentiles.
“Daily intake estimates for the elderly and very elderly are of a similar magnitude, with a tendency for lower 95 th percentiles.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn these surveys, the prevalence of energy drink consumers was most often zero and never exceeded 1% in toddlers, children aged 3-10 years, the elderly, very elderly, lactating women and pregnant women.
“In these surveys, the prevalence of”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Findingnone givenThe prevalence of energy drink consumers among the 17 surveys introduced into the EFSA Comprehensive Database in 2014 using the FoodEx2 code for energy drinks was <10%.
“The prevalence of”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAccording to this survey, 47, 26, 13, 9 and 5% of adult energy drink consumers declared consuming one, two, three, four and five or more cans of energy drinks in relation to a single sport session.
“According to this survey, 47, 26, 13, 9 and 5 % of this population declared that they consume one, two, three, four and five or more cans of”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims. The quote only partly states this claim.
FindingcitationThe EFSA energy drink report provides information about caffeine intakes by adolescents and adults from energy drinks on a single session, also in relation to a single session of physical exercise.
“The EFSA”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe highest prevalences of energy drink consumers were observed in adolescents (9% in the Netherlands, 7% in the UK and 5% in Finland) and adults (8% in Ireland, 4% in the Netherlands and 3% in the UK).
“The highest prevalences of”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn this survey, 48, 25, 13, 7 and 7% of adolescent energy drink consumers declared consuming one, two, three, four and five or more cans of energy drinks in relation to a single sport session.
“In this survey, 48, 25, 13, 7 and 7 % of this population declared that they consume one, two, three, four and five or more cans of”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenData are particularly scarce for pregnant and lactating women, and absent regarding the consumption of caffeine-containing supplements.
“Data are particularly scarce for pregnant and lactating women, and absent regarding the consumption of caffeine-containing supplements.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAmong the individual studies, a positive association between habitual caffeinated coffee consumption and CVD risk has been reported only for CHD in 8 out of the 56 studies reviewed, only 6 of which had any type of adjustment for confounding variables.
“Among the individual studies, a positive association between habitual caffeinated coffee consumption and CVD risk has been reported only for CHD (but not for stroke, AF or heart failure) in 8 out of the 56 studies reviewed, only 6 of which had any type of adjustment for confounding variables.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningOf the studies reporting a positive association, only two reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day, corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake.
“Of these, only two reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day (one for three or more cups per day, one for three to four cups per day), corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataFor 6 out of 14 Member States, the estimates of the 95th percentile of daily caffeine intake from all sources exceed 3 mg/kg bw for children.
“For 6 out of 14 Member States the estimates of the 95 th percentile of daily caffeine intake from all sources exceeds 3 mg/kg bw.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationFor the 3 mg/kg bw dose, only 1 out of 42 pre-term infants showed tachycardia and jittering, and only tachycardia with no jittering was observed in 8 out of 45 infants at doses 100-fold higher (30 mg/kg bw).
“For this dose, only 1 out of 42 pre-term infants showed tachycardia and jittering, and only tachycardia (with no jittering) was observed in 8 out of 45 infants at doses 100-fold higher (30 mg/kg bw).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Steer et al., 2003 source
Not checked in the free run.
May combine two claims.
Findingnone givenThe mean and the 95th percentile of the daily caffeine intakes from foods and beverages in the only survey available for pregnant women were 109 mg and 206 mg per day, respectively.
“The mean and the 95 th percentile of the daily caffeine intakes from foods and beverages in the only survey available were 109 mg and 206 mg per day, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe surveys considered did not report on the consumption of caffeine from food supplements, and there are no data on the frequency and quantity of consumption of caffeine from this source in Europe in different subgroups of the population.
“The Panel notes that the surveys considered did not report on the consumption of caffeine from food supplements, and that there are no data on the frequency and quantity of consumption of caffeine from this source in Europe in different subgroups of the population.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe mean and the 95th percentile of the daily caffeine intakes from food and beverages in the only survey available for lactating women were 31 mg and 97 mg per day, respectively, which are well below 200 mg.
“The mean and the 95 th percentile of the daily caffeine intakes from food and beverages in the only survey available were 31 mg and 97 mg per day, respectively, which are well below 200 mg.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenOnly limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, and there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.
“As only limited studies are available on the longer-term effects of caffeine on anxiety and behaviour in children and adolescents, there is substantial uncertainty regarding longer-term effects of habitual caffeine consumption in this age group.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenThe question of whether p-synephrine modifies the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans, and therefore no conclusions could be drawn.
“The Panel considers that the question of whether or not p-synephrine modifies the long-term effects of caffeine on the cardiovascular system has not been adequately investigated in humans, and therefore no conclusions could be drawn.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningThe scientific assessment is based on human intervention and observational studies with adequate control for confounding variables, which have been conducted in healthy subjects at recruitment.
“The scientific assessment is based on human intervention and observational studies with adequate control for confounding variables, which have been conducted in healthy subjects at recruitment.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenEstimates of the proportion of single days in which caffeine intake exceeds 3 mg/kg bw among all survey days using the EFSA Comprehensive Database were used as a conservative approximation.
“Estimates of the proportion of single days in which caffeine intake exceeds 3 mg/kg bw among all survey days using the EFSA Comprehensive Database were used as a conservative approximation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenOverall, at EU level to date, caffeine has only been assessed in the context of energy drinks but the safety of overall caffeine intake, from all sources, and acceptable use levels has not yet been assessed.
“Overall, at EU level to date, caffeine has only been assessed in the context of energy drinks but the safety of overall caffeine intake, from all sources, and acceptable use levels has not yet been assessed.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningWhenever available, human intervention studies and prospective cohort studies have been preferred over case-control and cross-sectional studies because of the lower risk of reverse causality and recall bias.
“Whenever available, human intervention studies and prospective cohort studies have been preferred over case-control and cross-sectional studies because of the lower risk of reverse causality and recall bias.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenCase reports of adverse events have not been considered for the scientific assessment.
“Case reports of adverse events have not been considered for the scientific assessment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningCaffeine is not an essential nutrient, and thus ULs cannot be derived.
“However, caffeine is not an essential nutrient, and thus ULs cannot be derived.”
Quote in the paperNot a substantial claim- Rests on an assumption: Caffeine is not an essential nutrient.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims. The quote only partly states this claim.
InterpretationreasoningOther common constituents of energy drinks at doses commonly present and/or moderate habitual alcohol consumption would not affect the safety of habitual caffeine consumption up to 400 mg per day.
“Other common constituents of”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThis approach is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support the proposed caffeine intake level of no safety concern.
“This approach is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support the proposed caffeine intake level of no safety concern.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningAdvice on the safe/recommended timing of caffeine consumption prior to physical activity cannot be provided by the derivation of an UL.
“In addition, advice on the safe/recommended timing of caffeine consumption prior to physical activity cannot be provided by the derivation of an UL.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine is not an essential nutrient.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningAs caffeine clearance in children and adolescents is at least that of adults, the same levels of no safety concern derived for adults (i.e. 5.7 mg/kg bw) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group.
“As caffeine clearance in children and adolescents is at least that of adults, the same levels of no safety concern derived for adults (i.e.5.7 mg/kg bw) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group (i.e.difference in pharmacodynamics).”
Quote in the paperNot a substantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
- Rests on an assumption: No data show a higher sensitivity to the effects of caffeine in children and adolescents (i.e., difference in pharmacodynamics).
May combine two claims.
Study design and conductnone givenThe 17 surveys from 11 Member States added in 2014 used the FoodEx2 code classification, which allows accurate reporting of 'energy drink' consumption.
“The 17 surveys from 11 Member States added in 2014 used the FoodEx2 code classification, which allows accurate reporting of “energy drink” consumption (Appendix A).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationThe 95th percentile estimates obtained from dietary surveys and age classes with fewer than 60 subjects may not be statistically robust and consequently were not considered in the table.
“(a): The 95 th percentile estimates obtained from dietary surveys and age classes with fewer than 60 subjects may not be statistically robust (EFSA, 2011b) and consequently were not considered in this table (“-”).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites EFSA, 2011b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningOwing to the differences in the methods used for data collection, direct country-to-country comparisons must be taken with caution.
“Owing to the differences in the methods used for data collection, direct country-to-country comparisons must be taken with caution.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningA 'night out', 'study session' or 'sport session' could last more than two hours, and it is not possible from the report to precisely define the time frame covered by a 'single session'.
“The Panel notes, however, that a “night out”, “study session” or “sport session” could last more than two hours, and it is not possible from the report to precisely define the time frame covered by a “single session”.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe 95th percentiles of caffeine intake on a single day were calculated to gather information on days of particularly high caffeine consumption, but these do not provide information about the proportion of subjects with high caffeine consumption days.
“The 95 th percentiles of caffeine intake on a single day have been calculated to gather information on days of particularly high caffeine consumption, but these do not provide information about the proportion of subjects with high caffeine consumption days.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSystematic reviews and meta-analysis have been used to summarise the scientific evidence whenever available.
“Systematic reviews and meta-analysis have been used to summarise the scientific evidence whenever available.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductreasoningIt is also possible that some of the brands of cocoa-beverage preparation powder consumed in particular by children are decaffeinated.
“It is also possible that some of them are decaffeinated.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningThe study could be used to calculate caffeine intakes from 'energy drinks' in a 'single session', either alone or in combination with physical exercise, but not to calculate total caffeine intakes from all sources or from sources other than 'energy drinks'.
“Therefore, the Panel considered that this study could be used to calculate caffeine intakes from “energy drinks” in a “single session”, either alone or in combination with physical exercise, but not to calculate total caffeine intakes from all sources or from sources other than “energy drinks”.”
Quote in the paperSubstantial claim- Rests on an assumption: Food frequency questionnaires specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningOwing to personal choices, individual consumers might have coffee beverages with lower or higher caffeine levels than those used in the present assessment.
“Owing to personal choices, individual consumers might therefore have coffee beverages with lower or higher caffeine levels than those used in the present assessment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningIt is not possible to exclude that some of the brands of cocoa-beverage preparation powder consumed in particular by children contain lower levels of caffeine than those used in the present assessment.
“However, it is not possible to exclude that some of the brands of cocoa-beverage preparation powder consumed in particular by children contain lower levels of caffeine than those used in the present assessment.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenThe EFSA Comprehensive European Food Consumption Database was used to calculate caffeine intake from food and beverages; it contains data from 39 surveys in 22 different European countries for a total of 66,531 participants.
“The EFSA Comprehensive European Food Consumption Database was used to calculate caffeine intake from food and beverages.It contains data from 39 surveys in 22 different European countries for a total of 66 531 participants.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe study provides useful information about the prevalence of 'energy drink' consumption in Europe, the number of 'energy drinks' (and the amount of their constituents, including caffeine) consumed in a 'single session' and the prevalence of 'energy drink' consumption in combination with physical activity.
“The Panel notes that this study provides useful information about the prevalence of “energy drink” consumption in Europe, the number of “energy drinks” (and the amount of their constituents, including caffeine) consumed in a “single session” and the prevalence of “energy drink” consumption in combination with physical activity.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe study contains information about the frequency of consumption of 'energy drinks' in combination with alcohol, but not on the amount of alcohol consumed in combination with 'energy drinks'.
“(iii) the study contains information about the frequency of consumption of “energy drinks” in combination with alcohol, but not on the amount of alcohol consumed in combination with “energy drinks”.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe EFSA report on energy drinks was used to calculate caffeine intakes from energy drinks in a single session in adults, either alone or in combination with physical exercise.
“The EFSA report on energy drinks was used to calculate caffeine intakes from”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningAlthough the time covered by the term single session is imprecise, these data give an idea of the amounts of caffeine from energy drinks consumed as a single dose or during short periods of time.
“Although the time covered by the term”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn humans, caffeine is rapidly (tmax 30-120 minutes) and completely absorbed after oral intake.
“In humans, caffeine is rapidly (t max 30-120 minutes) and completely absorbed after oral intake (Blanchard and Sawers, 1983).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Blanchard and Sawers, 1983 source
Not checked in the free run.
May combine two claims.
PremisereasoningThe Panel notes that high total caffeine intakes (500-750 mg per day) were used in the repeated-dose studies, that lower repeated doses of caffeine (<250 mg) have not been tested, and that the four-hour interval between doses is about one half-life and is likely to induce an increase in plasma caffeine concentrations throughout the day.
“The Panel notes the high total caffeine intakes used in these studies (500-750 mg per day), that lower repeated doses of caffeine (< 250 mg) have not been tested and that the time between doses (four hours), about one half-life, is likely to induce an increase in plasma caffeine concentrations throughout the day.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSingle caffeine doses of about 200-300 mg induced a mean increase in systolic blood pressure of about 3-8 mmHg and in diastolic blood pressure of about 4-6 mmHg, with high inter-individual variability.
“which induced a mean increase in SBP of about 3-8 mmHg and in DBP of about 4-6 mmHg, with high inter-individual variability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe EFSA Comprehensive Database is useful to gather data on daily caffeine intakes from all sources from unselected populations and population subgroups, as well as on the contribution of different food groups to total caffeine intakes.
“The EFSA Comprehensive Database is useful to gather data on daily caffeine intakes from all sources from unselected populations and population subgroups, as well as on the contribution of different food groups to total caffeine intakes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Lane et al. 2002, compared with placebo, caffeine significantly raised average systolic blood pressure through the entire day by about 4 mmHg and diastolic blood pressure by about 3 mmHg, while heart rate decreased by 2 bpm.
“Compared with placebo, caffeine significantly raised average SBP through the entire day by about 4 mmHg and DBP by about 3 mmHg, whereas heart rate (HR) decreased by 2 bpm, with no significant interaction between treatment and location (at work, at home).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lane et al., 2002
Not checked in the free run.
May combine two claims.
PremisecitationSouza et al. 2014 reported a significant decrease in systolic blood pressure and mean arterial blood pressure and a significant increase in heart rate after exercise with caffeine and placebo; diastolic blood pressure and heart rate (but not systolic blood pressure) were significantly higher at rest with caffeine than with placebo, as was peripheral vascular resistance in the nine hours post
“Souza et al. (2014) reported a significant decrease in SBP and MABP and a significant increase in HR after exercise with caffeine and placebo.DPB and HR (but not SPB) were significantly higher at rest with caffeine than with placebo, as was peripheral vascular resistance (SBP, DBP, HR, stroke volume or cardiac output) in the nine hours post exercise.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Souza et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Bischoff 2013 pre-study, a significant increase in systolic blood pressure (by about 7-8 mmHg) was reported following consumption of the sports drink plus caffeine in both preliminary tests, whereas consumption of the other beverages did not increase systolic blood pressure significantly, and no significant changes in diastolic blood pressure were noted.
“A significant increase in SBP (by about 7-8 mmHg) was reported following consumption of the sports drink plus caffeine in both preliminary tests, whereas consumption of the other beverages did not increase SBP significantly.No significant changes in DBP were noted.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bischoff, 2013
Not checked in the free run.
May combine two claims.
PremisecitationAll available studies in healthy individuals report a significant adverse effect of caffeine at doses of 100-250 mg on one or more measures of arterial compliance, denoting an increase in arterial stiffness, accompanied by a simultaneous increase in one or more measures of blood pressure.
“All studies available in healthy individuals (Mahmud and Feely, 2001;Vlachopoulos et al., 2003Vlachopoulos et al., , 2006;;Hartley et al., 2004;Karatzis et al., 2005;Swampillai et al., 2006) reported a significant adverse effect of caffeine (in supplements, coffee or tea) at doses of 100-250 mg on one or more measures of arterial compliance”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenParaxanthine, theophylline and theobromine are further metabolised and then excreted in the urine.
“Paraxanthine, theophylline and theobromine are further metabolised and then excreted in the urine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSignificant increases in systolic and diastolic blood pressure were reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in diastolic blood pressure but not systolic blood pressure was observed with 21 mg p-synephrine and 304 mg caffeine.
“Significant increases in SBP and DBP were also reported for a combination of 5.5 mg p-synephrine and 5.7 mg octopamine and caffeine (239.2 mg), and a significant increase in DBP, but not in SPB, was observed with 21 mg p-synephrine and 304 mg caffeine.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stohs et al., 2012 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel considers that the available resistance-exercise studies suggest an additive effect of caffeine and resistance training on blood pressure during exercise, and that caffeine could attenuate the decrease in blood pressure observed after resistance training.
“The Panel considers that, although these studies have small sample sizes and are difficult to compare, they suggest an additive effect of caffeine and resistance training on BP during exercise, and that caffeine could attenuate the decrease in BP observed after resistance training.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHigher CYP1A2 activity was found in smokers and men than in non-smokers and women, respectively.
“These authors also found a higher CYP1A2 activity in smokers and men than in non-smokers and women, respectively.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rasmussen et al., 2002 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe prevalence of energy drink consumers in the EFSA energy drink report survey is considerably higher than that calculated from the EFSA's Comprehensive Database, mainly because of differences in the definition of consumers and in the methodology used to retrieve consumption data.
“The Panel notes that the prevalence of”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAstorino et al. 2007 found that systolic blood pressure, heart rate and rate-pressure product (but not diastolic blood pressure) significantly increased during exercise with caffeine and placebo and were significantly higher before and during exercise with caffeine than with placebo, with no time by treatment interaction, suggesting an additive but not synergistic effect of caffeine and exercise.
“In the study by Astorino et al. (2007), SBP, HR and ratepressure product (but not DBP) significantly increased during exercise with caffeine and placebo and were significantly higher before and during exercise with caffeine than with placebo, but no time by treatment interaction was observed, suggesting an additive (but not synergistic) effect of caffeine and exercise on BP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Astorino et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationAstorino et al. 2013 found that systolic blood pressure significantly increased during all exercise protocols and significantly decreased post exercise with caffeine and placebo; systolic blood pressure was significantly higher before and two hours after exercise with caffeine than with placebo, whereas heart rate and diastolic blood pressure were not different; systolic blood pressure was higher,
“In the study by Astorino et al. (2013), in which four resistance exercise protocols were tested, SBP significantly increased during all exercise protocols and significantly decreased post exercise with caffeine and placebo.SBP was significantly higher before and two hours after exercise with caffeine than with placebo, whereas HR and DBP were not different between treatments.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Astorino et al., 2013 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe effect of caffeine on blood pressure was observed at single doses ranging from 80 to 300 mg, although most studies tested doses of about 200-300 mg.
“The effect was observed at single doses of caffeine ranging from 80 to 300 mg, although most studies tested doses of about 200-300 mg”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSuch differences do not allow direct between-country comparisons, and thus ranges of means and 95th percentiles across surveys should be interpreted with caution.
“Such differences do not allow direct between-country comparisons, and thus ranges of means and 95 th percentiles across surveys should be interpreted with caution.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCompared with decaffeinated coffee, caffeinated coffee significantly increases systolic blood pressure (130 mg caffeine) and diastolic blood pressure (80 and 130 mg caffeine), and decreases endothelium-dependent flow-mediated dilatation in habitual moderate coffee consumers after 12-24 hours' caffeine withdrawal.
“compared with decaffeinated coffee, caffeinated coffee has been reported to significantly increase SBP (130 mg caffeine) and DBP (80 and 130 mg caffeine), as well as to decrease endothelium-dependent flow-mediated dilatation (FMD) in habitual moderate coffee consumers after 12-24 hours' caffeine withdrawal”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationRepeated doses of 250 mg caffeine taken four hours apart may induce a significant increase in daytime blood pressure, blood pressure remains significantly elevated up to 9-12 hours after consumption of the last dose, and the effect depends on habitual caffeine consumption and is mostly observed after caffeine withdrawal.
“These studies suggest that repeated doses of 250 mg caffeine taken four hours apart may induce a significant increase in daytime BP, that BP remains significantly elevated up to 9-12 hours after consumption of the last dose and that the effect, which depends on habitual caffeine consumption, is mostly observed after caffeine withdrawal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHealth concerns expressed by national and international risk assessment bodies in relation to caffeine mostly refer to its effects on pregnancy outcomes, the cardiovascular system and the CNS.
“As indicated in the background provided by the European Commission and in Section 2.4 of this opinion, the health concerns expressed by national and international risk assessment bodies in relation to caffeine mostly refer to its effects on pregnancy outcomes, the cardiovascular system and the CNS.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe present opinion considers primarily human data and addresses specific subgroups of the population, such as pregnant and lactating women, children and subjects performing physical exercise.
“As in previous risk assessments by, for example, the SCF and EU Member State Committees, the present opinion considers primarily human data and addresses specific subgroups of the population, such as pregnant and lactating women, children and subjects performing physical exercise.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenConcerns were also raised with respect to caffeine in energy drinks, particularly if combined with alcohol, and to food supplements containing caffeine and p-synephrine.
“Concerns were also raised with respect to caffeine in so-called”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenOther primary metabolites of caffeine are theophylline and theobromine.
“Other primary metabolites are theophylline and theobromine.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe homozygote AA genotype has been considered by some authors as a fast metaboliser, while AC and CC genotypes were considered slow metabolisers.
“The homozygote AA genotype has been considered by some authors as a”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCaffeine significantly raises systolic and diastolic blood pressure in all hypertension-risk groups of men, with the strongest response among diagnosed hypertensive men (mean systolic increase of 10 mmHg) and a change 1.5 times greater than in men with optimal blood pressure.
“Caffeine significantly raised both SBP and DBP in all groups.However, the strongest response to caffeine was observed among diagnosed men (mean increase in SBP of 10 mmHg), followed by the stage 1 and high-normal groups and then by the normal and optimal groups, with a change 1.5 times greater in diagnosed hypertensive individuals than in the group with optimal BP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hartley et al., 2000 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Namdar et al. 2006, under hypoxia, caffeine significantly increased resting myocardial blood flow (1.71 ± 0.41 versus 2.22 ± 0.49 mL/min per g tissue; p < 0.001) and significantly decreased exercise-induced hyperaemic myocardial blood flow (5.15 ± 0.79 versus 3.98 ± 0.83 mL/min per g tissue; p < 0.005), leading to a decrease in myocardial flow reserve of 39% (3.13 ± 0.60 to 1.87 ± 0.45; p < 0.
“Caffeine significantly increased resting MBF (1.71 ± 0.41 mL/min per g tissue versus 2.22 ± 0.49 mL/min per g tissue; p < 0.001) and significantly decreased exercise-induced hyperaemic MBF (5.15 ± 0.79 mL/min per g tissue versus 3.98 ± 0.83 mL/min per g tissue; p < 0.005), leading to a decrease in MFR of 39 % (3.13 ± 0.60 to 1.87 ± 0.45; p < 0.005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Namdar et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the Stroke Onset Study, there was no apparent increase in risk in the hour following consumption of caffeinated tea (relative risk 0.9; 95% CI 0.4-2.0; p = 0.85) or cola (relative risk 1.0; 95% CI 0.4-2.4; p = 0.95).
“There was no apparent increase in risk in the hour following consumption of caffeinated tea (RR = 0.9; 95 % CI = 0.4-2.0;p = 0.85) or cola (RR = 1.0; 95 % CI = 0.4-2.4;p = 0.95)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mostofsky et al., 2010a, b
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of healthy trained male cyclists, compared with placebo, caffeine significantly increased core rectal temperature during exercise by up to about 0.5 degrees Celsius, whereas it had no significant effect on skin temperature, heart rate, loss of body mass or sweat rate.
“Compared with placebo, caffeine significantly increased core (rectal) temperature during exercise by up to about 0.5 C, whereas it had no significant effect on skin temperature, heart rate, loss of body mass or sweat rate.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Roelands et al., 2011 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningAlthough not formally tested, the Panel considers that changes in blood pressure and myocardial blood flow induced by repeated intakes of caffeine at doses and time intervals which would not exceed the maximum plasma concentrations achieved with a single dose of 200 mg of caffeine would also be of low clinical relevance for healthy individuals in the general population under normal environmental条件
“Although not formally tested, the Panel considers that changes in BP and MBF induced by repeated intakes of caffeine at doses and time intervals which would not exceed the maximum plasma concentrations achieved with a single dose of 200 mg of caffeine would also be of low clinical relevance for healthy individuals in the general population under normal environmental conditions.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
PremisecitationIn healthy males who were low habitual caffeine consumers (<100 mg/day), 5 mg/kg body weight of caffeine consumed daily for four consecutive days did not lead to significant changes in hydration measures compared with placebo.
“Similar results were obtained in two studies with a similar design conduced in healthy males, in which 5 mg/kg bw of caffeine were consumed daily for four consecutive days by low habitual caffeine consumers (< 100 mg/day) (Silva et al., 2013)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Silva et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of nonhabitual caffeine consumers, after caffeine consumption, sweating rate was significantly higher and the onset of sweating was significantly delayed during exercise.
“After caffeine consumption, sweating rate was significantly higher and the onset of sweating was significantly delayed during exercise.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kim et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Baylin et al. 2006, patients with light or occasional coffee intake (up to one cup per day; n = 66) had a relative risk of myocardial infarction in the hour after taking coffee of 4.14 (95% CI 2.03-8.42), those with moderate consumption (two to three cups per day; n = 280) had a relative risk of 1.60 (95% CI 1.16-2.21), and heavy drinkers (four or more cups per day; n = 120) had a relative risk
“patients with light/occasional intake of coffee (up to one cup per day; n = 66) had a RR of MI in the hour after taking coffee of 4.14 (95 % CI = 2.03-8.42),those with moderate consumption of coffee (two to three cups per day; n = 280) had a RR of 1.60 (95 % CI = 1.16-2.21),and heavy drinkers (four or more cups per day; n = 120) had a RR of 1.06 (95 % CI = 0.69-1.63;p = 0.006, test for interaction”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baylin et al., 2006 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe effect of caffeine on blood pressure may be more pronounced in subjects with high blood pressure and after caffeine withdrawal.
“The effect may be more pronounced in subjects with high BP and after caffeine withdrawal.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
PremisecitationIn a study of male recreational runners, no significant differences in core temperature were observed between the caffeine and placebo conditions.
“No significant differences in core temperature were observed between the caffeine and placebo conditions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ping et al., 2010
Not checked in the free run.
May combine two claims.
InterpretationcitationCaffeine antagonises the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries in a dose-dependent manner, and this effect leads to a reduction of myocardial blood flow and myocardial flow reserve during intense physical exercise, primarily in subjects with coronary artery disease, but also in healthy subjects to some degree.
“The Panel notes that caffeine antagonises the vasodilator effect of adenosine and other A 2A receptor agonists in the coronary arteries in a dose-dependent manner and this effect leads to a reduction of MBF and MFR during intense physical exercise, primarily in subjects with CAD, but also in healthy subjects to some degree.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine is a non-selective competitive A2A receptor antagonist that counteracts the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.
- Rests on an assumption: The cardiac hyperaemic response to physical exercise is primarily mediated by endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.
May combine two claims.
PremisecitationNamdar et al. 2009 found that resting myocardial blood flow was not significantly affected by caffeine in either patients with coronary artery disease or healthy controls; exercise-induced hyperaemic myocardial blood flow and myocardial flow reserve significantly decreased 50 minutes after caffeine ingestion; myocardial flow reserve decreased in healthy subjects by 14% (p < 0.05) and in coronary-
“Resting MBF was not significantly affected by caffeine consumption in either group.Exercise-induced hyperaemic MBF and MFR significantly decreased 50 minutes after caffeine ingestion compared with baseline measurements without caffeine.MFR significantly decreased in healthy subjects by 14 % (p < 0.05) and in CAD patients by 18 % (p < 0.05) in remote segments and by 25 % (p < 0.01) in stenotic”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Namdar et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the Stroke Onset Study, the risk of stroke onset was 2.3-fold higher (95% CI 1.4-4.0; p = 0.002) within one hour of stroke and the relative risk was 1.6 (95% CI 1.0-2.5; p = 0.05) in the second hour after alcohol use compared with periods of non-use; the relative risk returned to baseline thereafter.
“The risk of stroke onset was 2.3-fold higher (95 % CI = 1.4-4.0;p = 0.002) within one hour of stroke and RR was 1.6 (95 % CI = 1.0-2.5;p = 0.05) in the second hour after alcohol use compared with periods of non-use.The RR returned to baseline thereafter.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mostofsky et al., 2010a, b
Not checked in the free run.
May combine two claims.
PremisecitationIn Selb Semerl and Selb 2004, the estimated relative risk of dying within one hour after coffee consumption was 1.73 (95% CI 1.13-2.65) and was 3.00 (95% CI 1.61-5.68) within two hours after alcohol consumption.
“The estimated RR of dying within one hour after coffee consumption was 1.73 (95 % CI = 1.13-2.65)and was 3.00 (95 % CI = 1.61-5.68)within two hours after alcohol consumption.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Selb Semerl and Selb, 2004
Not checked in the free run.
May combine two claims.
InterpretationreasoningAvailable data suggest that blood pressure generally increases 30 minutes after caffeine consumption, reaches a peak after 60-90 minutes and returns to baseline after about two to four hours, which is consistent with the pharmacokinetics of caffeine.
“The available data suggest that BP generally increases 30 minutes after caffeine consumption, reaches a peak after 60-90 minutes and returns to baseline after about two to four hours, which is consistent with the pharmacokinetics of caffeine.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Baylin et al. 2006, usual coffee intake was the only variable that significantly modified the risk; age, sex, physical activity, history of diabetes, hypercholesterolaemia, hypertension, smoking status or having at least three or less than three risk factors for disease did not significantly modify the risk.
“This was the only variable that significantly modified the risk; age, sex or physical activity, history of diabetes, hypercholesterolaemia, hypertension, smoking status or having at least three (n = 101) or less than three of these risk factors for disease did not significantly modify the risk.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baylin et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationGaemperli et al. 2008 found that myocardial blood flow was not significantly different between caffeine and placebo at rest (1.13 ± 0.04 versus 1.06 ± 0.05 mL/min per g) or under stress (2.98 ± 0.14 versus 3.05 ± 0.14 mL/min per g), and there was no difference in myocardial flow reserve (2.75 ± 0.16 versus 2.97 ± 0.16 mL/min per g); the data show with one-sided 95% confidence that any myocardial
“The MBF (mean ± standard error of the mean (SEM)) was not significantly different between caffeine and placebo at rest (1.13 ± 0.04 mL/min per g versus 1.06 ± 0.05 mL/min per g) or under stress (2.98 ± 0.14 mL/min per g versus 3.05 ± 0.14 mL/min per g).There was no difference in MFR between caffeine and placebo (2.75 ± 0.16 mL/min per g versus 2.97 ± 0.16 mL/min per g).The data show with one-sided”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gaemperli et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of healthy men, compared with placebo, single doses of 9 mg/kg body weight caffeine consumed after four days of caffeine abstinence increased core rectal body temperature by 0.20-0.30 degrees Celsius, but not skin temperature.
“Compared with placebo, single doses of 9 mg/kg bw caffeine consumed after four days of caffeine abstinence also increased core (rectal) body temperature (by 0.20-0.30C), but not skin temperature, in 10 healthy men”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cheuvront et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of cyclists, rectal temperature in the caffeine plus carbohydrate-electrolyte trials was significantly higher than in placebo trials by 0.19 to 0.29 degrees Celsius after 60 minutes, but was significantly higher than in carbohydrate-electrolyte trials only in the last 15 minutes.
“Rectal temperature in the CAF + CE trials was significantly higher than in the placebo trials (by 0.19 to 0.29 C) after 60 minutes, but was significantly higher than in the CE trials only in the last 15 minutes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Millard-Stafford et al., 2007
Not checked in the free run.
May combine two claims.
PremisecitationTejani et al. 2014 showed that doses of caffeine of 200 mg and 400 mg significantly decreased the number of cardiac segments with reversible vascularisation defects, suggesting that caffeine at doses of 200 mg or greater could significantly counteract the vasodilator effect of regadenoson in the coronary arteries in patients with coronary artery disease.
“a similar study using regadenoson stress-single-photon emission computed tomography (SPECT) MPI in patients with CAD showed that doses of caffeine of 200 mg and 400 mg significantly decreased the number of cardiac segments with reversible vascularisation defects, suggesting that caffeine at doses of 200 mg or greater could significantly counteract the vasodilator effect of regadenoson in the”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tejani et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationSingle doses of caffeine of about 100-600 mg consumed prior to exercise did not lead to a significant increase in urinary volume or a significantly different water retention during dehydration, and did not induce adverse water-electrolyte imbalances compared with water or placebo, particularly in habitual caffeine consumers.
“Single doses of caffeine of about 100-600 mg consumed prior to exercise, however, did not lead to a significant increase in urinary volume or a significantly different water retention during dehydration, and did not induce adverse water-electrolyte imbalances compared with water or placebo, particularly in habitual caffeine consumers (Armstrong, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Armstrong, 2002 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Baylin et al. 2006, the relative risk after coffee intake was not significantly increased when two or three hours were selected as the hazard period, suggesting that the risk dropped to basal conditions between one and two hours after drinking coffee.
“The RR after coffee intake was not significantly increased when two or three hours were selected as the hazard period, suggesting that the risk dropped to basal conditions between one and two hours after drinking coffee.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baylin et al., 2006 source
Not checked in the free run.
May combine two claims.
InterpretationcitationRepeated doses of caffeine (250 mg) taken four hours apart also induce an increase in blood pressure (of about 3-4 mmHg) which may last up to 9-12 hours, particularly after caffeine withdrawal.
“The Panel also notes that repeated doses of caffeine (250 mg) taken four hours apart also induce an increase in BP (of about 3-4 mmHg) which may last up to 9-12 hours, particularly after caffeine withdrawal.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Premisenone givenThe Panel notes that the effect of higher doses of caffeine on coronary flow reserve has not been tested.
“The Panel notes that the effect of higher doses of caffeine has not been tested.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the Stroke Onset Study, the association between ischaemic stroke in the hour after coffee consumption was apparent only among those consuming at most one cup per day but not for patients who consumed coffee more regularly (p for trend = 0.002).
“The association between ischaemic stroke in the hour after coffee consumption was apparent only among those consuming at most one cup per day but not for patients who consumed coffee more regularly (p for trend = 0.002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mostofsky et al., 2010a, b
Not checked in the free run.
May combine two claims.
PremisecitationIn a study using the same caffeine dose, mean body temperature was significantly higher by 0.27 degrees Celsius one hour after caffeine consumption than with placebo only at the beginning of exercise, whereas no differences between caffeine and placebo were observed with respect to core, skin or mean temperature during exercise.
“Conversely, in another study using the same caffeine dose, mean body temperature was significantly higher (by 0.27 C) one hour after caffeine consumption than with placebo only at the beginning of the exercise (cycling for 30 minutes at 50 % of VO 2peak in a 40 °C and 25 % relative humidity environment), whereas no differences between caffeine and placebo were observed with respect to core, skin”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ely et al., 2011 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenChildren appear to develop tolerance to the central effects of caffeine at high habitual intakes (>300 mg per day) and show withdrawal symptoms.
“Children appear to develop tolerance to the central effects of caffeine at high habitual intakes (> 300 mg per day) and show withdrawal symptoms.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Jee et al. (1999), overall pooled estimates of treatment effect associated with coffee drinking were 2.4 mmHg (95% CI 1.0-3.7) for SBP and 1.2 mmHg (95% CI 0.4-2.1) for DBP.
“The overall pooled estimates of treatment effect associated with coffee drinking were 2.4 mmHg (95 % CI = 1.0-3.7 mmHg) for SBP and 1.2 mmHg for DBP (95 % CI = 0.4-2.1 mmHg).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jee et al., 1999 source
Not checked in the free run.
May combine two claims.
PremisecitationNo significant differences in self-rated anxiety or investigator-rated items of behaviour were found between placebo and caffeine at any dose.
“No significant differences in self-rated anxiety or investigatorrated items of behaviour were found between placebo and caffeine at any dose.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Elkins et al., 1981 source
Not checked in the free run.
- cites Rapoport et al., 1981b
Not checked in the free run.
May combine two claims.
PremisecitationIn a human intervention study, caffeine significantly increased urinary output and natriuresis, whereas taurine had no effect on either of these outcomes and did not appear to modify the diuretic effects of caffeine when administered simultaneously.
“Caffeine significantly increased urinary output and natriuresis, whereas taurine had no effect on either of these outcomes and did not appear to modify the diuretic effects of caffeine when administered simultaneously.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Riesenhuber et al., 2006 source
Not checked in the free run.
May combine two claims.
Premiseown dataCaffeine significantly increased SBP and DBP in studies with a majority of women (n=8), but not in those with a majority of men (n=17).
“Caffeine significantly increased SBP and DBP in studies with a majority of women (n = 8), but not in those with a majority of men (n = 17).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationScores for feeling nervous or jittery were significantly higher for the 3 mg/kg body weight dose than for placebo, and for the 10 mg/kg body weight dose than for the 3 mg/kg body weight dose.
“Scores for this side effect were significantly higher for the 3 mg/kg bw dose than for placebo, and for the 10 mg/kg bw dose than for the 3 mg/kg bw dose.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Elkins et al., 1981 source
Not checked in the free run.
- cites Rapoport et al., 1981b
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of children, caffeine intake was not significantly associated with any measures of self-reported anxiety, whereas a significant linear association was reported between caffeine concentrations in saliva and the anxiety state item in the VAA-R scale only.
“Caffeine intake was not significantly associated with any of these measures of self-reported anxiety, whereas a significant linear association was reported between caffeine concentrations in saliva and the anxiety state item in the VAA-R scale only.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bernstein et al., 1994 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenHigher intakes of caffeine (10 mg/kg body weight per day) may increase anxiety and adversely affect behaviour and sleep in habitual low caffeine consumers.
“whereas higher intakes (10 mg/kg bw per day) may increase anxiety and adversely affect behaviour and sleep in habitual low caffeine consumers.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe Panel notes that the Noordzij et al. (2005) meta-analysis shows a sustained BP-raising effect of continuous (≥7 days) caffeine consumption at doses of about 400 mg/day, but not at lower doses.
“The Panel notes that this metaanalysis shows a sustained BP-raising effect of continuous (≥ 7 days) caffeine consumption at doses of about 400 mg per day, but not at lower doses.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThe Panel notes the scarcity of studies available, the low number of children enrolled, and the heterogeneity of the studies regarding testing conditions, which hampers the comparability of the results.
“However, the Panel also notes the scarcity of studies available and the low number of children enrolled, as well as the heterogeneity of the studies regarding the testing conditions (e.g. with respect to the tools used to assess anxiety and behavioural changes, and to the caffeine status before testing), which hampers the comparability of the results.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Noordzij et al. (2005), after excluding nine coffee trials with an open design, changes in SBP were 2.81 mmHg (95% CI 1.08-4.53) and in DBP were 1.17 mmHg (95% CI 0.54-1.81); HR did not change significantly.
“After excluding nine coffee trials with an open design, changes in SBP were 2.81 mmHg (95 % CI = 1.08-4.53mmHg) and in DBP were 1.17 mmHg (95 % CI = 0.54-1.81mmHg).HR did not change significantly.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Jee et al. (1999), duration of run-in and coffee dose significantly modified the effect of coffee on BP; studies with shorter run-ins and the highest doses of coffee showed the biggest effect on BP.
“Duration of run-in and coffee dose significantly modified the effect of coffee on BP.Studies with shorter run-ins and the highest doses of coffee showed the biggest effect on BP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jee et al., 1999 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Noordzij et al. (2005) stratified analyses, type of intervention, sex and caffeine dose significantly affected changes in BP, whereas age, baseline BP, baseline caffeine intake and study duration did not.
“the type of intervention, sex and caffeine dose significantly affected changes in BP, whereas age, baseline BP, baseline caffeine intake and study duration (< 6 weeks or ≥ 6 weeks) did not.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningThe Panel considers that intravenous route of administration is not appropriate to investigate the effects of oral caffeine consumption on anxiety.
“The Panel considers that this route of administration is not appropriate to investigate the effects of oral caffeine consumption on anxiety.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nickell and Uhde (1994)
Not checked in the free run.
May combine two claims.
PremisecitationIn the meta-analysis by Noordzij et al. (2005), combining all caffeine and coffee studies, SBP significantly increased by 2.04 mmHg (95% CI 1.10-2.99) and DBP significantly increased by 0.73 mmHg (95% CI 0.14-1.31).
“Combining all caffeine and coffee studies, SBP significantly increased by 2.04 mmHg (95 % CI = 1.10-2.99mmHg) and DBP significantly increased by 0.73 mmHg (95 % CI = 0.14-1.31mmHg).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIn children, single doses of caffeine of 3 mg/kg body weight do not appear to induce anxiety or behavioural changes, although inter-individual variability in relation to habitual caffeine intakes has not been studied.
“In children, similar single doses of caffeine on a weight basis (3 mg/kg bw) do not appear to induce anxiety or behavioural changes, although inter-individual variability in relation to habitual caffeine intakes has not been studied.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Steffen et al. (2012), heterogeneity in pooled SBP (I2=72%) and DBP (I2=41%) analysis was explored by type of coffee, sex and prestudy BP in subgroup analyses, but no significant interactions were found.
“Heterogeneity in the pooled SBP (I 2 = 72 %) and DBP (I 2 = 41 %) analysis was explored by considering type of coffee, sex and prestudy BP in subgroup analyses, but no significant interactions were found.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Steffen et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationPrevious meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages, mostly coffee, and the risk of cardiovascular disease from case-control studies, but not from prospective cohort studies.
“Previous meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages (mostly coffee) and the risk of CVD from case-control studies, but not from prospective cohort studies (Greenland, 1993;Kawachi et al., 1994;Sofi et al., 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationCaffeine from any source at doses ≥410 mg/day significantly increased SBP (mean 2.98, 95% CI 2.15-3.80) and DBP (mean 1.96, 95% CI 1.19-2.73), whereas caffeine doses <410 mg/day did not (SBP mean 0.72, 95% CI -0.35 to 1.78; DBP mean -0.52, 95% CI -1.62 to 0.57).
“Caffeine from any source at doses ≥ 410 mg per day significantly increased SBP (mean 2.98, 95 % CI = 2.15-3.80)and DBP (mean 1.96, 95 % CI = 1.19-2.73),whereas caffeine doses < 410 mg per day did not (change in SBP = mean 0.72, 95 % CI = -0.35 to 1.78; change in DBP = mean -0.52, 95 % CI = -1.62 to 0.57).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe tools used to assess self-reported anxiety have been developed to discriminate between children with high and low anxiety levels, rather than to assess changes in anxiety.
“The Panel also notes that the above-mentioned tools to assess self-reported anxiety have been developed to discriminate between children with high and low anxiety levels, rather than to assess changes in anxiety.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Interpretationnone givenThe Panel considers that results obtained in children with attention deficit hyperactivity disorders cannot be extrapolated to children in the general population.
“The Panel considers that results obtained in children with ADHD cannot be extrapolated to children in the general population and will not be further considered in this opinion”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Noordzij et al. (2005), changes in SBP and DBP for coffee (18 strata) were 1.22 mmHg (0.52-1.92) and 0.49 mmHg (-0.06 to 1.04), and for caffeine (seven strata) were 4.16 mmHg (2.13-6.20) and 2.41 mmHg (0.98-3.84).
“Changes (mean and 95 % CI) in SBP and DBP for coffee (18 strata) were 1.22 mmHg (0.52-1.92 mmHg) and 0.49 mmHg (-0.06 to 1.04 mmHg), and for caffeine (seven strata) were 4.16 mmHg (2.13-6.20 mmHg) and 2.41 mmHg (0.98-3.84 mmHg).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Noordzij et al., 2005 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel notes that caffeine intakes were not significantly associated with anxiety, and that caffeine concentrations in saliva were generally not associated with self-reported measures of anxiety in the Bernstein et al. study.
“The Panel notes that caffeine intakes were not significantly associated with anxiety, and that caffeine concentrations in saliva were generally not associated with self-reported measures of anxiety in this study.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bernstein et al., 1994 source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenThe Panel notes that the studies available at doses of ≤3 mg/kg body weight have small sample sizes and are heterogeneous in design, and that doses between 3 and 10 mg/kg body weight per day have not been investigated.
“The Panel also notes that the studies available at doses of ≤ 3 mg/kg bw have small sample sizes and are heterogeneous in design, and that doses between 3 and 10 mg/kg bw per day have not been investigated.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn Steffen et al. (2012), the pooled weighted difference in mean change of SBP was -0.55 mmHg (95% CI -2.46 to 1.36) and of DBP was -0.45 mmHg (95% CI -1.52 to 0.61).
“The pooled weighted difference in mean change of SBP was -0.55 mmHg (95 % CI = -2.46 to 1.36 mmHg) and of DBP was -0.45 mmHg (95 % CI = -1.52 to 0.61 mmHg).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Steffen et al., 2012 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIn the context of this opinion, a reduction in the perceived exertion or effort during exercise can be considered a potential adverse health effect for the general population under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that may compromise the cardiovascular and/or musculoskeletal systems.
“In the context of this opinion, however, a reduction in the perceived exertion/effort during exercise can be considered a potential adverse health effect for the general population (not limited to adults performing endurance exercise willing to obtain such an effect) under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.
Probably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenHigher doses of alcohol have not been systematically investigated.
“Higher doses of alcohol have not been systematically investigated.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPalatini et al. (2007) reported an increased risk of developing sustained hypertension associated with caffeinated coffee consumption compared with no consumption, with no significant difference in risk among categories of coffee intake.
“the study by Palatini et al. (2007) reported an increased risk of developing sustained hypertension associated with caffeinated coffee consumption compared with no consumption, with no significant difference in risk among categories of coffee intake”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Palatini et al., 2007
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel notes that although the case-control study suggests polymorphisms of CYP1A2 may affect risk of MI in relation to caffeine consumption, which may be further affected by HTR2A polymorphisms, the results have not yet been replicated and the hypothesis has not been tested in prospective cohort studies.
“The Panel notes that, although this case-control study suggests that polymorphisms of the CYP1A2 gene may affect the risk of MI in relation to caffeine consumption, which may be further affected by polymorphisms of the serotonin receptor gene HTR2A, the results have not yet been replicated and the hypothesis has not been tested in prospective cohort studies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cornelis et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Ding et al. (2014), compared with the lowest coffee consumption, RRs of CHD were 0.89 (95% CI 0.85-0.94) for the first category (median 1.5 cups/day), 0.90 (0.84-0.97) for the second (3.5 cups/day), and 0.93 (0.84-1.02) for the third (5 cups/day).
“Compared with the lowest category of coffee consumption (median zero cups per day), the RRs of CHD were 0.89 (95 % CI = 0.85-0.94)for the first category (median 1.5 cups per day), 0.90 (95 % CI = 0.84-0.97)for the second category (median 3.5 cups per day) and 0.93 (95 % CI = 0.84-1.02)for the third category of coffee consumption (median five cups per day).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Ding et al. (2014), coffee consumption was inversely associated with risk of CVD up to eight cups/day; no association was observed between coffee consumption and CHD risk at higher intake.
“Coffee consumption was inversely associated with the risk of CVD up to eight cups per day.No association was observed between coffee consumption and CHD risk at higher intake.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ding et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Sofi et al. (2007), cumulative RRs for CHD were 1.04 (95% CI 0.90-1.19) for one to two cups/day, 1.05 (0.90-1.22) for three to four cups/day, and 1.16 (0.95-1.41) for four or more cups/day compared with none or less than one cup/day.
“The cumulative RR for all cohort studies was 1.04 (95 % CI = 0.90-1.19)for the first category of coffee consumption (one to two cups per day), 1.05 (95 % CI = 0.90-1.22)for the second category (three to four cups per day) and 1.16 (95 % CI = 0.95-1.41)for the third category (four or more cups per day) compared with the reference category (none or less than one cup per day).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sofi et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationIn NHS I and II, significant inverse associations between intake of caffeinated coffee and risk of hypertension were observed in both cohorts, but not with decaffeinated coffee.
“In multivariate models including beverage type, rather than actual caffeine intake, significant inverse associations between intake of caffeinated coffee (p for trend = 0.02 and 0.03 in NHS I and NHS II, respectively) and the risk of hypertension was observed in both cohorts, but an association was not found with decaffeinated coffee (p for trend = 0.08 and 0.67 in NHS I and NHS II, respectively).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
The quote only partly states this claim.
PremisecitationHodgson et al. (1999) found that changes in 24-hour ambulatory BP did not differ significantly among interventions (250 mg caffeine in hot water, black tea or green tea, five cups/day for seven days) with respect to baseline in 13 subjects with high-normal SBP and DBP.
“Changes in 24-hour ambulatory BP did not differ significantly among interventions with respect to baseline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hodgson et al., 1999 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe two Palatini studies exclusively enrolled subjects with never-treated stage 1 hypertension at baseline and do not provide information about the general (unselected) adult population.
“However, these two studies exclusively enrolled subjects with never-treated stage 1 hypertension at baseline (incidence of hypertension requiring medication of 50.7 % in the six-year follow-up) and do not provide information about the general (unselected) adult population.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Palatini et al., 2007
Not checked in the free run.
- cites Palatini et al., 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a case-control study (Cornelis et al., 2006), among carriers of the slow *1F allele of CYP1A2, multivariate-adjusted ORs for non-fatal MI associated with consumption of less than one, one, two to three and four or more cups of coffee per day were 1.00, 0.99, 1.36, and 1.64, respectively; corresponding ORs for the rapid *1A/*1A genotype were 1.00, 0.75, 0.78, and 0.99 (p=0.04 for gene by coffee
“In total, 55 % of cases (n = 1 114) and 54 % of controls (n = 1 082) were carriers of the slow *1F allele, for which the multivariate-adjusted odds ratios (ORs) and 95 % CIs for non-fatal MI associated with the consumption of less than one, one, two to three and four or more cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83)and 1.64 (1.14-2.34),respectively.Cor”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cornelis et al., 2006 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Wu et al. (2009), pooled RRs of CHD for all studies combined were 0.96 (95% CI 0.87-1.06) for moderate, 1.04 (0.92-1.17) for heavy, and 1.07 (0.87-1.32) for very heavy coffee consumption.
“The pooled RRs of CHD for all studies combined were 0.96 (95 % CI = 0.87-1.06)for the moderate, 1.04 (95 % CI = 0.92-1.17)for the heavy and 1.07 (95 % CI = 0.87-1.32)for the very heavy categories of coffee consumption.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al., 2009
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe Panel notes the low number of coffee abstainers and the low number of incident cases of hypertension in this group in Uiterwaal et al. (2007).
“The Panel notes the low number of coffee abstainers included in the study and the low number of incident cases of hypertension in this group.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Uiterwaal et al., 2007 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn Grobbee et al. (1990), risk of CHD, CABG, PTCA, stroke or total CVD did not increase significantly across categories of caffeinated or decaffeinated coffee consumption or total caffeine intake, except for a significant p trend (0.04) for increased risk of CABG and PTCA in the highest category of decaffeinated coffee consumption.
“The risk of CHD (total, non-fatal MI and fatal CHD), coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA), stroke or total CVD did not increase significantly across categories of caffeinated or decaffeinated coffee consumption (one or less cup, two to three cups and four or more cups per day compared with none) or of total caffeine intake (quintiles: 0-”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Grobbee et al., 1990 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Uiterwaal et al. (2007), higher coffee intake was not associated with an increased risk of hypertension, whereas coffee abstainers showed a decreased risk compared with the reference category.
“In the study by Uiterwaal et al. (2007), where the category of more than zero to three cups per day was taken as the reference, higher coffee intake was not associated with an increased risk of hypertension, whereas coffee abstainers showed a decreased risk compared with the reference category.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Uiterwaal et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationIn NHS II, caffeinated tea intake was significantly associated with incident hypertension, but not in NHS I.
“A significant association between caffeinated tea intake and incident hypertension was found in the cohort of younger women in NHS II (p for trend = 0.01), but not in NHS I (p for trend = 0.79).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Greenberg et al. (2008), risk of CHD, stroke and total CVD did not increase significantly across categories of total caffeine intake or caffeinated beverages consumed; risk of CVD and CHD mortality significantly decreased across categories in subjects ≥65 years, normotensive individuals and subjects with untreated stage 1 hypertension, whereas decaffeinated beverages did not affect risk.
“The risk of CHD, stroke and total CVD did not increase significantly across categories of total caffeine intake (> 30, 30-100, 100-350 and ≥ 350 mg per day) or of caffeinated beverages consumed (< 0.5, 0.5 to < 2, 2 to < 4 and ≥ 4 servings per day).The risk of CVD and CHD mortality significantly decreased across categories of caffeine and caffeinated beverages consumption in subjects ≥ 65 years of”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Greenberg et al., 2008 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe Panel notes that almost no study reported an increased risk of CHD associated with habitual coffee consumption of four or less cups/day, corresponding to about 400 mg/day caffeine, which may be an underestimation of total caffeine intake.
“The Panel also notes that almost no study reported an increased risk of CHD associated with habitual coffee consumption of four or less cups per day, corresponding to about 400 mg per day of caffeine, which may be an underestimation of total caffeine intake considering that other sources of caffeine were not taken into account in the majority of the studies”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn NHS I and II, categorical analysis found an inverse U-shaped association between caffeine consumption and incident hypertension; compared with the lowest quintile, the third quintile had significant 14% and 15% increased risk, whereas no increased risk was observed in the highest quintile.
“Using categorical analysis, an inverse U-shaped association between caffeine consumption and incident hypertension was found.Compared with participants in the lowest quintile of caffeine consumption (mean intakes 14.8 and 19.6 mg per day), those in the third quintile (209.3 and 174.7 mg per day) had a significant 14 % and 15 % increased risk of hypertension in NHS I and NHS II, respectively,”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn Hu et al. (2007), caffeinated coffee drinking was positively associated with initiation of antihypertensive treatment (p for trend=0.024), but the association was no longer significant when baseline BP was considered.
“Caffeinated coffee drinking was also positively associated with initiation of antihypertensive treatment (p for trend = 0.024 across categories of coffee intake: zero to one cup per day, two to three cups per day, four to five cups per day, six to seven cups per day and eight or more cups per day) in the study by Hu et al. (2007), which enrolled never-treated hypertensive and normotensive subjects”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hu et al., 2007
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThe Panel notes that the interaction between coffee intake and sex on the incidence of hypertension was not statistically significant, and thus subgroup analyses by sex were not statistically justified.
“The Panel also notes that the interaction between coffee intake and sex on the incidence of hypertension was not statistically significant, and thus subgroup analyses by sex were not statistically justified.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenAlthough polymorphisms of the CYP1A2 gene may affect the risk of hypertension associated with caffeine consumption, this hypothesis has not been tested prospectively in unselected populations.
“Although it has been suggested that polymorphisms of the CYP1A2 gene may affect the risk of hypertension associated with caffeine consumption and explain in part the different findings among studies, this hypothesis has not been tested prospectively in unselected populations.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn a dose-response meta-analysis, the best-fitting model showed an inverse J-shaped curve (p for quadratic <0.001), with risk of hypertension increasing up to three cups/day (RR 1.07, 95% CI 0.97-1.20) and decreasing with higher intake (RR for six cups vs zero: 0.99, 95% CI 0.89-1.10).
“In a dose-response meta-analysis, the best-fitting model showed an inverse “J-shaped” curve (p for quadratic term < 0.001), with the risk of hypertension increasing up to three cups per day (RR for the comparison of three cups with zero cups per day: 1.07, 95 % CI = 0.97-1.20)and decreasing with higher intake (RR for the comparison of six cups with zero cups per day: 0.99, 95 % CI = 0.89-1.10).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationIn Jee et al. (1999), a significant effect of caffeinated coffee on BP was observed only by pooling studies using five or more cups of coffee, but not in studies using ≤4.5 cups.
“A significant effect of caffeinated coffee on BP was observed only by pooling studies using five or more cups of coffee, but not in studies using ≤ 4.5 cups.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jee et al., 1999 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel notes that different types of caffeinated beverages were differently associated with risk of incident hypertension: caffeinated coffee inversely, caffeinated tea (in one cohort) and cola beverages directly.
“The Panel also notes that different types of caffeinated beverages were differently associated with the risk of incident hypertension.Whereas caffeinated (but not decaffeinated) coffee was inversely associated with the risk of hypertension, caffeinated tea (in one cohort) and cola beverages (in both cohorts) were directly associated with that risk.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Winkelmayer et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the CARE Study Group, caffeine consumption of > 200 mg per day during pregnancy was associated with a reduction in birth weight of about 60-70 g, with a significant trend for greater reduction in birth weight with higher caffeine intake (p = 0.004).
“Caffeine consumption of > 200 mg per day during pregnancy was associated with a reduction in birth weight of about 60-70 g, with a significant trend for greater reduction in birth weight with higher caffeine intake (p = 0.004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites CARE Study Group, 2008 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningProspective cohort studies on the relationship between habitual caffeine intake and long-term changes in BP and on the risk of incident hypertension are conflicting and difficult to interpret.
“Prospective cohort studies on the relationship between habitual caffeine intake and long-term changes in BP and on the risk of incident hypertension are conflicting and difficult to interpret.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationOverall, the results from case-control and cross-sectional studies support a positive association between caffeine intake and the risk of adverse birth weight-related outcomes, whereas the relationship between caffeine consumption during pregnancy and other pregnancy outcomes was less consistent.
“Overall, the results from these studies support a positive association between caffeine intake and the risk of adverse birth weight-related outcomes, whereas the relationship between caffeine consumption during pregnancy and other pregnancy outcomes (e.g. in relation to length of gestation or fetal death) was less consistent (COT, 2008)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites COT, 2008
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel notes that the CARE Study Group shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight- and fetal death-related outcomes, and that the risk becomes significant at caffeine doses ≥ 200 mg per day for FGR and at ≥ 300 mg per day for late miscarriage or stillbirth.
“The Panel notes that this study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-and fetal death-related outcomes, and that the risk becomes significant at caffeine doses ≥ 200 mg per day for FGR and at ≥ 300 mg per day for late miscarriage or stillbirth.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the Sengpiel et al. (2013) study, total and coffee caffeine intakes were significantly associated with higher odds for SGA in all three SGA models, and with soft drink and black tea caffeine in two SGA models.
“Total and coffee caffeine intakes were significantly associated with higher odds for SGA in all three SGA models, and with soft drink and black tea caffeine in two SGA models.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sengpiel et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSimilar results were obtained in the meta-analysis by Kim et al. (2012).
“Similar results were obtained in the meta-analysis by Kim et al. (2012)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kim et al. (2012) source
Not checked in the free run.
May combine two claims.
PremisecitationIn the Sengpiel et al. (2013) study, total caffeine and soft drink caffeine were significantly associated with decreased gestational length in non-coffee drinkers, whereas no association was found with black tea or chocolate caffeine.
“Conversely, total caffeine and soft drink caffeine were significantly associated with decreased gestational length in non-coffee drinkers, whereas no association was found with black tea or chocolate caffeine.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sengpiel et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the McMahon et al. (2014) study, both genotypes were individually associated with total caffeine consumption and with the consumption of caffeinated drinks at all time points, but not with the consumption of decaffeinated drinks.
“Both genotypes were individually associated with total caffeine consumption and with the consumption of caffeinated drinks (coffee and tea) at all time points, but not with the consumption of decaffeinated drinks.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McMahon et al., 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the McMahon et al. (2014) study, the proportion of phenotypic variance explained by the two genotypes was small: CYP1A1 accounted for 0.15-0.88%, AHR for 0.04-0.048%, and the two combined for about 0.16-1.28%.
“the proportion of phenotypic variance (i.e.observed variability in caffeine intake) explained by these two genotypes was small: CYP1A1 accounted for 0.15-0.88%, AHR accounted for 0.04-0.048% and the two combined accounted for about 0.16-1.28%.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McMahon et al., 2014 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe Panel notes that the Sengpiel et al. (2013) study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-related outcomes, with risk becoming statistically significant at caffeine doses > 50 mg per day but increasing notably at > 200 mg per day.
“The Panel notes that this study shows a dose-dependent positive association between caffeine intake during pregnancy and adverse birth weight-related outcomes.The risk becomes statistically significant at caffeine doses > 50 mg per day but increases notably at > 200 mg per day.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn the study by Lopez-Garcia et al. (2009), total caffeine intake, consumption of caffeinated beverages and consumption of decaffeinated coffee were not significantly associated with an increased risk of stroke.
“Total caffeine intake, consumption of caffeinated beverages (tea, caffeinated soft drink and caffeinated coffee) and consumption of decaffeinated coffee were not significantly associated with an increased risk of stroke.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lopez-Garcia et al. (2009)
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe conclusion that single doses of caffeine up to 200 mg are unlikely to induce clinically relevant changes in MBF may not hold when caffeine is consumed prior to physical exercise under unusual environmental conditions such as very high altitude.
“The Panel notes that this may not be the case when caffeine is consumed prior to physical exercise under unusual environmental conditions (e.g.very high altitude).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSingle doses of caffeine of no concern derived for adults (3 mg/kg bw per day) may also apply to children, considering that caffeine clearance in children and adolescents is at least that of adults, and that the limited studies available on the acute effects of caffeine on anxiety and behaviour in children and adolescents support this level of no concern.
“The Panel considers that single doses of caffeine of no concern derived for adults (3 mg/kg bw per day) may also apply to children, considering that caffeine clearance in children and adolescents is at least that of adults, and that the limited studies available on the acute effects of caffeine on anxiety and behaviour in children and adolescents support this level of no concern.”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
May combine two claims.
Study design and conductcitation95th percentile caffeine intake estimates based on dietary surveys or age classes with fewer than 60 days of data may not be statistically robust, and were consequently not considered.
“(a): The 95 th percentile estimates based on dietary surveys/age classes with fewer than 60 days of data may not be statistically robust (EFSA, 2011b) and consequently were not considered (-).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites EFSA, 2011b
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe approach of setting a level of no safety concern for habitual caffeine consumption by children and adolescents at 3 mg/kg bw per day is rather conservative in relation to the effects of caffeine on the cardiovascular system, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour support this caffeine intake level of no safety concern.
“The Panel notes that this approach is rather conservative in relation to the effects of caffeine on the CVS, but the limited studies available regarding the longer-term effects of caffeine on anxiety and behaviour in children and adolescents support this caffeine intake level of no safety concern.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe same levels of no concern derived for adults (5.7 mg/kg bw for a 70-kg adult) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine in this age group.
“Therefore, the same levels of no concern derived for adults (i.e.5.7 mg/kg bw for a 70-kg adult) may also apply to children, unless there are data showing a higher sensitivity to the effects of caffeine of this age group (i.e.difference in pharmacodynamics).”
Quote in the paperSubstantial claim- Rests on an assumption: Caffeine clearance in children and adolescents is at least that of adults.
May combine two claims.
Premisenone givenNo health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for habitual caffeine consumption up to 400 mg per day, and no new data have become available on these or other clinical outcomes which could justify modifying these conclusions.
“No health concerns in relation to acute toxicity, bone status, cardiovascular health, cancer risk or male fertility have been raised by other bodies in previous assessments for this level of habitual caffeine consumption and no new data have become available on these or other clinical outcomes which could justify modifying these conclusions.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDaily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw, which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study.
“Daily caffeine intakes by the breastfed infant would not exceed 0.3 mg/kg bw (Hildebrandt and Gundert-Remy, 1983), which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study (Steer et al., 2003).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Hildebrandt and Gundert-Remy, 1983
Not checked in the free run.
- cites Steer et al., 2003 source
Not checked in the free run.
The quote only partly states this claim.
InterpretationreasoningThe use of a conservative caffeine value for chocolate beverages may have led to an overestimation of caffeine intakes in children and toddlers.
“The Panel notes that chocolate beverages were important contributors to total caffeine intakes in this age group in most countries, and that the use of a conservative caffeine value for this food category may have led to an overestimation of caffeine intakes in children.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Caffeine clearance in children and adolescents is at least that of adults.
“considering that caffeine clearance in children and adolescents is at least that of adults”
“As caffeine clearance in children and adolescents is at least that of adults”
“considering that caffeine clearance in children and adolescents is at least that of adults”
“As mentioned above, caffeine clearance in children and adolescents is at least that of adults.”
The paper relies on this without support.
Caffeine is not an essential nutrient.
“However, caffeine is not an essential nutrient, and thus ULs cannot be derived.”
The paper relies on this without support.
No data show a higher sensitivity to the effects of caffeine in children and adolescents (i.e., difference in pharmacodynamics).
“unless there are data showing a higher sensitivity to the effects of caffeine in this age group (i.e.difference in pharmacodynamics).”
The paper relies on this without support.
Cocoa-based beverages might present significant variability in caffeine levels because of the amount and type of cocoa present in different brands.
“Cocoa-based beverages are another food product that might present significant variability in caffeine levels because of the amount and type of cocoa present in the different brands.”
The paper relies on this without support.
Food frequency questionnaires specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods.
“(ii) FFQs specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods;”
The paper relies on this without support.
The dietary surveys included in the EFSA Comprehensive Database provide representative estimates of caffeine intake for the respective populations.
“Daily caffeine intake from all sources could be estimated for adults from 16 Member States.”
The paper relies on this without support.
The EFSA energy drink report data are representative of energy drink consumers in the EU.
“Data were available from 16 Member States (Zucconi et al., 2013).”
The paper relies on this without support.
Caffeine is a non-selective competitive A2A receptor antagonist that counteracts the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.
“Caffeine (like other methylxanthines) is a non-selective competitive A 2A receptor antagonist which counteracts the vasodilator effect of adenosine and other A 2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.”
The paper relies on this without support.
The cardiac hyperaemic response to physical exercise is primarily mediated by endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.
“The cardiac hyperaemic response to physical exercise is primarily mediated by the endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.”
The paper relies on this without support.
p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α1- and β-adrenoreceptors.
“p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α 1 -and β-adrenoreceptors.”
The paper relies on this without support.
Synephrine is more hydrophilic than ephedrine and amphetamines, leading to lower transit across the blood-brain barrier and consequently lower or no central nervous system stimulation.
“In contrast with ephedrine and amphetamines, which have known psychostimulating effects in the CNS, synephrine is more hydrophilic, which leads to a lower transit across the blood-brain barrier and consequently to lower, or no, CNS stimulation.”
The authors state this as an assumption.
The perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.
“under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.”
The paper relies on this without support.
FGR and SGA are associated with increased risk of perinatal morbidity and mortality.
“FGR and SGA are associated with increased risk of perinatal morbidity and mortality.”
The paper relies on this without support.
FGR is correlated with increased risk of metabolic diseases later in life.
“FGR has been found to be correlated with increased risk of metabolic diseases later in life.”
The paper relies on this without support.
Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.
“Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.”
The authors state this as an assumption.
The relationship between caffeine intake during pregnancy and adverse birth weight-related outcomes is causal in the context of this safety assessment.
“the Panel assumes that the relationship is causal in the context of this safety assessment.”
The paper relies on this without support.
The half-life of caffeine in women is mean four hours, range two to eight hours, and the half-life in infants is longer, namely 50-103 hours in neonates with no CYP1A2 activity and about 14 hours at three to four months of age.
“the half-life of caffeine (mean four hours, range two to eight hours) in women and the longer half-life in infants (i.e.50-103 hours in neonates with no CYP1A2 activity, about 14 hours at three to four months of age).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Caffeine stimulates sympathetic nervous system activity and easily crosses the blood-brain barrier with stimulatory effects on the CNS.
“It is consumed from the diet and absorbed into the blood, stimulates the sympathetic nervous system activity, and easily crosses the blood–brain barrier (BBB) with stimulatory effects also on the central nervous system (CNS) [196,200].”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [200]
Section 4.1.1 says caffeine is rapidly absorbed after oral intake and freely crosses the blood–brain barrier; section 4.2 describes its psychomotor stimulant effect in the CNS. Section 4.4.1 lists sympathetic nervous system activation as a possible mechanism of caffeine’s acute cardiovascular effects, but says the contribution of that mechanism is unclear. The citing sentence presents sympathetic stimulation without that qualification. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe European Food Safety Authority concluded that a single dose of 200 mg or less of caffeine, as well as chronic intakes at or below 200 mg, consumed by lactating women pose no safety concerns for breastfed infants.
“the European Food Safety Authority concluded that a single dose of 200 mg or less of caffeine (about two cups) consumed by lactating women, as well as chronic intakes at or below 200 mg, pose no safety concerns for breastfed infants (151).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [151]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
CARE study's energy-drink contribution is reported as both 1% and about 2%
MinorThe CARE study's source breakdown assigns energy drinks 1% of caffeine intake, while the later summary describes their contribution alone as about 2%.
“Hot chocolate, "energy drinks" and alcoholic drinks contributed 2, 1 and < 1 % to caffeine intake, respectively.”
“"Energy drinks" contributed 2 % (alone) (CARE Study Group, 2008) and 7 % (in combination with sugar-containing soft drinks) (Sengpiel et al., 2013) to caffeine intake in the two studies reporting on this source.”
Cites
The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-6-487_2 · Cited by 4,508 · see citing works
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1× · see citing works
“Tolerance in humans develops to some, but not to all, effects of caffeine and the development of tolerance is highly variable among the population (Fredholm et al., 1999).”
BackgroundThe Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
Maclure, M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115853 · Cited by 2,327 · cited 1× · see citing works
“Control information for each case was based on the subject’s past exposure experience, and a self-matched analysis was conducted (Maclure, 1991).”
MethodEffects of caffeine on human health
Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A., & Feeley, M. (2003) · Food Additives and Contaminants · doi:10.1080/0265203021000007840 · Cited by 1,199 · cited 11× · see citing works
“Health Canada considered that the potential for taurine and glucuronolactone to interact with caffeine and the health effects of excessive intake of taurine and glucuronolactone were unknown.”
BackgroundMethodInfluentialUse of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment
Authority, E. F. S. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2097 · Cited by 1,190 · see citing works
Heckman, M. A., Weil, J., & de Mejı́a, E. G. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01561.x · Cited by 1,072 · see citing works
The merck index: An encyclopedia of chemicals, drugs and biologicals
Bennett, G. (1992) · Journal of Hazardous Materials · doi:10.1016/0304-3894(92)87022-8 · Cited by 944 · see citing works
Effects of Caffeine on Plasma Renin Activity, Catecholamines and Blood Pressure
Robertson, D., Frölich, J. C., Carr, R. K., Watson, J. T., Hollifield, J. W., Shand, D. G., & Oates, J. A. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801262980403 · Cited by 757 · cited 1× · see citing works
“Early metabolic studies found that single caffeine doses of 200–250 mg acutely increase plasma renin activity, catecholamine concentrations and blood pressure (BP), and are able to induce cardiac (mostly atrial) arrhythmias in healthy, caffeine-naive subjects (Robertson et al., 1978; Dobmeyer et al., 1983).”
BackgroundSachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751 · cited 2× · see citing works
“A single base change of A to C at position 734 within intron 1 of the CYP1A2 gene decreases inducibility of the enzyme (Sachse et al., 1999; Han et al., 2001).”
BackgroundAssociation of Coffee Drinking with Total and Cause-Specific Mortality
Freedman, N. D., Park, Y., Abnet, C. C., Hollenbeck, A. R., & Sinha, R. R. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112010 · Cited by 597 · see citing works
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 585 · cited 1× · see citing works
“Symptoms such as headache, fatigue, decreased energy and activeness, decreased alertness, drowsiness, decreased contentedness, depressed mood, difficulty concentrating, irritability and being not clear headed are observed 12–24 hours after abstinence and this clinical situation is called caffeine withdrawal syndrome (…”
BackgroundDing, M., Bhupathiraju, S. N., Satija, A., van Dam, R. M., & Hu, F. B. (2014) · Circulation · doi:10.1161/circulationaha.113.005925 · Cited by 565 · see citing works
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3269-3 · Cited by 539 · cited 1× · see citing works
“Its mechanism of action appears to be substantially different from that of “dopaminomimetic” psychostimulants, such as cocaine and amphetamine (Fisone et al., 2004; Ferre, 2008).”
BackgroundDoherty, M., & Smith, P. M. (2005) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2005.00445.x · Cited by 512 · cited 1× · see citing works
“EFSA Journal 2015;13(5):4102 48 mostly cross-over), placebo-controlled intervention studies which examined the effects of caffeine ingestion on ratings of perceived exertion (RPE) during exercise (Doherty and Smith, 2005).”
BackgroundCoffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490 · cited 3× · see citing works
“This polymorphism is also referred to as CYP1A2*1F or -163C>A (AA, AC, CC) genotypes (Cornelis et al., 2006; Djordjevic et al., 2010) or as single nucleotide polymorphism (SNP) “rs762551” registered in the SNP Database of the US National Center for Biotechnology Information (http://www.”
BackgroundTemporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy
Tracy, T. S., Venkataramanan, R., Glover, D. D., & Caritis, S. N. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.030 · Cited by 449 · see citing works
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440 · cited 2× · see citing works
“Prolonged administration of an adenosine A2A receptor antagonist does not induce tolerance to its motor stimulant effect, suggesting that caffeine tolerance may be dependent on blockade of A1, rather than A2A, receptors (Ferre, 2008).”
BackgroundDose‐Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans
Kaplan, G. B., Greenblatt, D. J., Ehrenberg, B. L., Goddard, J. E., Cotreau, M. M., Harmatz, J. S., & Shader, R. I. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04356.x · Cited by 387 · see citing works
The absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378 · cited 1× · see citing works
“In humans, caffeine is rapidly (tmax 30–120 minutes) and completely absorbed after oral intake (Blanchard and Sawers, 1983).”
BackgroundNoordzij, M., Uiterwaal, C. S., Arends, L. R., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166828.94699.1d · Cited by 376 · cited 1× · see citing works
“Three meta-analyses of RCTs (Jee et al., 1999; Noordzij et al., 2005; Steffen et al., 2012) have investigated the effects of caffeine or coffee consumption for ≥ 7 days (after habituation to caffeine takes place) on fasting BP in unselected populations.”
BackgroundClinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
Carrillo, J. A., & Benítez, J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00004 · Cited by 366 · cited 1× · see citing works
“In addition, severe liver disorders (Arnaud, 1993) and some drugs (Carrillo and Benitez, 2000) have been reported to cause a significant inhibition of CYP1A2 activity.”
BackgroundCaffeine disposition after oral doses
Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.132 · Cited by 353 · cited 1× · see citing works
“The kinetics of caffeine have been reported to be linear in doses up to 10 mg/kg bw (Bonati et al., 1982), whereas a later study claimed non-linearity beginning at doses as high as 500 mg, corresponding to about 7.”
BackgroundCoffee, caffeine and blood pressure: a critical review
Nurminen, M.-L., Niittynen, L., Korpela, R., & Vapaatalo, H. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600899 · Cited by 351 · cited 1× · see citing works
“Possible mechanisms for the acute cardiovascular effects of caffeine include antagonistic effects on adenosine receptors, activation of the sympathetic nervous system (release of catecholamines from adrenal medulla), stimulation of the adrenal cortex (release of corticosteroids), renal effects (diuresis, natriuresis,…”
BackgroundMesas, A. E., Leon-Muñoz, L. M., Rodriguez-Artalejo, F., & Lopez-Garcia, E. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.016667 · Cited by 350 · cited 2× · see citing works
“, 2009a, b) and meta-analyses (Mesas et al., 2011) focusing on particular population subgroups with a disease condition or a risk factor for disease will not be considered specifically.”
BackgroundMorning Surge in Blood Pressure and Cardiovascular Risk
Kario, K. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157149 · Cited by 341 · cited 1× · see citing works
“There is marked diurnal variation in the onset time of cardiovascular events, with a peak in the early morning, which parallels the significant diurnal variation in BP observed in hypertensive subjects, with a decrease during sleep and a surge in the morning (Kario, 2010).”
BackgroundAssociation between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334 · see citing works
Coffee, caffeine, and cardiovascular disease in men.
Grobbee, D. E., Rimm, E. B., Giovannucci, E., Colditz, G., Stampfer, M., & Willett, W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231504 · Cited by 322 · see citing works
Heart failure in the general population of men - morbidity, risk factors and prognosis
Wilhelmsen, L., Rosengren, A., Eriksson, H., & Lappas, G. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00801.x · Cited by 315 · see citing works
Genetics of caffeine consumption and responses to caffeine
Yang, A., Palmer, A. A., & de Wit, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1900-1 · Cited by 310 · cited 1× · see citing works
“gov/SNP/) (Yang et al., 2010) with unknown functional relevance concerning caffeine metabolism.”
BackgroundAuthority, E. F. S. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.1970 · Cited by 308 · see citing works
Effects of Energy Drink Ingestion on Alcohol Intoxication
Ferreira, S. E., de Mello, M. T., Pompéia, S., & Formigoni, M. L. O. D. S. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00070.x · Cited by 291 · cited 1× · see citing works
“Seven studies addressing the research question were excluded from the meta-analysis because they did not address subjective intoxication directly (Liguori and Robinson, 2001; Ferreira et al., 2006; Alford et al., 2012) or the publication did not contain sufficient detail to calculate the effect size for pooling in a m…”
BackgroundRétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278 · cited 1× · see citing works
“, 2010) and in the effects of caffeine on sleep (Retey et al., 2007; Byrne et al., 2012).”
BackgroundJee, S. H., He, J., Whelton, P. K., Suh, I., & Klag, M. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.647 · Cited by 276 · cited 2× · see citing works
“Three meta-analyses of RCTs (Jee et al., 1999; Noordzij et al., 2005; Steffen et al., 2012) have investigated the effects of caffeine or coffee consumption for ≥ 7 days (after habituation to caffeine takes place) on fasting BP in unselected populations.”
BackgroundMethodHabitual caffeine intake and the risk of hypertension in women
Winkelmayer, W. C. (2005) · JAMA · doi:10.1001/jama.294.18.2330 · Cited by 274 · see citing works
Caffeine metabolism in the newborn
Aldridge, A., Aranda, J. V., & Neims, A. H. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979254447 · Cited by 268 · see citing works
Ghotbi, R., Christensen, M., Roh, H., Ingelman‐Sundberg, M., Aklillu, E., & Bertilsson, L. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0288-2 · Cited by 265 · cited 1× · see citing works
“CYP1A2 enzyme induction and higher caffeine clearance in smokers have also been reported in other studies (Joeres et al., 1988; Ghotbi et al., 2007).”
ResultGreen and Black Tea Consumption and Risk of Stroke: A Meta-Analysis
Arab, L., Liu, W., & Elashoff, D. (2009) · Stroke · doi:10.1161/strokeaha.108.538470 · Cited by 264 · cited 1× · see citing works
“One meta-analysis (Arab et al., 2009) of prospective cohort studies which assessed the relationship between green and black tea consumption and the risk of stroke and included data from nine individual studies involving 4 378 strokes among 194 965 individuals in total found similar results.”
ResultAndersen, L. F., Jacobs, D. R., Carlsen, M. H., & Blomhoff, R. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.5.1039 · Cited by 262 · see citing works
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252 · cited 1× · see citing works
“Polymorphisms of the adenosine receptor gene ADORA2A have been suggested as the cause of some of the inter-individual variability observed in the anxiogenic response to caffeine (Childs et al., 2008; Rogers et al., 2010) and in the effects of caffeine on sleep (Retey et al.”
BackgroundGathering consumption data on specific consumer groups of energy drinks
Zucconi, S., Volpato, C., Adinolfi, F., Gandini, E., Gentile, E., Loi, A., & Fioriti, L. (2013) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2013.en-394 · Cited by 243 · cited 2× · see citing works
“Data were available from 16 Member States (Zucconi et al., 2013).”
BackgroundMethodRasmussen (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00008 · Cited by 241 · see citing works
Henzlova, M. J., Cerqueira, M. D., Mahmarian, J. J., et al. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.08.011 · Cited by 235 · see citing works
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension
Palatini, P., Ceolotto, G., Ragazzo, F., Dorigatti, F., Saladini, F., Papparella, I., Mos, L., Zanata, G., & Santonastaso, M. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832ba850 · Cited by 230 · cited 1× · see citing works
“A subsequent study by the same authors (Palatini et al., 2009) reported an increased risk of developing sustained hypertension requiring pharmacological treatment with increasing caffeinated coffee consumption in carriers of the slow CC or CA allele (59 %) of the CYP1A2 gene, but not in carriers of the fast AA allele,…”
BackgroundMineharu, Y., Koizumi, A., Wada, Y., Iso, H., Watanabe, Y., Date, C., Yamamoto, A., Kikuchi, S., Inaba, Y., Toyoshima, H., et al. (2009) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2009.097311 · Cited by 230 · see citing works
CARE Study Group (2008) · BMJ · doi:10.1136/bmj.a2332 · Cited by 228 · see citing works
Multiple Effects of Caffeine on Simulated High-Intensity Team-Sport Performance
STUART, G. R., Hopkins, W. G., Cook, C. J., & Cairns, S. P. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000177216.21847.8a · Cited by 220 · cited 1× · see citing works
“These conclusions were supported by the results of a double-blind, cross-over, placebo-controlled intervention study published after the meta-analysis by Doherty and Smith (2005), where nine competitive male rugby players ingested either caffeine (6 mg/kg bw) or placebo (dextrose) 70 minutes before performing a rugby…”
ResultChilds, E., & de Wit, H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0341-3 · Cited by 219 · see citing works
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/76.5.823 · Cited by 218 · see citing works
Coffee Consumption and Coronary Heart Disease in Men and Women: A Prospective Cohort Study
Lopez-Garcia, E., van Dam, R. M., Willett, W. C., Rimm, E. B., Manson, J. E., Stampfer, M. J., Rexrode, K. M., & Hu, F. B. (2006) · Circulation · doi:10.1161/circulationaha.105.598664 · Cited by 215 · see citing works
Rogers, P. J., Hohoff, C., Heatherley, S. V., Mullings, E. L., Maxfield, P. J., Evershed, R. P., Deckert, J., & Nutt, D. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.71 · Cited by 212 · cited 2× · see citing works
“In adults, tolerance to the anxiogenic effect of caffeine develops with frequent consumption, even in genetically susceptible individuals (Rogers et al., 2010).”
BackgroundCaffeine Reduces Low-Frequency Delta Activity in the Human Sleep EEG
Landolt, H. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00079-f · Cited by 198 · cited 5× · see citing works
“4 mg/kg bw per day in a 70-kg adult) have been shown to increase sleep latency and reduce sleep duration when consumed close to bedtime (Landolt et al., 1995), whereas doses < 100 mg do not appear to have such an effect on sleep (Dorfman and Jarvik, 1970).”
BackgroundInfluentialCoffee Consumption and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies
Larsson, S. C., & Orsini, N. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr226 · Cited by 196 · cited 1× · see citing works
“Two meta-analyses of prospective cohort studies have specifically addressed the association between coffee consumption and the risk of stroke (Larsson and Orsini, 2011; Kim et al., 2012).”
BackgroundWoodward, M., & Tunstall-Pedoe, H. (1999) · Journal of Epidemiology and Community Health · doi:10.1136/jech.53.8.481 · Cited by 196 · see citing works
Klatsky, A. L., Armstrong, M. A., & FRIEDMAN, G. D. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90064-b · Cited by 195 · see citing works
Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195 · cited 2× · see citing works
“Caffeine has a plasma half-life of about four hours with range of about two to eight hours (Knutti et al., 1981; Abernethy and Todd, 1985; Abernethy et al., 1985; Balogh et al., 1995).”
BackgroundResultAcute Effect of Caffeine on Arterial Stiffness and Aortic Pressure Waveform
Mahmud, A., & Feely, J. (2001) · Hypertension · doi:10.1161/01.hyp.38.2.227 · Cited by 192 · cited 1× · see citing works
“All studies available in healthy individuals (Mahmud and Feely, 2001; Vlachopoulos et al., 2003, 2006; Hartley et al., 2004; Karatzis et al., 2005; Swampillai et al., 2006) reported a significant adverse effect of caffeine (in supplements, coffee or tea) at doses of 100–250 mg on one or more measures of arterial compl…”
BackgroundSengpiel, V., Elind, E., Bacelis, J., Nilsson, S., Grove, J., Myhre, R., Haugen, M., Meltzer, H. M., Alexander, J., Jacobsson, B., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-42 · Cited by 190 · cited 4× · see citing works
“This conclusion is based on two prospective cohort studies (CARE Study Group, 2008; Sengpiel et al., 2013) showing a dose-dependent positive association between caffeine intakes during pregnancy and the risk of adverse birth weight-related outcomes (i.”
BackgroundInfluentialEffects of Acute Administration of Caffeine on Vascular Function
Umemura, T., Ueda, K., Nishioka, K., Hidaka, T., Takemoto, H., Nakamura, S., Jitsuiki, D., Soga, J., Goto, C., Chayama, K., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.058 · Cited by 189 · cited 1× · see citing works
“Conversely, a significant increase in acetylcholine-mediated, endothelium-dependent forearm blood flow (measured by brachial impedance plethysmography), which was reversible with the infusion of a nitric oxide synthetase inhibitor, was reported for a caffeine dose of 300 mg, which also induced a significant increase i…”
BackgroundCaffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders
Pollak, C. P., & Bright, D. (2003) · PEDIATRICS · doi:10.1542/peds.111.1.42 · Cited by 188 · cited 2× · see citing works
“The NNT noted that the only study which assessed the relationship between habitual caffeine consumption and sleep patterns in adolescents (Pollak and Bright, 2003) did not allow conclusions to be drawn on a causal effect of caffeine on disturbed sleep (i.e. it was an observational study and reverse…”
BackgroundWu, J.-N., Ho, S. C., Zhou, C., Ling, W.-H., Chen, W.-Q., Wang, C.-L., & Chen, Y.-M. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.06.051 · Cited by 185 · cited 1× · see citing works
“Two meta-analyses of prospective cohort studies have specifically addressed the association between coffee consumption and CHD risk (Sofi et al., 2007; Wu et al., 2009).”
BackgroundHabitual Coffee Consumption and Risk of Heart Failure: A Dose-Response Meta-Analysis
Mostofsky, E., Rice, M. S., Levitan, E. B., & Mittleman, M. A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.967299 · Cited by 185 · cited 1× · see citing works
“A systematic review and a dose–response meta-analysis of prospective studies assessed the relationship between habitual caffeinated coffee consumption and the risk of heart failure (Mostofsky et al., 2012).”
BackgroundAn alcohol model of impaired inhibitory control and its treatment in humans.
Fillmore, M. T., & Vogel-Sprott, M. D. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.1.49 · Cited by 184 · see citing works
Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors
Wilhelmsen, L., Rosengren, A., & Lappas, G. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00902.x · Cited by 184 · see citing works
Coffee consumption and the incidence of coronary heart disease.
LaCroix, A. Z., Mead, L. A., Liang, K.-Y., Thomas, C. B., & Pearson, T. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151601 · Cited by 183 · see citing works
Tantcheva‐Poór, I., Zaigler, M., Rietbrock, S., & Fuhr, U. (1999) · PubMed · Cited by 180 · see citing works
Detrimental effects of energy drink consumption on platelet and endothelial function
Worthley, M. I., Prabhu, A., De Sciscio, P., Schultz, C., Sanders, P., & Willoughby, S. R. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.09.013 · Cited by 179 · cited 13× · see citing works
“In 2009, the Panel on Food Additives and Nutrient Sources Added to Food (ANS Panel) concluded that exposure to taurine and D-glucurono-γ-lactone at levels commonly used in “energy drinks” was not of safety concern, even for consumers of high levels (EFSA (European Food Safety Authority), EFSA Journal 2015;13(5):4102 1…”
BackgroundInfluentialThe disposition of caffeine during and after pregnancy.
Aldridge, A., Bailey, J. R., & Neims, A. H. (1981) · PubMed · Cited by 178 · see citing works
Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk
Anderson, T. J. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70990-4 · Cited by 178 · cited 1× · see citing works
“The clinical relevance of acute changes in endothelial function and arterial compliance following an intervention is unclear, particularly when simultaneous changes in BP occur (Anderson, 2006; McCall et al., 2011).”
BackgroundCoffee Consumption and the Risk of Coronary Heart Disease and Death
Kleemola, P., Jousilahti, P., Pietinen, P., Vartiainen, E., & Tuomilehto, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3393 · Cited by 177 · see citing works
The effect of caffeine on placental and fetal blood flow in human pregnancy
Kirkinen, P. P., Jouppila, P. I., KOIVULA, A., Vuori, J., & Puukka, M. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90250-8 · Cited by 176 · cited 1× · see citing works
“By increasing the levels of circulating catecholamines, caffeine could induce uteroplacental vasoconstriction and fetal hypoxia (Kirkinen et al., 1983), as well as impair normal cell development by increasing cellular cyclic adenosine monophosphate (Weathersbee and Lodge, 1977).”
BackgroundEffects on blood pressure of drinking green and black tea
Hodgson, J. M., Puddey, I. B., Burke, V., Beilin, L. J., & Jordan, N. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00002 · Cited by 170 · cited 2× · see citing works
“One study not included in the meta-analyses above (Hodgson et al., 1999) assessed the effects of consuming 250 mg of caffeine in hot water, black tea or green tea (five cups per day) for seven days on 24-hour ambulatory SBP and DBP in 13 subjects with high–normal SBP and DBP in a cross-over design.”
BackgroundCardiovascular effects of caffeine in men and women
Hartley, T. R., Lovallo, W. R., & Whitsett, T. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.057 · Cited by 168 · cited 2× · see citing works
“All studies available in healthy individuals (Mahmud and Feely, 2001; Vlachopoulos et al., 2003, 2006; Hartley et al., 2004; Karatzis et al., 2005; Swampillai et al., 2006) reported a significant adverse effect of caffeine (in supplements, coffee or tea) at doses of 100–250 mg on one or more measures of arterial compl…”
BackgroundEffect of pregnancy on the pharmacokinetics of caffeine
Knutti, R., Rothweiler, H., & Schlatter, C. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637512 · Cited by 168 · see citing works
Merten, C., Ferrari, P., Bakker, M. I., Boss, A., Hearty, À. P., Leclercq, C., Lindtner, O., Tlustos, C., Verger, P., Volatier, J., et al. (2011) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2011.576440 · Cited by 167 · cited 1× · see citing works
“It was first created in 2010 (EFSA, 2011a; Huybrechts et al., 2011; Merten et al., 2011) and then updated in 2014 12 .”
BackgroundThe Arrhythmogenic Effects of Caffeine in Human Beings
Dobmeyer, D. J., Stine, R. A., Leier, C. V., Greenberg, R. M., & Schaal, S. F. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304073081405 · Cited by 167 · cited 1× · see citing works
“Early metabolic studies found that single caffeine doses of 200–250 mg acutely increase plasma renin activity, catecholamine concentrations and blood pressure (BP), and are able to induce cardiac (mostly atrial) arrhythmias in healthy, caffeine-naive subjects (Robertson et al., 1978; Dobmeyer et al., 1983).”
BackgroundCoffee Consumption and Risk of Stroke in Women
Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K. M., Logroscino, G., Hu, F. B., & van Dam, R. M. (2009) · Circulation · doi:10.1161/circulationaha.108.826164 · Cited by 167 · see citing works
Zhang, Z., Hu, G., Caballero, B., Appel, L., & Chen, L. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004044 · Cited by 166 · cited 2× · see citing works
“Two systematic reviews and meta-analyses of prospective cohort studies have addressed the association between coffee consumption and the risk of incident hypertension (Zhang et al., 2011; Steffen et al., 2012).”
BackgroundA meta‐analysis of coffee, myocardial infarction, and coronary death
Greenland, S. (1993) · Epidemiology · doi:10.1097/00001648-199307000-00013 · Cited by 163 · cited 1× · see citing works
“Previous meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages (mostly coffee) and the risk of CVD from case–control studies, but not from prospective cohort studies (Greenland, 1993; Kawachi et al., 1994; Sofi et al., 2007).”
Marczinski, C. A., & Fillmore, M. T. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.4.450 · Cited by 162 · see citing works
Marczinski, C., Fillmore, M., Bardgett, M., & Howard, M. A. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01464.x · Cited by 161 · see citing works
Ginsberg, G., Hattis, D. B., Russ, A., & Sonawane, B. R. (2004) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390490273550 · Cited by 161 · cited 1× · see citing works
“The half-life of caffeine in neonates who have no CYP1A2 activity has been reported to range from 50 to 103 hours (Ginsberg et al., 2004; Grosso et al., 2006).”
BackgroundEffect of Coffee on Endothelial Function in Healthy Subjects: The Role of Caffeine
PAPAMICHAEL, C. M., AZNAOURIDIS, K. A., KARATZIS, E. N., KARATZI, K. N., STAMATELOPOULOS, K. S., VAMVAKOU, G., LEKAKIS, J. P., & MAVRIKAKIS, M. E. (2005) · Clinical Science · doi:10.1042/cs20040358 · Cited by 161 · cited 1× · see citing works
“In studies assessing endothelial function, compared with decaffeinated coffee, caffeinated coffee has been reported to significantly increase SBP (130 mg caffeine) and DBP (80 and 130 mg caffeine), as well as to decrease endothelium-dependent flow-mediated dilatation (FMD) in habitual moderate coffee consumers after 1…”
BackgroundHigh dose caffeine citrate for extubation of preterm infants: a randomised controlled trial
Steer, P. A., Flenady, V., Shearman, A., Charles, B. G., Gray, P. H., Henderson-Smart, D., Bury, G., Fraser, S., Hegarty, J., Rogers, Y., et al. (2004) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2002.023432 · Cited by 158 · see citing works
Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women
Tverdal, A., Stensvold, I., Solvoll, K., Foss, O. P., Lund-Larsen, P., & Bjartveit, K. (1990) · BMJ · doi:10.1136/bmj.300.6724.566 · Cited by 157 · see citing works
Kokubo, Y., Iso, H., Saito, I., Yamagishi, K., Yatsuya, H., Ishihara, J., Inoue, M., & Tsugane, S. (2013) · Stroke · doi:10.1161/strokeaha.111.677500 · Cited by 156 · see citing works
Hypertension risk status and effect of caffeine on blood pressure
Hartley, T. R., Sung, B. H., Pincomb, G. A., Whitsett, T. L., Wilson, M. F., & Lovallo, W. R. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.137 · Cited by 156 · cited 1× · see citing works
“The effects of a single dose of caffeine on arterial BP were investigated in 182 men stratified in five groups by their risk of hypertension (Hartley et al., 2000).”
BackgroundCaffeine, Body Fluid-Electrolyte Balance, and Exercise Performance
Armstrong, L. E. (2002) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.12.2.189 · Cited by 153 · cited 1× · see citing works
“Single doses of caffeine of about 100–600 mg consumed prior to exercise, however, did not lead to a significant increase in urinary volume or a significantly different water retention during dehydration, and did not induce adverse water–electrolyte imbalances compared with water or placebo, particularly in habitual ca…”
BackgroundCaffeine dependence in teenagers
Bernstein, G. A., Carroll, M. E., THURAS, P. D., Cosgrove, K., & Roth, M. E. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00181-8 · Cited by 151 · cited 2× · see citing works
“…no observed effect level (NOEL) of 0.3 mg/kg bw (Goldstein and Wallace, 1997) and a lowest observed adverse effect level (LOAEL) of 1.0–1.3 mg/kg bw (Bernstein et al., 2002; Heatherley et al., 2006) were established for tolerance development with withdrawal symptoms, whereas a LOAEL of 2.5 mg/kg…”
BackgroundInfluentialTea and Coffee Consumption and Cardiovascular Morbidity and Mortality
Gans, J. M. D. K., Uiterwaal, C. S. P. M., van der Schouw, Y. T., Boer, J. M. A., Grobbee, D. E., Verschuren, W. M. M., & Beulens, J. W. J. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.201939 · Cited by 150 · see citing works
Coffee consumption and risk of coronary heart disease: a meta‐analysis
Sofi, F., Conti, A. A., Gori, A. M., Eliana Luisi, M. L., Casini, A., Abbate, R., & Gensini, G. F. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.07.013 · Cited by 148 · cited 3× · see citing works
“Two meta-analyses of prospective cohort studies have specifically addressed the association between coffee consumption and CHD risk (Sofi et al., 2007; Wu et al., 2009).”
BackgroundMaturation of caffeine elimination in infancy
Aranda, J. V., Collinge, J. M., Zinman, R., & Watters, G. (1979) · Archives of Disease in Childhood · doi:10.1136/adc.54.12.946 · Cited by 148 · cited 1× · see citing works
“However, the half-life of caffeine is rapidly reduced in the first months of life, decreasing to 14 hours at three to four months of age and to two to three hours at five to six months of age (Aranda et al., 1979).”
BackgroundSequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption
Sulem, P., Gudbjartsson, D. F., Geller, F., Prokopenko, I., Feenstra, B., Aben, K. K. H., Franke, B., den Heijer, M., Kovacs, P. L., Stümvoll, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr086 · Cited by 145 · cited 1× · see citing works
“A meta-analysis of four genome-wide association studies of coffee consumption (in the Netherlands, Germany, US and Iceland) found two sequence variants (one locus between CYP1A1 and CYP1A2 gene and one in the aryl-hydrocarbon receptor (AHR) gene) which were associated with a difference in coffee consumption (Sulem et…”
BackgroundBakker, R., Steegers, E. A., Obradov, A., Raat, H., Hofman, A., & Jaddoe, V. W. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28792 · Cited by 144 · cited 1× · see citing works
“The third study (Bakker et al., 2010) was conducted in 7 346 pregnant women participating in a population-based prospective cohort study from early pregnancy onwards in the Netherlands (2001– 2005).”
BackgroundDoes coffee drinking increase the risk of coronary heart disease? Results from a meta‐analysis
Kawachi, I., Colditz, G. A., & Stone, C. B. (1994) · Heart · doi:10.1136/hrt.72.3.269 · Cited by 144 · cited 2× · see citing works
“Previous meta-analyses have consistently reported positive associations between habitual consumption of caffeine-containing foods and beverages (mostly coffee) and the risk of CVD from case–control studies, but not from prospective cohort studies (Greenland, 1993; Kawachi et al., 1994; Sofi et al., 2007).”
BackgroundResultSteffen, M., Kuhle, C., Hensrud, D., Erwin, P. J., & Murad, M. H. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283588d73 · Cited by 139 · cited 2× · see citing works
“Two systematic reviews and meta-analyses of prospective cohort studies have addressed the association between coffee consumption and the risk of incident hypertension (Zhang et al., 2011; Steffen et al., 2012).”
BackgroundHemodynamic effects of ephedra-free weight-loss supplements in humans
HALLER, C. A., Benowitz, N. L., & Jacob, P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.034 · Cited by 138 · cited 2× · see citing works
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundCaffeine: its direct and indirect influence on reproduction.
Ps, W., & Lodge, J. R. (1977) · PubMed · Cited by 136 · see citing works
Grasser, E. K., Yepuri, G., Dulloo, A. G., & Montani, J. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0661-8 · Cited by 135 · cited 1× · see citing works
“Two randomised cross-over studies (Worthley et al., 2010; Grasser et al., 2014) assessed the effects of two “energy drinks” containing caffeine, taurine and D-glucurono-γ-lactone on BP and endothelial function compared with the same volume of water.”
BackgroundBech, B. H., Obel, C., Henriksen, T. B., & Olsen, J. (2007) · BMJ · doi:10.1136/bmj.39062.520648.be · Cited by 135 · cited 3× · see citing works
“Two Cochrane systematic reviews addressing the effects of maternal caffeine consumption during pregnancy on fetal, neonatal and/or pregnancy outcomes, conducted four years apart (Jahanfar and Sharifah, 2009; Jahanfar and Jaafar, 2013), identified only one human intervention study which addressed this topic (Bech et al…”
BackgroundInfluentialCaffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study
Frost, L., & Vestergaard, P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.578 · Cited by 133 · see citing works
Rieg, T., Steigele, H., Schnermann, J., Richter, K., Osswald, H., & Vallon, V. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080432 · Cited by 133 · cited 1× · see citing works
“The diuretic activity of caffeine can be explained by an interaction with the adenosine receptor A1 in the kidney, leading to inhibition of renal re-absorption and causing diuresis and natriuresis (Rieg et al., 2005).”
BackgroundDietary factors and incident atrial fibrillation: the Framingham Heart Study
Shen, J., Johnson, V. M., SULLIVAN, L. M., Jacques, P. F., Magnani, J. W., Lubitz, S. A., Pandey, S., Levy, D. A., Vasan, R. S., Quatromoni, P. A., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001305 · Cited by 133 · see citing works
An alcohol model of impaired inhibitory control and its treatment in humans.
Fillmore, M. T., & Vogel-Sprott, M. D. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.7.1.49 · Cited by 133 · see citing works
CARE Study Group (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000345709.26015.c0 · Cited by 132 · see citing works
Berthou, F., Flinois, J.-P., Ratanasavanh, D., Beaune, P. H., Riché, C., & Guillouzo, A. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07190-9 · Cited by 127 · cited 1× · see citing works
“Activity of CYP1A2 accounts for about 95 % of caffeine clearance, a smaller proportion is metabolised by CYP3A4, xanthine oxidase and N-acetyltransferase 2 (Berthou et al., 1991; Miners and Birkett, 1996).”
BackgroundCaffeine antagonism of alcohol-induced driving impairment
Liguori, A., & Robinson, J. H. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00196-4 · Cited by 124 · cited 1× · see citing works
“Seven studies addressing the research question were excluded from the meta-analysis because they did not address subjective intoxication directly (Liguori and Robinson, 2001; Ferreira et al., 2006; Alford et al., 2012) or the publication did not contain sufficient detail to calculate the effect size for pooling in a m…”
BackgroundTsutsumi, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116495 · Cited by 124 · cited 1× · see citing works
“Similar quantitative and progressive reductions of CYP1A2 activity during pregnancy have been reported (Tsutsumi et al., 2001).”
BackgroundCoffee and tea consumption and risk of stroke subtypes in male smokers
Larsson, S. C., Männistö, S., Virtanen, M. J., Kontto, J., Albanes, D., & Virtamo, J. (2008) · Stroke · doi:10.1161/strokeaha.107.504183 · Cited by 122 · cited 1× · see citing works
“(2007) described above in relation to CHD risk, two studies investigated the relationship between total caffeine intake from coffee and tea (Larsson et al., 2008), or from coffee, tea, caffeinated soft drinks and chocolate candy (Lopez-Garcia et al.”
BackgroundMarczinski, C. A., Fillmore, M. T., Stamates, A. L., Ramsey, M. A., & Young, C. R. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0026136 · Cited by 122 · see citing works
The use of caffeine as a metabolic probe for human drug metabolizing enzymes
Miners, J. O., & Birkett, D. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02014-4 · Cited by 121 · cited 1× · see citing works
“Activity of CYP1A2 accounts for about 95 % of caffeine clearance, a smaller proportion is metabolised by CYP3A4, xanthine oxidase and N-acetyltransferase 2 (Berthou et al., 1991; Miners and Birkett, 1996).”
BackgroundCoffee Drinking Is Dose-Dependently Related to the Risk of Acute Coronary Events in Middle-Aged Men
Happonen, P., Voutilainen, S., & Salonen, J. T. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2381 · Cited by 120 · see citing works
Huybrechts, I., Sioen, I., Boon, P., Ruprich, J., Lafay, L., Turrini, A., Amiano, P., Hirvonen, T., Neve, M. D., Arcella, D., et al. (2011) · Archives of Public Health · doi:10.1186/0778-7367-69-4 · Cited by 120 · cited 1× · see citing works
“It was first created in 2010 (EFSA, 2011a; Huybrechts et al., 2011; Merten et al., 2011) and then updated in 2014 12 .”
BackgroundCaffeine Affects Cardiovascular and Neuroendocrine Activation at Work and Home
Lane, J. D., Pieper, C. F., Phillips-Bute, B. G., Bryant, J. E., & Kuhn, C. M. (2002) · Psychosomatic Medicine · doi:10.1097/01.psy.0000021946.90613.db · Cited by 118 · cited 3× · see citing works
“Two studies (Lane et al., 2002; Farag et al., 2005b) have investigated the effects of repeated doses of caffeine consumed within a day on 12- to 18-hour ambulatory BP in healthy habitual caffeine consumers (Appendix F).”
BackgroundMethodMarczinski, C. A., Fillmore, M. T., Henges, A. L., Ramsey, M. A., & Young, C. R. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01868.x · Cited by 118 · see citing works
Karatzis, E., Papaioannou, T. G., Aznaouridis, K., Karatzi, K., Stamatelopoulos, K., Zampelas, A., Papamichael, C., Lekakis, J., & Mavrikakis, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.013 · Cited by 116 · cited 1× · see citing works
“All studies available in healthy individuals (Mahmud and Feely, 2001; Vlachopoulos et al., 2003, 2006; Hartley et al., 2004; Karatzis et al., 2005; Swampillai et al., 2006) reported a significant adverse effect of caffeine (in supplements, coffee or tea) at doses of 100–250 mg on one or more measures of arterial compl…”
BackgroundKietzmann, M. (1994) · Toxicon · doi:10.1016/0041-0101(94)90091-4 · Cited by 116 · see citing works
Stohs, S. J., Preuss, H. G., & Shara, M. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4446 · Cited by 115 · cited 1× · see citing works
“aurantium extracts on BP have been investigated in a number of controlled human interventions as safety outcomes, which have been recently reviewed (Stohs et al., 2012).”
BackgroundSeville (sour) Orange Juice: Synephrine Content and Cardiovascular Effects in Normotensive Adults
Penzak, S. R., Jann, M. W., Cold, J. A., Hon, Y. Y., Desai, H. D., & Gurley, B. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012652 · Cited by 114 · cited 4× · see citing works
“On the basis of these and other human intervention studies (Penzak et al., 2001), the Swedish National Food Agency (SLE, 2010) and (ANSES, 2014) concluded that the effects of single-ingredient preparations (p-synephrine) are seen from about 20 mg, that at 50 mg there is a clear effect on heart rate and systolic and di…”
BackgroundMethodInfluentialFluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption
Armstrong, L. E., Pumerantz, A. C., Roti, M. W., Judelson, D. A., Watson, G., Dias, J. C., Sökmen, B., Casa, D. J., Maresh, C. M., Lieberman, H., et al. (2005) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.15.3.252 · Cited by 112 · cited 1× · see citing works
“In addition, doses of caffeine up to 6 mg/kg bw per day consumed for four days by habitual caffeine consumers (one week run-in with doses of 3 mg/kg bw per day) did not lead to significant changes in body mass, urine osmolality, urine specific gravity, urine colour, 24-hour urine volume, 24-hour Na + and K + excretion…”
BackgroundAcute Effects of Coffee on Endothelial Function in Healthy Subjects
Buscemi, S., Verga, S., Batsis, J. A., Donatelli, M., Tranchina, M. R., Belmonte, S., Mattina, A., Re, A., & Cerasola, G. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.9 · Cited by 110 · cited 1× · see citing works
“In studies assessing endothelial function, compared with decaffeinated coffee, caffeinated coffee has been reported to significantly increase SBP (130 mg caffeine) and DBP (80 and 130 mg caffeine), as well as to decrease endothelium-dependent flow-mediated dilatation (FMD) in habitual moderate coffee consumers after 1…”
BackgroundCaldeira, D., Martins, C., Alves, L. B., Pereira, H., Ferreira, J. J., & Costa, J. (2013) · Heart · doi:10.1136/heartjnl-2013-303950 · Cited by 109 · cited 1× · see citing works
“Two systematic reviews and meta-analyses of prospective cohort studies have specifically addressed the association between habitual caffeine consumption and risk of atrial fibrillation (AF) (Caldeira et al., 2013; Cheng et al., 2014).”
BackgroundInduction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
Djordjević, N., Ghotbi, R., Јаnkovic, S., & Aklillu, E. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0823-4 · Cited by 108 · cited 2× · see citing works
“In addition, coffee consumption of more than two cups per day was significantly associated with higher CYP1A2 activity in non-smoking Swedes and Serbs, but only in the CYP1A2 -163AA genotype (Djordjevic et al., 2010).”
BackgroundDiuretic potential of energy drinks
Riesenhuber, A., Boehm, M., Posch, M., & Aufricht, C. (2006) · Amino Acids · doi:10.1007/s00726-006-0363-5 · Cited by 108 · cited 4× · see citing works
“EFSA Journal 2015;13(5):4102 46 In a human intervention study (Riesenhuber et al., 2006), 12 participants received, in a random order, each of four different test drinks at weekly intervals in a blinded fashion (750 mL of each fluid) containing: (i) 80 mg caffeine and 1 g taurine per 250 mL, (ii) 80 mg caffeine per 25…”
BackgroundMethodInfluentialCaffeine effects on learning, performance, and anxiety in normal school‐age children
BERNSTEIN, G. A., CARROLL, M. E., CROSBY, R. D., PERWIEN, A. R., GO, F. S., & BENOWITZ, N. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00016 · Cited by 108 · cited 12× · see citing works
“…reporting on intervention studies (Elkins et al., 1981; Rapoport et al., 1981a, 1984; Baer, 1987; Zahn and Rapoport, 1987; Leviton, 1992; Bernstein et al., 1994; Stein et al., 1996) conducted in pre-school and school children with caffeine doses up to 10 mg/kg bw (3, 5 or 10 mg/kg bw),…”
BackgroundMethodInfluentialFloegel, A., Pischon, T., Bergmann, M. M., Teucher, B., Kaaks, R., & Boeing, H. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023648 · Cited by 107 · see citing works
Bidel, S., Hu, G., Qiao, Q., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2006) · Diabetologia · doi:10.1007/s00125-006-0435-9 · Cited by 107 · see citing works
Caffeine consumption and incident atrial fibrillation in women
Conen, D., Chiuve, S. E., Everett, B. M., Zhang, S. M., Buring, J. E., & Albert, C. M. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29627 · Cited by 107 · see citing works
Cheng, M., Hu, Z., Lu, X., Huang, J., & Gu, D. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.12.026 · Cited by 106 · cited 2× · see citing works
“Two systematic reviews and meta-analyses of prospective cohort studies have specifically addressed the association between habitual caffeine consumption and risk of atrial fibrillation (AF) (Caldeira et al., 2013; Cheng et al., 2014).”
BackgroundThe effect of pregnancy on the pharmacokinetics of caffeine
Knutti, R., Rothweiler, H., & Schlatter, C. (1982) · Archives of Toxicology · doi:10.1007/978-3-642-68511-8_33 · Cited by 106 · see citing works
Transient Exposure to Coffee as a Trigger of a First Nonfatal Myocardial Infarction
Baylin, A., Hernandez-Diaz, S., Kabagambe, E. K., Siles, X., & Campos, H. (2006) · Epidemiology · doi:10.1097/01.ede.0000229444.55718.96 · Cited by 104 · cited 1× · see citing works
“In one study (Baylin et al., 2006), 530 first incident cases of non-fatal MI between 1994 and 1998 were recruited in Costa Rica.”
BackgroundSugiyama, K., Kuriyama, S., Akhter, M., Kakizaki, M., Nakaya, N., Ohmori‐Matsuda, K., Shimazu, T., Nagai, M., Sugawara, Y., Hozawa, A., et al. (2010) · Journal of Nutrition · doi:10.3945/jn.109.109314 · Cited by 104 · see citing works
Heart Rate as an Independent Risk Factor for Cardiovascular Disease
Palatini, P. (2007) · Drugs · doi:10.2165/00003495-200767002-00002 · Cited by 99 · cited 1× · see citing works
“Two studies used drug-treated hypertension as the outcome: one recruited only untreated hypertensive individuals at baseline (Palatini, 2007) and the second recruited both normotensive individuals and untreated hypertensive individuals (Hu et al.”
ResultPharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects.
Shi, J., Benowitz, N. L., Denaro, C. P., & Sheiner, L. B. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.3 · Cited by 99 · cited 1× · see citing works
“Fast tolerance development has been observed concerning the pressor effects of caffeine (Shi et al., 1993).”
BackgroundAcute effects of caffeine in normal prepubertal boys
(1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.2.178 · Cited by 98 · cited 5× · see citing works
“EFSA Journal 2015;13(5):4102 47 Of the studies mentioned above, only two (three publications) have assesed the effects of single doses of caffeine in healthy children (Elkins et al., 1981; Rapoport et al., 1981b; Bernstein et al., 1994).”
BackgroundInfluentialRautiainen, S., Levitan, E. B., Orsini, N., Åkesson, A., Morgenstern, R., Mittleman, M. A., & Wolk, A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.03.008 · Cited by 97 · see citing works
Byrne, E. M., Johnson, J., McRae, A. F., Nyholt, D. R., Medland, S. E., Gehrman, P., Heath, A. C., Madden, P. A. F., Montgomery, G. W., Chenevix‐Trench, G., et al. (2012) · SLEEP · doi:10.5665/sleep.1962 · Cited by 96 · cited 1× · see citing works
“, 2010) and in the effects of caffeine on sleep (Retey et al., 2007; Byrne et al., 2012).”
BackgroundBehavioral Effects of Caffeine in Children
Rapoport, J. L. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220063010 · Cited by 95 · cited 1× · see citing works
“For children, the SCF considered seven publications reporting on intervention studies (Elkins et al., 1981; Rapoport et al., 1981a, 1984; Baer, 1987; Zahn and Rapoport, 1987; Leviton, 1992; Bernstein et al., 1994; Stein et al., 1996) conducted in pre-school and school children with caffeine doses…”
BackgroundCOFFEE CONSUMPTION AND MORTALITY IN THE CHICAGO WESTERN ELECTRIC COMPANY STUDY
Legrady, D., Dyer, A. R., Shekelle, R. B., Stamler, J., Liu, K., Paul, O., Lepper, M. H., & Shryock, A. M. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114717 · Cited by 93 · cited 1× · see citing works
“, 1990), five to six cups per day (Stensvold and Tverdal, 1995), and six or more cups per day (LeGrady et al., 1987).”
BackgroundCoffee Consumption and Risk of Stroke in Women
Larsson, S. C., Virtamo, J., & Wolk, A. (2011) · Stroke · doi:10.1161/strokeaha.110.603787 · Cited by 93 · see citing works
Coffee intake and incidence of hypertension
Uiterwaal, C. S., Verschuren, W. M., Bueno-de-Mesquita, H. B., Ocké, M., Geleijnse, J. M., Boshuizen, H. C., Peeters, P. H., Feskens, E. J., & Grobbee, D. E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.718 · Cited by 91 · see citing works
Coffee, Caffeine, and Risk of Hospitalization for Arrhythmias
Klatsky, A. L., Hasan, A. S., Armstrong, M. A., Udaltsova, N. V., & Morton, C. C. (2011) · The Permanente Journal · doi:10.7812/tpp/11-020 · Cited by 90 · see citing works
Han, X., Ouyang, D., Lu, P., Jiang, C.-H., Shu, Y., Chen, X., Tan, Z.-R., & Zhou, H. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00006 · Cited by 89 · cited 2× · see citing works
“A single base change of A to C at position 734 within intron 1 of the CYP1A2 gene decreases inducibility of the enzyme (Sachse et al., 1999; Han et al., 2001).”
BackgroundCOFFEE USE PRIOR TO MYOCARDIAL INFARCTION RESTUDIED: HEAVIER INTAKE MAY INCREASE THE RISK
KLATSKY, A. L., FRIEDMAN, G. D., & ARMSTRONG, M. A. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115684 · Cited by 89 · cited 1× · see citing works
“, 1994), four to six cups per day for non-fatal MI but not for other coronary cases (Klatsky et al., 1990), five to six cups per day (Stensvold and Tverdal, 1995), and six or more cups per day (LeGrady et al.”
BackgroundJoeres, R. P., Klinker, H., Heusler, H., Epping, J., Zilly, W., & Richter, E. (1988) · Hepatology · doi:10.1002/hep.1840080323 · Cited by 88 · cited 1× · see citing works
“CYP1A2 enzyme induction and higher caffeine clearance in smokers have also been reported in other studies (Joeres et al., 1988; Ghotbi et al., 2007).”
ResultBlood Pressure and Heart Rate Effects Following a Single Dose of Bitter Orange
Bui, L. T., Nguyen, D. T., & Ambrose, P. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g488 · Cited by 88 · cited 4× · see citing works
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundInfluentialHowland, J., Rohsenow, D. J., Arnedt, J. T., Bliss, C. A., Hunt, S. K., Calise, T. V., Heeren, T., Winter, M. R., Littlefield, C. A., & Gottlieb, D. J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03219.x · Cited by 88 · see citing works
Exploring the benefits and challenges of establishing a DRI-like process for bioactives
Lupton, J. R., Atkinson, S. A., Chang, N., Fraga, C. G., Levy, J., Messina, M. J., Richardson, D. P., van Ommen, B., Yang, Y., Griffiths, J. C., et al. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0666-3 · Cited by 87 · see citing works
Robertson, D., Hollister, A. S., Kincaid, D., Workman, R. J., Goldberg, M. R., Tung, C., & Smith, B. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90435-2 · Cited by 87 · see citing works
Ammon, H., Bieck, P., Mandalaz, D., & Verspohl, E. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb01553.x · Cited by 86 · see citing works
Caffeine effects on short‐term performance during prolonged exercise in the heat
DEL COSO, J., ESTEVEZ, E., & MORA-RODRIGUEZ, R. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181621336 · Cited by 85 · see citing works
Caffeine reduces myocardial blood flow during exercise
Higgins, J. P., & Babu, K. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.023 · Cited by 85 · cited 1× · see citing works
“A recent narrative review summarises the mechanisms by which caffeine could reduce myocardial blood flow (MBF) during exercise (Higgins and Babu, 2013).”
BackgroundMattioli, A. V., Bonatti, S., ZENNARO, M., & Mattioli, G. (2005) · EP Europace · doi:10.1016/j.eupc.2004.02.006 · Cited by 83 · see citing works
Greenberg, J. A., Dunbar, C. C., Schnoll, R., Kokolis, R., Kokolis, S., & Kassotis, J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.392 · Cited by 83 · see citing works
Effects of Coffee on Ambulatory Blood Pressure in Older Men and Women
Rakic, V., Burke, V., & Beilin, L. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.869 · Cited by 82 · see citing works
Behavioral and Cognitive Effects of Caffeine in Boys and Adult Males
Rapoport, J. L., JENSVOLD, M., Elkins, R., Buchsbaum, M. S., Weingartner, H., LUDLOW, C., Zahn, T. P., Berg, C. J., & NEIMS, A. H. (1981) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198111000-00007 · Cited by 82 · cited 2× · see citing works
“The publications reviewed concerning caffeine intakes in children mostly addressed the effects of caffeine on the central nervous system (CNS), and were those considered by the SCF (1999) together with three additional studies (Rapoport et al., 1981b; Hale et al., 1995; Davis and Osorio, 1998).”
BackgroundEnergy drinks mixed with alcohol: misconceptions, myths, and facts
Verster, J. C., Aufricht, C., & Alford, C. (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s29313 · Cited by 80 · see citing works
No effect of nutritional adenosine receptor antagonists on exercise performance in the heat
Cheuvront, S. N., Ely, B. R., Kenefick, R. W., Michniak-Kohn, B. B., Rood, J. C., & Sawka, M. N. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90812.2008 · Cited by 80 · cited 1× · see citing works
“30 C), but not skin temperature, in 10 healthy men performing 30 minutes of cycle ergometry at 50 % VO2peak followed by a 15-minute performance time trial at 40 C and 20–30 % relative humidity (Cheuvront et al., 2009).”
MethodBehavioral and Cognitive Effects of Methylxanthines
Stein, M. A. (1996) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1996.02170280054010 · Cited by 79 · cited 3× · see citing works
“, 1995; Davis and Osorio, 1998) and a systematic review and meta-analysis of human studies (Stein et al., 1996) which investigated the effects of caffeine on behaviour in children and adolescents have already been considered by other assessment bodies.”
BackgroundEffect of Caffeine on Aortic Elastic Properties and Wave Reflection
Vlachopoulos, C., Hirata, K., & O'Rourke, M. F. (2003) · Journal of Hypertension · doi:10.1097/00004872-200303000-00022 · Cited by 79 · see citing works
Dissociative antagonistic effects of caffeine on alcohol-induced impairment of behavioral control.
Marczinski, C. A., & Fillmore, M. T. (2003) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.11.3.228 · Cited by 78 · see citing works
The impact of alcohol and energy drink consumption on intoxication and risk-taking behavior
Peacock, A., Bruno, R., Martin, F. H., & Carr, A. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12086 · Cited by 78 · cited 1× · see citing works
“Another systematic review (Peacock et al., 2013) restricted the question to the consumption of alcohol together with “energy drinks” (rather than with caffeine from any source) and addressed a wide variety of (physiological and psychological) outcomes, mostly using cross-sectional studies.”
BackgroundHeinz, A. J., de Wit, H., Lilje, T. C., & Kassel, J. D. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0032337 · Cited by 78 · see citing works
Periextubation caffeine in preterm neonates: a randomized dose response trial
Steer, P., Flenady, V., Shearman, A., Lee, T., Tudehope, D., & Charles, B. (2003) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2003.00207.x · Cited by 77 · cited 1× · see citing works
“3 mg/kg bw (Hildebrandt and Gundert-Remy, 1983), which is 10-fold below the lowest dose of 3 mg/kg bw tested in a dose finding study (Steer et al., 2003).”
BackgroundStohs, S. J., Preuss, H. G., Keith, S. C., Keith, P. L., Miller, H. B., & Kaats, G. R. (2011) · International Journal of Medical Sciences · doi:10.7150/ijms.8.295 · Cited by 77 · cited 4× · see citing works
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundInfluentialZhang, W. L., López‐García, E., Li, T. Y., Hu, F. B., & van Dam, R. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1311-1 · Cited by 76 · see citing works
Coffee and acute ischemic stroke onset: The Stroke Onset Study
Mostofsky, E., Schlaug, G., Mukamal, K. J., Rosamond, W. D., & Mittleman, M. A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb443d · Cited by 75 · see citing works
Psychostimulant and other effects of caffeine in 9- to 11-year-old children
Heatherley, S. V., Hancock, K. M. F., & Rogers, P. J. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01457.x · Cited by 74 · cited 2× · see citing works
“3 mg/kg bw (Bernstein et al., 2002; Heatherley et al., 2006) were established for tolerance development with withdrawal symptoms, whereas a LOAEL of 2.”
BackgroundInfluentialEvaluation of the central effects of alcohol and caffeine interaction.
Azcona, O., Barbanoj, M. J., Torrent, J., & Jané, F. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04562.x · Cited by 74 · cited 1× · see citing works
“, 2012) or the publication did not contain sufficient detail to calculate the effect size for pooling in a meta-analysis (Rush et al., 1989; Azcona et al., 1995; Marczinski and Fillmore, 2003; Attwood et al., 2012).”
BackgroundCaffeine intake during pregnancy, late miscarriage and stillbirth
Greenwood, D. C., Alwan, N., Boylan, S., Cade, J. E., Charvill, J., Chipps, K. C., Cooke, M. S., Dolby, V. A., Hay, A. W. M., Kassam, S., et al. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9443-7 · Cited by 74 · see citing works
Assessing caffeine intake in the United Kingdom diet
Fitt, E., Pell, D., & Cole, D. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.07.092 · Cited by 74 · cited 1× · see citing works
“In order to calculate dietary intakes of caffeine, data from a survey conducted in the UK were used whenever available (Fitt et al., 2013).”
MethodGrosso, L. M., Triche, E. W., Belanger, K. D., Benowitz, N. L., Holford, T. R., & Bracken, M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj125 · Cited by 74 · see citing works
Is Coffee Consumption a Contributor to Cardiovascular Disease?
Wilson, P. W. F. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050125025 · Cited by 71 · see citing works
HALLER, C. A., Duan, M., Jacob, P., & Benowitz, N. L. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03144.x · Cited by 71 · cited 2× · see citing works
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundNo effect of caffeine on exercise performance in high ambient temperature
Roelands, B., Buyse, L., Pauwels, F., Delbeke, F., Deventer, K., & Meeusen, R. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-1945-9 · Cited by 70 · see citing works
Mukamal, K. J., Hallqvist, J., Hammar, N., Ljung, R., Gémes, K., Ahlbom, A., Ahnve, S., & Janszky, I. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.009 · Cited by 69 · cited 1× · see citing works
“Four studies were conducted in Sweden (Wilhelmsen et al., 2001b; Ahmed et al., 2009; Mukamal et al., 2009; Levitan et al., 2011), where a standard cup of coffee is 150 mL, and one was conducted in Finland (Wang et al.”
BackgroundSuperko, H. R., Bortz, W. M., Williams, P., Albers, J., & Wood, P. D. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.599 · Cited by 69 · see citing works
Balogh, A., Henschel, L., Klinger, G., Vollanth, R., B�rner, A., & Kuhnz, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192743 · Cited by 66 · cited 3× · see citing works
“Caffeine has a plasma half-life of about four hours with range of about two to eight hours (Knutti et al., 1981; Abernethy and Todd, 1985; Abernethy et al., 1985; Balogh et al., 1995).”
BackgroundResultKiller, S. C., Blannin, A. K., & Jeukendrup, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084154 · Cited by 65 · cited 1× · see citing works
“, 2013) and 4 mg/kg bw per day of caffeine from coffee were consumed for three consecutive days by habitual coffee consumers (three to six cups of coffee per day) (Killer et al., 2014).”
BackgroundCoffee Consumption and Risk of Cardiovascular Events After Acute Myocardial Infarction
Silletta, M. G., Marfisi, R., Levantesi, G., Boccanelli, A., Chieffo, C., Franzosi, M., Geraci, E., Maggioni, A. P., Nicolosi, G. L., Schweiger, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.712976 · Cited by 65 · see citing works
Effect of decaffeinated versus regular coffee on blood pressure. A 12-week, double-blind trial.
Dusseldorp, M., Smits, P., Thien, T. A., & Katan, M. (1989) · Hypertension · doi:10.1161/01.hyp.14.5.563 · Cited by 63 · see citing works
Franks, A. M., Schmidt, J. M., McCain, K. R., & Fraer, M. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q555 · Cited by 62 · cited 1× · see citing works
“One open-label, randomised, two-period cross-over study investigated the effects of a single dose of an “energy drink” on BP compared with caffeine alone (Franks et al., 2012).”
BackgroundGreenberg, J. A., Chow, G., & Ziegelstein, R. C. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.046 · Cited by 61 · see citing works
Zhang, W., López‐García, E., Li, T. Y., Hu, F. B., & van Dam, R. M. (2009) · Diabetes Care · doi:10.2337/dc08-2251 · Cited by 61 · see citing works
MURRAY, S. S., BJELKE, E., GIBSON, R. W., & SCHUMAN, L. M. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113145 · Cited by 61 · cited 2× · see citing works
“Two studies (Murray et al., 1981; Stensvold and Tverdal, 1995) were not adjusted for any confounding variable.”
BackgroundComparative stimulant and diuretic actions of caffeine and theobromine in man
Dorfman, L. J., & Jarvik, M. E. (1970) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1970116869 · Cited by 61 · cited 3× · see citing works
“The NNT concluded that there were no data to conclude that caffeine would not have the same sleep-depriving effect in children and adolescents as in adults, and that, in adults, doses less than 100 mg, equivalent to 1.4 mg/kg bw, did not seem to have an effect on sleep (Dorfman and Jarvik, 1970).”
BackgroundInfluentialCaffeine decreases exercise-induced myocardial flow reserve
Namdar, M., Koepfli, P., Grathwohl, R., Siegrist, P. T., Klainguti, M., Schepis, T., Delaloye, R., Wyss, C. A., Fleischmann, S. P., Gaemperli, O., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.064 · Cited by 60 · see citing works
The effects of energy drink in combination with alcohol on performance and subjective awareness
Alford, C., Hamilton-Morris, J., & Verster, J. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2677-1 · Cited by 60 · cited 1× · see citing works
“Seven studies addressing the research question were excluded from the meta-analysis because they did not address subjective intoxication directly (Liguori and Robinson, 2001; Ferreira et al., 2006; Alford et al., 2012) or the publication did not contain sufficient detail to calculate the effect size for pooling in a m…”
BackgroundShort-term metabolic and hemodynamic effects of ephedra and guarana combinations
HALLER, C., JACOBIII, P., & BENOWITZ, N. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.023 · Cited by 59 · cited 2× · see citing works
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundCoffee Consumption in Hypertensive Men in Older Middle-Age and the Risk of Stroke
Hakim, A. A., Ross, G. W., Curb, J. D., Rodriguez, B. L., Burchfiel, C. M., Sharp, D. S., Yano, K., & Abbott, R. D. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00023-7 · Cited by 59 · see citing works
Coffee consumption and stroke risk: A meta‐analysis of epidemiologic studies
Kim, B., Nam, Y., Kim, J., Choi, H., & Won, C. (2012) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2012.33.6.356 · Cited by 56 · see citing works
Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women
Hu, G., Jousilahti, P., Nissinen, A. M., Bidel, S., Antikaínen, R., & Tuomilehto, J. O. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.457 · Cited by 55 · cited 3× · see citing works
“Two studies used drug-treated hypertension as the outcome: one recruited only untreated hypertensive individuals at baseline (Palatini, 2007) and the second recruited both normotensive individuals and untreated hypertensive individuals (Hu et al., 2007).”
BackgroundResultInfluentialWatson, J. M., Jenkins, E. J., Hamilton, P., Lunt, M. J., & Kerr, D. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.455 · Cited by 55 · see citing works
Does caffeine counteract alcohol-induced impairment? The ironic effects of expectancy.
Fillmore, M. T., Roach, E. L., & Rice, J. T. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.745 · Cited by 55 · see citing works
Leurs, L. J., Schouten, L. J., Goldbohm, R. A., & van den Brandt, P. A. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001923 · Cited by 55 · see citing works
Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population
Happonen, P., Läärä, E., Hiltunen, L. A., & Luukinen, H. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507871650 · Cited by 55 · see citing works
Increase in the Thermic Effect of Food in Women by Adrenergic Amines Extracted from Citrus Aurantium
Gougeon, R., Harrigan, K., Tremblay, J., Hedrei, P., Lamarche, M., & Morais, J. A. (2005) · Obesity Research · doi:10.1038/oby.2005.141 · Cited by 55 · cited 1× · see citing works
“, 2006) or an unclear study design (Gougeon et al., 2005) will not be considered.”
BackgroundROSENGREN, A., & WILHELMSEN, L. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00407.x · Cited by 54 · see citing works
Rietveld, E. C., Broekman, M. M. M., Houben, J. J. G., Eskes, T. K. A. B., & van Rossum, J. M. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00548769 · Cited by 54 · cited 2× · see citing works
“These results are consistent with earlier studies on the influence of sex steroids on caffeine metabolism (Rietveld et al., 1984; Abernethy and Todd, 1985; Balogh et al., 1995).”
BackgroundResultFiltered coffee raises serum cholesterol: results from a controlled study
Strandhagen, E., & Thelle, D. S. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601668 · Cited by 54 · see citing works
Attwood, A. S., Rogers, P. J., Ataya, A. F., Adams, S. H., & Munafo, M. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2601-0 · Cited by 54 · see citing works
Flagged first, then by citations
13 of the 309 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- EFSA (European Food Safety Authority), 2009, Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) on a request from the European Commission on the use of taurine and D‐glucurono‐γ‐lactone as constituents of the so‐called “energy” drinks, The EFSA Journal, 935, 1
- Evira, 2013, Food supplements containing synephrine and caffeine withdrawn from sale, 15, 22
- Jacobsen, 1986, Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study, Journal of the National Cancer Institute, 76, 823
- Kalman, 2002, A double blind clinical evaluation of the metabolic effects of Xenadrine EFXTM compared to two ephedra‐containing products in normal healthy volunteers. Presented at the annual meeting of the American College of Nutrition, Abstract No. 101, Journal of the American College of Nutrition, 21, 488
- SHC (Superior Health Council), 2012, “The use of caffeine in foodstuffs”, 27
- Zhang, 2009, Coffee consumption and risk of cardiovascular disease and total mortality among women with type 2 diabetes, Circulation, 119, E298
Cited by
Sorted by citations
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632 · see citing works
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557 · see citing works
van Dam, R. M., Hu, F. B., & Willett, W. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1816604 · Cited by 508 · see citing works
Wikoff, D. S., Welsh, B. T., Henderson, R. G., Brorby, G. P., Britt, J. K., Myers, E. F., Goldberger, J. J., Lieberman, H. R., O’Brien, C. P., Peck, J. D., et al. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.04.002 · Cited by 451 · see citing works
Nutrition and Kidney Stone Disease
Siener, R. (2021) · Nutrients · doi:10.3390/nu13061917 · Cited by 369 · see citing works
Caffeine in the Diet: Country-Level Consumption and Guidelines
Reyes, C. M., & Cornelis, M. C. (2018) · Nutrients · doi:10.3390/nu10111772 · Cited by 273 · see citing works
Peacock, A., Hutchinson, D. M., Wilson, J., McCormack, C. A., Bruno, R., Olsson, C. A., ALLSOP, S. J., Elliott, E. J., Burns, L., & Mattick, R. P. (2018) · Nutrients · doi:10.3390/nu10030319 · Cited by 279 · see citing works
Klingel, T., Kremer, J. I., Gottstein, V., Rajcic de Rezende, T., Schwarz, S., & Lachenmeier, D. W. (2020) · Foods · doi:10.3390/foods9050665 · Cited by 264 · see citing works
Caffeine Consumption through Coffee: Content in the Beverage, Metabolism, Health Benefits and Risks
DePaula, J., & Farah, A. (2019) · Beverages · doi:10.3390/beverages5020037 · Cited by 240 · see citing works
Caffeine and cardiovascular health
Turnbull, D., Rodricks, J. V., Mariano, G. F., & Chowdhury, F. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.07.025 · Cited by 216 · see citing works
Validation of Coffee By-Products as Novel Food Ingredients
Iriondo-DeHond, A., Aparicio García, N., Fernandez-Gomez, B., Guisantes-Batan, E., Velázquez Escobar, F., Blanch, G. P., San Andres, M. I., Sanchez-Fortun, S., & del Castillo, M. D. (2019) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2018.06.010 · Cited by 214 · see citing works
Effects of coffee/caffeine on brain health and disease: What should I tell my patients?
Nehlig, A. (2015) · Practical Neurology · doi:10.1136/practneurol-2015-001162 · Cited by 206 · see citing works
The Impact of Coffee on Health
Nieber, K. (2017) · Planta Medica · doi:10.1055/s-0043-115007 · Cited by 203 · see citing works
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188 · see citing works
Caffeine intake and its sources: A review of national representative studies
Verster, J. C., & Koenig, J. S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1247252 · Cited by 189 · see citing works
Coffee consumption and disease correlations
Gökcen, B. B., & Şanlıer, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1369391 · Cited by 188 · see citing works
Consumers’ Perceptions of Coffee Health Benefits and Motives for Coffee Consumption and Purchasing
Samoggia, A., & Riedel, B. (2019) · Nutrients · doi:10.3390/nu11030653 · Cited by 179 · see citing works
Applications of Compounds from Coffee Processing By-Products
Iriondo-DeHond, A., Iriondo-DeHond, M., & del Castillo, M. D. (2020) · Biomolecules · doi:10.3390/biom10091219 · Cited by 167 · see citing works
Female Fertility and the Nutritional Approach: The Most Essential Aspects
Skoracka, K., Ratajczak, A. E., Rychter, A. M., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab068 · Cited by 151 · see citing works
Koletzko, B. V., Cremer, M., Flothkötter, M., Gräf, C., Hauner, H., Hellmers, C., Kersting, M., Krawinkel, M. B., Przyrembel, H., Röbl-Mathieu, M., et al. (2018) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0713-1058 · Cited by 141 · see citing works
Nutritional characterization of carobs and traditional carob products
Papaefstathiou, E., Agapiou, A., Giannopoulos, S., et al. (2018) · Food Science & Nutrition · doi:10.1002/fsn3.776 · Cited by 134 · see citing works
Estimation of caffeine intake from analysis of caffeine metabolites in wastewater
Gracia‐Lor, E., Rousis, N. I., Zuccato, E., Bade, R., Baz‐Lomba, J. A., Castrignanò, E., Causanilles, A., Hernández, F. J., Kasprzyk‐Hordern, B., Kinyua, J., et al. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.07.258 · Cited by 126 · see citing works
Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis
Iriondo-DeHond, A., Uranga, J. A., del Castillo, M. D., & Abalo, R. (2020) · Nutrients · doi:10.3390/nu13010088 · Cited by 126 · see citing works
A Review of Natural Stimulant and Non‐stimulant Thermogenic Agents
Stohs, S. J., & Badmaev, V. (2016) · Phytotherapy Research · doi:10.1002/ptr.5583 · Cited by 122 · see citing works
Toxicity Potential of Nutraceuticals
Gupta, R. C., Srivastava, A., & Lall, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7899-1_18 · Cited by 119 · see citing works
Agudelo-Ochoa, G. M., Pulgarín-Zapata, I. C., Velásquez-Rodriguez, C. M., Duque-Ramı́rez, M., Naranjo-Cano, M., Quintero-Ortiz, M. M., Lara-Guzmán, Ó., & Muñoz-Durango, K. (2016) · Journal of NutriLife · doi:10.3945/jn.115.224774 · Cited by 105 · see citing works
Waugh, D. T., Potter, W. T., Limeback, H., & Godfrey, M. E. R. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13030259 · Cited by 100 · see citing works
Impacts of Caffeine during Pregnancy
Qian, J., Chen, Q., Ward, S. M., Duan, E., & Zhang, Y. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.004 · Cited by 99 · see citing works
“consumption remain below 200–300 mg as a safe dosage for pregnant health [68,69].”
BackgroundEnergy Drinks: A Contemporary Issues Paper
Higgins, J. P., Babu, K. M., Deuster, P. A., & Shearer, J. (2018) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000454 · Cited by 103 · see citing works
Removal of caffeine from wastewater using electrochemical advanced oxidation process: A mini review
Raj, R., Tripathi, A., Das, S., & Ghangrekar, M. M. (2021) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2021.100129 · Cited by 94 · see citing works
Bartella, L., Donna, L. D., Napoli, A., Siciliano, C., Sindona, G., & Mazzotti, F. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.11.072 · Cited by 88 · see citing works
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033243 · Cited by 87 · see citing works
Ehlers, A., Marakis, G. N., Lampen, A., & Hirsch‐Ernst, K. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.05.028 · Cited by 82 · see citing works
Nutritional strategies of high level natural bodybuilders during competition preparation
Chappell, A., Simper, T. N., & Barker, M. E. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0209-z · Cited by 82 · see citing works
Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal Relationship
Kolb, H., Martin, S., & Kempf, K. (2021) · Nutrients · doi:10.3390/nu13041144 · Cited by 86 · see citing works
Derossi, A., Ricci, I., Caporizzi, R., Fiore, A. G., & Severini, C. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8826 · Cited by 72 · see citing works
Gottstein, V., Bernhardt, M., Dilger, E., Keller, J., Breitling-Utzmann, C. M., Schwarz, S., Kuballa, T., Lachenmeier, D. W., & Bunzel, M. (2021) · Foods · doi:10.3390/foods10081705 · Cited by 74 · see citing works
Basrai, M., Schweinlin, A., Menzel, J., Mielke, H., Weikert, C., Dusemund, B., Putze, K., Watzl, B., Lampen, A., & Bischoff, S. C. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxy303 · Cited by 71 · see citing works
Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow
Middleton, A., Reynolds, J., Cable, S., Baltazar, M. T., Li, H., Bevan, S. J., Carmichael, P. L., Dent, M. P., Hatherell, S., Houghton, J., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac068 · Cited by 72 · see citing works
Papadopoulou, E., Botton, J., Brantsæter, A. L., Haugen, M. A., Alexander, J., Meltzer, H. M., Bačelis, J., Elfvin, A., Jacobsson, B., & Sengpiel, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018895 · Cited by 71 · see citing works
Jeszka‐Skowron, M., Frankowski, R., & Zgoła‐Grześkowiak, A. (2020) · LWT · doi:10.1016/j.lwt.2020.109344 · Cited by 69 · see citing works
Samoggia, A., Riedel, B., & Ruggeri, A. (2020) · British Food Journal · doi:10.1108/bfj-03-2019-0172 · Cited by 68 · see citing works
Prevalence of energy drink consumption world‐wide: A systematic review and meta‐analysis
Diego, G. A., Krotter, A., & Pérez, Á. G. (2023) · Addiction · doi:10.1111/add.16390 · Cited by 81 · see citing works
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 71 · see citing works
Riera‐Sampol, A., Cañellas, L. R., Martínez, S. G., Moir, H. J., & Tauler, P. (2022) · Nutrients · doi:10.3390/nu14081661 · Cited by 76 · see citing works
Trends and patterns of caffeine consumption among US teenagers and young adults, NHANES 2003–2012
Tran, N. L., Barraj, L. M., Bi, X., & Jack, M. M. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.007 · Cited by 77 · see citing works
A Critical Review on the Role of Food and Nutrition in the Energy Balance
Bo, S., Fadda, M., Fedele, D., Pellegrini, M., Ghigo, E., & Pellegrini, N. (2020) · Nutrients · doi:10.3390/nu12041161 · Cited by 64 · see citing works
Khouja, C., Kneale, D., Brunton, G., Raine, G., Stansfield, C., Sowden, A. J., Sutcliffe, K., & Thomas, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2020-047746 · Cited by 63 · see citing works
Coffee and caffeine consumption and the risk of hypertension in postmenopausal women
Rhee, J. J., Qin, F., Hedlin, H., Chang, T. I., Bird, C. E., Zaslavsky, O., Manson, J. E., Stefanick, M. L., & Winkelmayer, W. C. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.120147 · Cited by 63 · see citing works
Alcohol mixed with energy drink (AMED): A critical review and meta‐analysis
Verster, J. C., Benson, S., Johnson, S. J., Alford, C., Godefroy, S. B., & Scholey, A. B. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2650 · Cited by 61 · see citing works
Lieberman, H. R., Agarwal, S., & Fulgoni, V. L. I. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.08.152 · Cited by 63 · see citing works
Functional Needs, Emotions, and Perceptions of Coffee Consumers and Non-Consumers
Samoggia, A., Prete, M. D., & Argenti, C. (2020) · Sustainability · doi:10.3390/su12145694 · Cited by 69 · see citing works
Antiaging effects of dietary supplements and natural products
Gao, L., Liu, X., Luo, X., Lou, X., Li, P., Li, X., & Liu, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192714 · Cited by 60 · see citing works
“Although the evidence for the adverse effects of caffeine on fetal health is inconclusive, caution is recommended to limit caffeine intake to 200 mg/day during pregnancy (Tetens, 2015).”
BackgroundOverview of Caffeine Effects on Human Health and Emerging Delivery Strategies
Saraiva, S. M., Jacinto, T. A., Gonçalves, A. C., Gaspar, D., & Silva, L. R. (2023) · Pharmaceuticals · doi:10.3390/ph16081067 · Cited by 77 · see citing works
A Comprehensive Overview of the Risks and Benefits of Coffee Consumption
Pourshahidi, L. K., Navarini, L., Petracco, M., & Strain, J. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12206 · Cited by 62 · see citing works
Neves, D., & Caldas, E. D. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.03.063 · Cited by 59 · see citing works
Lyngsø, J., Ramlau‐Hansen, C. H., Bay, B., Ingerslev, H. J., Hulmán, Á., & Kesmodel, U. S. (2017) · Clinical Epidemiology · doi:10.2147/clep.s146496 · Cited by 60 · see citing works
Romualdo, G. R., Bartolomeu, A. R., Vinken, M., Cogliati, B., Moreno, F. S., García, M. Á., & Barbisan, L. F. (2019) · Food Research International · doi:10.1016/j.foodres.2019.05.029 · Cited by 62 · see citing works
Gupta, P., Shah, D., Kumar, P., Bedi, N., Mittal, H. G., Mishra, K., Khalil, S., Elizabeth, K., Dalal, R. M., Harish, R., et al. (2019) · Indian Pediatrics · doi:10.1007/s13312-019-1612-5 · Cited by 59 · see citing works
Doepker, C. L., Franke, K. S., Myers, E. F., Goldberger, J. J., Lieberman, H. R., O’Brien, C. P., Peck, J. D., Tenenbein, M., Weaver, C. M., & Wikoff, D. S. (2018) · Nutrients · doi:10.3390/nu10101536 · Cited by 58 · see citing works
Temporal pattern of eating in night shift workers
Shaw, E., Dorrian, J., Coates, A. M., Leung, G. K. W., Davis, R., Rosbotham, E. J., Warnock, R., Huggins, C. E., & Bonham, M. P. (2019) · Chronobiology International · doi:10.1080/07420528.2019.1660358 · Cited by 59 · see citing works
An Assessment of the Bioactivity of Coffee Silverskin Melanoidins
Tores de la Cruz, S., Iriondo-DeHond, A., Herrera, T., Lopez-Tofiño, Y., Galvez-Robleño, C., Prodanov, M., Velazquez-Escobar, F., Abalo, R., & del Castillo, M. D. (2019) · Foods · doi:10.3390/foods8020068 · Cited by 57 · see citing works
Dörsam, A. F., Preissl, H. T., Micali, N., Lörcher, S. B., Zipfel, S., & Giel, K. E. (2019) · Nutrients · doi:10.3390/nu11040840 · Cited by 55 · see citing works
Ríos, M. B., Iriondo‐DeHond, A., Iriondo-DeHond, M., Herrera, T., Velasco, D., Gómez‐Alonso, S., Callejo, M. J., & del Castillo, M. D. (2020) · Molecules · doi:10.3390/molecules25061358 · Cited by 60 · see citing works
Bury, D., Alexander‐White, C., M.A., H. J. C. I., Cronin, M., Desprez, B., Detroyer, A., Efremenko, A. Y., Firman, J. W., Hack, E., Hewitt, N. J., et al. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104931 · Cited by 56 · see citing works
Selahvarzi, A., Sanjabi, M. R., Ramezan, Y., et al. (2021) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.15726 · Cited by 55 · see citing works
Coffee with High but Not Low Caffeine Content Augments Fluid and Electrolyte Excretion at Rest
Seal, A. D., Bardis, C. N., Gavrieli, A., Grigorakis, P., Adams, J. D., Arnaoutis, G., Yannakoulia, M., & Kavouras, S. A. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00040 · Cited by 55 · see citing works
Yüksel, B., Öncü, T., & Şen, N. (2022) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2022.08.004 · Cited by 54 · see citing works
Guglielmetti, A., Fernández-Gómez, B., Zeppa, G., & del Castillo, M. D. (2019) · Polish Journal of Food and Nutrition Sciences · doi:10.31883/pjfns-2019-0012 · Cited by 55 · see citing works
Temporal patterns of caffeine intake in the United States
Martyn, D. M., Lau, A., Richardson, P., & Roberts, A. S. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.059 · Cited by 51 · see citing works
Dual Sensory Impairment and Cognitive Impairment in the Korean Longitudinal Elderly Cohort
Byeon, G., Oh, G. H., Jhoo, J. H., Jang, J., Bae, J. B., Han, J. W., Kim, T. H., Kwak, K. P., Kim, B., Kim, S. G., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011845 · Cited by 51 · see citing works
Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations
Lorenzo, C. D., Ballerini, G., Barbanti, P., Bernardini, A., D’Arrigo, G., Egeo, G., Frediani, F., Garbo, R., Pierangeli, G., Prudenzano, M. P., et al. (2021) · Nutrients · doi:10.3390/nu13072307 · Cited by 51 · see citing works
Caffeine toxicity in forensic practice: possible effects and under-appreciated sources
Musgrave, I., Farrington, R., Hoban, C. L., & Byard, R. W. (2016) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-016-9786-9 · Cited by 48 · see citing works
Mattioli, A. V., Migaldi, M., & Farinetti, A. (2018) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000626 · Cited by 47 · see citing works
Attinà, A., Leggeri, C., Paroni, R., Pivari, F., Dei Cas, M., Mingione, A., Dri, M., Marchetti, M., & Di Renzo, L. (2021) · Nutrients · doi:10.3390/nu13051570 · Cited by 47 · see citing works
Caffeine and blood pressure: a critical review perspective
Giuseppe, R. D., Napoli, I. D., Granata, F., Mottolese, A., & Cena, H. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422419000015 · Cited by 47 · see citing works
Cantele, C., Rojo-Poveda, O., Bertolino, M., Ghirardello, D., Cardenia, V., Barbosa‐Pereira, L., & Zeppa, G. (2020) · Foods · doi:10.3390/foods9060715 · Cited by 47 · see citing works
“7 mg/kg body weight (bw) per day for a 70 kg adult) does not give rise to safety concerns for healthy adults with the exceptions of pregnant and lactating women, adolescents, and children, for whom the EFSA sets a limit of 200 mg per day (approximately 3 mg/kg bw per day) [38].”
BackgroundMendes, V., Coelho, M., Tomé, Â., Cunha, R., & Manadas, B. (2019) · Molecules · doi:10.3390/molecules24162863 · Cited by 38 · see citing works
Caffeine Intake During Pregnancy and Neonatal Anthropometric Parameters
Wierzejska, R. E., Jarosz, M. J., & Wojda, B. K. (2019) · Nutrients · doi:10.3390/nu11040806 · Cited by 45 · see citing works
Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
Hladun, O., Papaseit, E., Martín, S., Barriocanal, A. M., Poyatos, L., Farré, M., & Pérez‐Mañá, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101532 · Cited by 45 · see citing works
Exposure and perceptions of marketing for caffeinated energy drinks among young Canadians
Hammond, D. G., & Reid, J. L. (2017) · Public Health Nutrition · doi:10.1017/s1368980017002890 · Cited by 44 · see citing works
Reichert, C., Veitz, S., Bühler, M., Gruber, G., Deuring, G., Rehm, S., Rentsch, K., Garbazza, C., Meyer, M., Slawik, H. C., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114283 · Cited by 50 · see citing works
Energy Drinks and Adverse Health Events in Children and Adolescents: A Literature Review
Li, P., Haas, N. A., Dalla‐Pozza, R., Jakob, A., Oberhoffer, F. S., & Mandilaras, G. (2023) · Nutrients · doi:10.3390/nu15112537 · Cited by 51 · see citing works
Sánchez, J. M. (2017) · Foods · doi:10.3390/foods6120109 · Cited by 44 · see citing works
Cañellas, L. R., Riera‐Sampol, A., Aguiló, A., Martínez, S. G., & Tauler, P. (2020) · Nutrients · doi:10.3390/nu12082325 · Cited by 44 · see citing works
Neurobehavioral hazard identification and characterization for caffeine
Turnbull, D., Rodricks, J. V., & Mariano, G. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.12.002 · Cited by 45 · see citing works
Consumption of green coffee and the risk of chronic diseases
Şanlıer, N., Atik, A., & Atik, İ. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1461061 · Cited by 43 · see citing works
Can Nutrition Help in the Treatment of Infertility?
Aoun, A., Khoury, V. E., & Malakieh, R. (2021) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2021.26.2.109 · Cited by 42 · see citing works
Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing
Rajagopal, R., Baltazar, M. T., Carmichael, P. L., Dent, M. P., Head, J., Li, H., Müller, I. I., Reynolds, J., Sadh, K., Simpson, W., et al. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.838466 · Cited by 43 · see citing works
Samoggia, A., & Rezzaghi, T. (2021) · Nutrients · doi:10.3390/nu13020344 · Cited by 43 · see citing works
António, J., Newmire, D. E., Stout, J. R., Antonio, B. B., Gibbons, M., Lowery, L. M., Harper, J., Willoughby, D. S., Evans, C., Anderson, D., et al. (2024) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2024.2323919 · Cited by 48 · see citing works
Sager, M., Schick, P., Merdivan, S., Grimm, M. F., Schneider, F., Kromrey, M., Hasan, M., Oswald, S., Kühn, J., Koziolek, M., et al. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.03.011 · Cited by 41 · see citing works
Gracia‐Lor, E., Rousis, N. I., Zuccato, E., & Castiglioni, S. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141331 · Cited by 40 · see citing works
The human lens: An antioxidant-dependent tissue revealed by the role of caffeine
Ruiß, M., Findl, O., & Kronschläger, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101664 · Cited by 41 · see citing works
Falcão, M. A. P., de Souza, L. S., Dolabella, S. S., Guimarães, A. G., & Walker, C. I. B. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3399-7 · Cited by 39 · see citing works
Analysis of Consumption of Energy Drinks by a Group of Adolescent Athletes
Nowak, D., & Jasionowski, A. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080768 · Cited by 40 · see citing works
Mandilaras, G., Li, P., Dalla‐Pozza, R., Haas, N. A., & Oberhoffer, F. S. (2022) · Cells · doi:10.3390/cells11030498 · Cited by 39 · see citing works
Puupponen, M., Tynjälä, J., Tolvanen, A. J., et al. (2021) · International Journal of Public Health · doi:10.3389/ijph.2021.620268 · Cited by 38 · see citing works
Green coffee: economic relevance and a systematic review of the effects on human health
Bosso, H., Barbalho, S. M., Goulart, R. D. Á., & Otoboni, A. M. M. B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1948817 · Cited by 36 · see citing works
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7085 · Cited by 37 · see citing works
- Authors
- EFSA Panel on Dietetic Products, N. A. A. (.
- Corresponding author
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
- Venue
- EFSA Journal
- Publisher
- Wiley
- Published
- 2015-05
- Volume
- 13
- Issue
- 5
- ISSN
- 1831-4732 (ISSN-L)
- OpenAlex
- W2556574846
- Semantic Scholar
- 93010f7646e6d0cc6fc186329453458c9dd74fb5
- Cited by
- 613
- References
- 309
- Citations by year
- 2026: 65 · 2025: 73 · 2024: 72 · 2023: 56 · 2022: 62 · 2021: 90 · 2020: 45 · 2019: 38 · 2018: 48 · 2017: 38 · 2016: 19 · 2015: 6
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- EFSA Journal (publishedVersion, cc-by-nd)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pharmacology › Coffee research and impacts
- Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
- Physical Sciences › Chemistry › Analytical Chemistry › Dye analysis and toxicity
- Keywords
- caffeine, food safety, dietary intake, energy drinks, p-synephrine, alcohol, physical activity, taurine, pregnancy, lactation, breastfeeding, children and adolescents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review